[{"entities":{"hashtags":[{"start":52,"end":60,"tag":"Iclusig"}],"urls":[{"start":115,"end":137,"url":"http://t.co/721dXyDKXS","expanded_url":"http://bit.ly/1aBZRJ8","display_url":"bit.ly/1aBZRJ8"}],"mentions":{},"annotations":{}},"text":"We recommended changes in use of leukaemia medicine #Iclusig (ponatinib) in order to minimise risk of blood clots: http://t.co/721dXyDKXS","created_at":"2013-11-25T10:56:12.000Z","author_id":"116716199","lang":"en","conversation_id":"404926486777307136","possibly_sensitive":false,"id":"404926486777307136","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":30,"end":45,"tag":"contraceptives"}],"urls":[{"start":74,"end":96,"url":"http://t.co/7tcQRaJck3","expanded_url":"http://bit.ly/17THqeA","display_url":"bit.ly/17THqeA"}],"mentions":{},"annotations":{}},"text":"Benefits of combined hormonal #contraceptives continue to outweigh risks: http://t.co/7tcQRaJck3","created_at":"2013-11-25T10:54:55.000Z","author_id":"116716199","lang":"en","conversation_id":"404926163421630464","possibly_sensitive":false,"id":"404926163421630464","source":"Twitter Web Client","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":74,"end":81,"tag":"safety"},{"start":85,"end":91,"tag":"urine"},{"start":100,"end":110,"tag":"medicines"}],"urls":[{"start":112,"end":134,"url":"http://t.co/Kx59vobu6g","expanded_url":"http://bit.ly/18Wo9cH","display_url":"bit.ly/18Wo9cH"}],"mentions":{},"annotations":{}},"text":"We're seeking comments on a new draft guideline on the adventitious agent #safety of #urine-derived #medicines: http://t.co/Kx59vobu6g","created_at":"2013-11-25T10:10:24.000Z","author_id":"116716199","lang":"en","conversation_id":"404914962406989824","possibly_sensitive":false,"id":"404914962406989824","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":60,"end":67,"tag":"safety"},{"start":71,"end":77,"tag":"urine"},{"start":86,"end":96,"tag":"medicines"}],"urls":[{"start":115,"end":137,"url":"http://t.co/lkJszDo8z2","expanded_url":"http://bit.ly/18Wo9cH","display_url":"bit.ly/18Wo9cH"}],"mentions":{},"annotations":{}},"text":"We've published a draft guideline on the adventitious agent #safety of #urine-derived #medicines for consultation: http://t.co/lkJszDo8z2","created_at":"2013-11-22T17:01:59.000Z","author_id":"116716199","lang":"en","conversation_id":"403931378368413698","possibly_sensitive":false,"id":"403931378368413698","source":"bitly bitlink","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":116,"end":130,"tag":"immunotherapy"}],"urls":[{"start":93,"end":115,"url":"http://t.co/fPcOyjDgDf","expanded_url":"http://ow.ly/r5Ay0","display_url":"ow.ly/r5Ay0"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"annotations":[{"start":26,"end":39,"probability":0.6249,"type":"Organization","normalized_text":"ESMO Symposium"}]},"text":"RT @myESMO: Webcasts from ESMO Symposium on Immuno-Oncology 2013 now available (free access) http://t.co/fPcOyjDgDf #immunotherapy","created_at":"2013-11-22T16:59:29.000Z","author_id":"116716199","lang":"en","conversation_id":"403930747444027392","possibly_sensitive":false,"id":"403930747444027392","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"403930277267128320"}]},{"entities":{"hashtags":[{"start":109,"end":113,"tag":"HIV"},{"start":120,"end":125,"tag":"AIDS"}],"urls":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"},{"start":65,"end":78,"username":"ECDC_HIVAIDS","id":"2182569746"}],"annotations":[{"start":41,"end":47,"probability":0.5799,"type":"Product","normalized_text":"Twitter"}]},"text":"RT @ECDC_EU: Our HIV/AIDS team has a new Twitter profile! Follow @ECDC_HIVAIDS to keep informed about ECDC’s #HIV &amp; #AIDS news and activiti…","created_at":"2013-11-22T16:58:37.000Z","author_id":"116716199","lang":"en","conversation_id":"403930530166472704","possibly_sensitive":false,"id":"403930530166472704","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"403915654669283329"}]},{"entities":{"hashtags":[{"start":79,"end":89,"tag":"EFPIAlive"}],"urls":[{"start":55,"end":77,"url":"http://t.co/qgZNjR6yju","expanded_url":"http://bit.ly/1bU707U","display_url":"bit.ly/1bU707U"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"text":"RT @EFPIA: Dec 2 - EFPIA Live Webinar - More Info here http://t.co/qgZNjR6yju  #EFPIAlive","created_at":"2013-11-22T16:58:27.000Z","author_id":"116716199","lang":"da","conversation_id":"403930489175556096","possibly_sensitive":false,"id":"403930489175556096","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"403914134644740096"}]},{"entities":{"hashtags":{},"urls":[{"start":116,"end":138,"url":"http://t.co/9nXfAo6sLJ","expanded_url":"http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON341221","display_url":"mhra.gov.uk/NewsCentre/Pre…"}],"mentions":[{"start":3,"end":13,"username":"MHRApress","id":"330990243"}],"annotations":[{"start":32,"end":56,"probability":0.6506,"type":"Organization","normalized_text":"European Medicines Agency"}]},"text":"RT @MHRApress: MHRA responds to European Medicines Agency review conclusions about combined hormonal contraceptives http://t.co/9nXfAo6sLJ","created_at":"2013-11-22T16:58:08.000Z","author_id":"116716199","lang":"en","conversation_id":"403930406300299264","possibly_sensitive":false,"id":"403930406300299264","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"403912364757499904"}]},{"entities":{"hashtags":[{"start":21,"end":32,"tag":"Parliament"},{"start":42,"end":50,"tag":"Horizon"},{"start":79,"end":88,"tag":"research"}],"urls":[{"start":56,"end":78,"url":"http://t.co/AxT4dk2LBg","expanded_url":"http://www.biocentury.com/dailynews/politics/2013-11-21/eu-parliament-approves-horizon-2020","display_url":"biocentury.com/dailynews/poli…"}],"mentions":{},"annotations":{}},"text":"RT @sailinsomnia: EU #Parliament approves #Horizon 2020 http://t.co/AxT4dk2LBg #research","created_at":"2013-11-22T16:57:07.000Z","author_id":"116716199","lang":"en","conversation_id":"403930152809144320","possibly_sensitive":false,"id":"403930152809144320","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"403910030497300481"}]},{"entities":{"hashtags":[{"start":117,"end":125,"tag":"CDCchat"}],"urls":{},"mentions":[{"start":3,"end":10,"username":"CDCgov","id":"146569971"}],"annotations":{}},"text":"RT @CDCgov: Antibiotics are powerful medicines. Keep them working. Get Smart about using antibiotics correctly. Join #CDCchat TODAY at 1PM …","created_at":"2013-11-22T16:56:53.000Z","author_id":"116716199","lang":"en","conversation_id":"403930093719801856","possibly_sensitive":false,"id":"403930093719801856","source":"TweetDeck","public_metrics":{"retweet_count":47,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"403909545098887168"}]},{"entities":{"hashtags":[{"start":18,"end":21,"tag":"UK"}],"urls":[{"start":64,"end":86,"url":"http://t.co/kVwEiXMgyf","expanded_url":"http://www.pharmatimes.com/Article/13-11-22/UPDATED_UK_govt_unveils_rare_diseases_strategy.aspx","display_url":"pharmatimes.com/Article/13-11-…"}],"mentions":{},"annotations":{}},"text":"RT @sailinsomnia: #UK government unveils rare diseases strategy http://t.co/kVwEiXMgyf","created_at":"2013-11-22T16:56:41.000Z","author_id":"116716199","lang":"en","conversation_id":"403930042842886144","possibly_sensitive":false,"id":"403930042842886144","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"403909371584733184"}]},{"entities":{"hashtags":{},"urls":[{"start":69,"end":91,"url":"http://t.co/RbqeRL9gys","expanded_url":"http://bit.ly/I7P52x","display_url":"bit.ly/I7P52x"}],"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"annotations":{}},"text":"RT @FDAanimalhealth: Veterinary Medicine Advisory Committee Disbands http://t.co/RbqeRL9gys","created_at":"2013-11-22T14:44:11.000Z","author_id":"116716199","lang":"en","conversation_id":"403896698415493120","possibly_sensitive":false,"id":"403896698415493120","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"403896526058950656"}]},{"entities":{"hashtags":[{"start":18,"end":29,"tag":"scientific"},{"start":52,"end":60,"tag":"ESCAIDE"}],"urls":[{"start":84,"end":106,"url":"http://t.co/ILVMpMtslO","expanded_url":"http://bit.ly/1aCmSLT","display_url":"bit.ly/1aCmSLT"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"text":"RT @ECDC_EU: More #scientific posters from the 2013 #ESCAIDE conference now online: http://t.co/ILVMpMtslO","created_at":"2013-11-22T14:03:55.000Z","author_id":"116716199","lang":"en","conversation_id":"403886564041691136","possibly_sensitive":false,"id":"403886564041691136","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"403886364896141312"}]},{"entities":{"hashtags":[{"start":35,"end":44,"tag":"Abraxane"},{"start":69,"end":80,"tag":"pancreatic"},{"start":81,"end":88,"tag":"cancer"}],"urls":[{"start":90,"end":112,"url":"http://t.co/PIyas9YtdU","expanded_url":"http://bit.ly/1i1AYfp","display_url":"bit.ly/1i1AYfp"}],"mentions":{},"annotations":{}},"text":"We've recommended extending use of #Abraxane to include treatment of #pancreatic #cancer: http://t.co/PIyas9YtdU","created_at":"2013-11-22T13:54:55.000Z","author_id":"116716199","lang":"en","conversation_id":"403884297956106240","possibly_sensitive":false,"id":"403884297956106240","source":"bitly bitlink","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":34,"end":38,"tag":"HIV"}],"urls":[{"start":49,"end":71,"url":"http://t.co/ukbKnRfoWD","expanded_url":"http://bit.ly/1emapMW","display_url":"bit.ly/1emapMW"}],"mentions":{},"annotations":{}},"text":"We've recommended approval of new #HIV medicine: http://t.co/ukbKnRfoWD","created_at":"2013-11-22T13:53:38.000Z","author_id":"116716199","lang":"en","conversation_id":"403883975011491840","possibly_sensitive":false,"id":"403883975011491840","source":"bitly bitlink","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":48,"end":61,"tag":"tuberculosis"}],"urls":[{"start":63,"end":85,"url":"http://t.co/nCtD4tWcA1","expanded_url":"http://bit.ly/1i1ALJf","display_url":"bit.ly/1i1ALJf"}],"mentions":{},"annotations":{}},"text":"We've recommended two new treatment options for #tuberculosis: http://t.co/nCtD4tWcA1","created_at":"2013-11-22T13:52:44.000Z","author_id":"116716199","lang":"en","conversation_id":"403883748946882560","possibly_sensitive":false,"id":"403883748946882560","source":"bitly bitlink","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":38,"end":50,"tag":"daclatasvir"}],"urls":[{"start":52,"end":74,"url":"http://t.co/3tn1iLL9sg","expanded_url":"http://bit.ly/17yT6q0","display_url":"bit.ly/17yT6q0"}],"mentions":{},"annotations":{}},"text":"We've advised on compassionate use of #daclatasvir: http://t.co/3tn1iLL9sg","created_at":"2013-11-22T13:51:46.000Z","author_id":"116716199","lang":"en","conversation_id":"403883507464040448","possibly_sensitive":false,"id":"403883507464040448","source":"bitly bitlink","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":30,"end":41,"tag":"sofosbuvir"},{"start":71,"end":81,"tag":"hepatitis"}],"urls":[{"start":85,"end":107,"url":"http://t.co/BoT7WvCl4j","expanded_url":"http://bit.ly/1bIip72","display_url":"bit.ly/1bIip72"}],"mentions":{},"annotations":{}},"text":"We've recommended approval of #sofosbuvir for the treatment of chronic #hepatitis C: http://t.co/BoT7WvCl4j","created_at":"2013-11-22T13:50:42.000Z","author_id":"116716199","lang":"en","conversation_id":"403883236558131200","possibly_sensitive":false,"id":"403883236558131200","source":"bitly bitlink","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":4,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":50,"end":72,"url":"http://t.co/GjnqCdtG7k","expanded_url":"http://bit.ly/1fqSKGT","display_url":"bit.ly/1fqSKGT"}],"mentions":{},"annotations":{}},"text":"We've just published the CHMP meeting highlights: http://t.co/GjnqCdtG7k","created_at":"2013-11-22T13:49:23.000Z","author_id":"116716199","lang":"en","conversation_id":"403882908366417920","possibly_sensitive":false,"id":"403882908366417920","source":"bitly bitlink","public_metrics":{"retweet_count":4,"reply_count":2,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"annotations":{}},"text":"RT @myESMO: Cont. of Bevacizumab w/ 2nd-line chemo after std 1st-Line Bevacizumab-cont. therapy in mCRC: value of KRAS status? http://t.co/…","created_at":"2013-11-22T13:25:31.000Z","author_id":"116716199","lang":"en","conversation_id":"403876898968584192","possibly_sensitive":false,"id":"403876898968584192","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"403876682563858432"}]},{"entities":{"hashtags":[{"start":42,"end":54,"tag":"Horizon2020"}],"urls":[{"start":110,"end":132,"url":"http://t.co/4VZcrsFeq7","expanded_url":"http://bit.ly/NAexperts","display_url":"bit.ly/NAexperts"}],"mentions":[{"start":3,"end":12,"username":"EU_H2020","id":"920249612329504768"},{"start":79,"end":93,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"text":"RT @EU_H2020: Could you be one of the new #Horizon2020 independent experts the @EU_Commission is looking for? http://t.co/4VZcrsFeq7","created_at":"2013-11-22T13:20:39.000Z","author_id":"116716199","lang":"en","conversation_id":"403875675536232449","possibly_sensitive":false,"id":"403875675536232449","source":"TweetDeck","public_metrics":{"retweet_count":60,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"403874818266644481"}]},{"entities":{"hashtags":{},"urls":[{"start":113,"end":135,"url":"http://t.co/hXrZfFmn0q","expanded_url":"http://bit.ly/17yLpQN","display_url":"bit.ly/17yLpQN"}],"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"annotations":{}},"text":"RT @AEMPSGOB: Report on the therapeutic positioning of vandetanib (Caprelsa®) in medullary cancer of the thyroid http://t.co/hXrZfFmn0q","created_at":"2013-11-22T13:19:30.000Z","author_id":"116716199","lang":"en","conversation_id":"403875388566159360","possibly_sensitive":false,"id":"403875388566159360","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":79,"end":101,"url":"http://t.co/FdXb1ewRLp","expanded_url":"http://bit.ly/1c9yhS3","display_url":"bit.ly/1c9yhS3"}],"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"annotations":{}},"text":"RT @AEMPSGOB: Report on the therapeutic positioning of vemurafenib (Zelboraf®) http://t.co/FdXb1ewRLp","created_at":"2013-11-22T13:18:42.000Z","author_id":"116716199","lang":"en","conversation_id":"403875186476204032","possibly_sensitive":false,"id":"403875186476204032","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":110,"end":115,"tag":"MHRA"}],"urls":{},"mentions":{},"annotations":{}},"text":"RT @sailinsomnia: Getting new drugs to market safely: exclusive interview with the new chief executive of the #MHRA | PJ Online http://t.co…","created_at":"2013-11-22T12:25:33.000Z","author_id":"116716199","lang":"en","conversation_id":"403861808672292864","possibly_sensitive":false,"id":"403861808672292864","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"403861349085622272"}]},{"entities":{"hashtags":[{"start":18,"end":22,"tag":"FDA"}],"urls":[{"start":68,"end":90,"url":"http://t.co/1wdvIG3R7m","expanded_url":"http://reut.rs/19JDkWh","display_url":"reut.rs/19JDkWh"}],"mentions":[{"start":95,"end":103,"username":"Reuters","id":"1652541"}],"annotations":[{"start":47,"end":61,"probability":0.263,"type":"Place","normalized_text":"Forest, Richter"}]},"text":"RT @sailinsomnia: #FDA declines to approve new Forest, Richter drug http://t.co/1wdvIG3R7m via @reuters","created_at":"2013-11-22T12:25:13.000Z","author_id":"116716199","lang":"en","conversation_id":"403861725042049024","possibly_sensitive":false,"id":"403861725042049024","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"403861268269776896"}]},{"entities":{"hashtags":[{"start":37,"end":54,"tag":"thiocolchicoside"}],"urls":[{"start":78,"end":100,"url":"http://t.co/ob5ucbBrGt","expanded_url":"http://bit.ly/19NKmJm","display_url":"bit.ly/19NKmJm"}],"mentions":{},"annotations":{}},"text":"We've recommended restricting use of #thiocolchicoside by mouth or injection: http://t.co/ob5ucbBrGt","created_at":"2013-11-22T12:22:34.000Z","author_id":"116716199","lang":"en","conversation_id":"403861058798227456","possibly_sensitive":false,"id":"403861058798227456","source":"bitly bitlink","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":55,"end":63,"tag":"Iclusig"}],"urls":[{"start":118,"end":140,"url":"http://t.co/MOD7Hfj3zS","expanded_url":"http://bit.ly/1aBZRJ8","display_url":"bit.ly/1aBZRJ8"}],"mentions":{},"annotations":{}},"text":"We've recommended changes in use of leukaemia medicine #Iclusig (ponatinib) in order to minimise risk of blood clots: http://t.co/MOD7Hfj3zS","created_at":"2013-11-22T12:21:28.000Z","author_id":"116716199","lang":"en","conversation_id":"403860783790301184","possibly_sensitive":false,"id":"403860783790301184","source":"bitly bitlink","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":3,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":30,"end":45,"tag":"contraceptives"}],"urls":[{"start":74,"end":96,"url":"http://t.co/n3K4MBRpnC","expanded_url":"http://bit.ly/17THqeA","display_url":"bit.ly/17THqeA"}],"mentions":{},"annotations":{}},"text":"Benefits of combined hormonal #contraceptives continue to outweigh risks: http://t.co/n3K4MBRpnC","created_at":"2013-11-22T12:20:17.000Z","author_id":"116716199","lang":"en","conversation_id":"403860484606418944","possibly_sensitive":false,"id":"403860484606418944","source":"bitly bitlink","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":32,"end":40,"tag":"vacancy"},{"start":76,"end":90,"tag":"antimicrobial"},{"start":91,"end":102,"tag":"resistance"},{"start":127,"end":139,"tag":"recruitment"}],"urls":[{"start":104,"end":126,"url":"http://t.co/yiOIu2kduF","expanded_url":"http://bit.ly/HG8XKi","display_url":"bit.ly/HG8XKi"}],"mentions":{},"annotations":{}},"text":"Two more weeks to apply for our #vacancy in the secretariat for opinions on #antimicrobial #resistance: http://t.co/yiOIu2kduF #recruitment","created_at":"2013-11-22T12:16:45.000Z","author_id":"116716199","lang":"en","conversation_id":"403859594000084992","possibly_sensitive":false,"id":"403859594000084992","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":28,"end":36,"tag":"vacancy"},{"start":76,"end":90,"tag":"Antimicrobial"},{"start":128,"end":140,"tag":"recruitment"}],"urls":[{"start":104,"end":126,"url":"http://t.co/8cI1saLeFn","expanded_url":"http://bit.ly/19CcFPb","display_url":"bit.ly/19CcFPb"}],"mentions":{},"annotations":{}},"text":"Two more weeks to apply for #vacancy in European Surveillance of Veterinary #Antimicrobial Consumption: http://t.co/8cI1saLeFn  #recruitment","created_at":"2013-11-22T12:16:23.000Z","author_id":"116716199","lang":"en","conversation_id":"403859504791445504","possibly_sensitive":false,"id":"403859504791445504","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":32,"end":40,"tag":"vacancy"},{"start":58,"end":69,"tag":"accountant"},{"start":95,"end":107,"tag":"recruitment"}],"urls":[{"start":71,"end":93,"url":"http://t.co/evNlWFZo96","expanded_url":"http://bit.ly/1gqZB3q","display_url":"bit.ly/1gqZB3q"}],"mentions":{},"annotations":{}},"text":"Two more weeks to apply for our #vacancy for a management #accountant: http://t.co/evNlWFZo96  #recruitment","created_at":"2013-11-22T12:16:07.000Z","author_id":"116716199","lang":"en","conversation_id":"403859437447704578","possibly_sensitive":false,"id":"403859437447704578","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":51,"end":62,"tag":"biosimilar"}],"urls":[{"start":116,"end":138,"url":"http://t.co/dXh6Fp3tLh","expanded_url":"http://bit.ly/I0SUXE","display_url":"bit.ly/I0SUXE"}],"mentions":{},"annotations":{}},"text":"One week left to comment on our draft guideline on #biosimilar medicines containing biotechnology-derived proteins: http://t.co/dXh6Fp3tLh","created_at":"2013-11-22T12:14:29.000Z","author_id":"116716199","lang":"en","conversation_id":"403859025952927745","possibly_sensitive":false,"id":"403859025952927745","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":110,"end":115,"tag":"pain"}],"urls":[{"start":117,"end":139,"url":"http://t.co/Cto5QQSUsx","expanded_url":"http://bit.ly/19yEoMs","display_url":"bit.ly/19yEoMs"}],"mentions":{},"annotations":{}},"text":"One week left to comment on our draft guideline on the clinical development of medicines for the treatment of #pain: http://t.co/Cto5QQSUsx","created_at":"2013-11-22T12:11:26.000Z","author_id":"116716199","lang":"en","conversation_id":"403858256876941313","possibly_sensitive":false,"id":"403858256876941313","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":52,"end":63,"tag":"veterinary"},{"start":85,"end":99,"tag":"antimicrobial"}],"urls":[{"start":112,"end":134,"url":"http://t.co/0TNrxR4BIK","expanded_url":"http://bit.ly/1hRrYJO","display_url":"bit.ly/1hRrYJO"}],"mentions":{},"annotations":{}},"text":"One week left to comment on our draft guideline for #veterinary medicines containing #antimicrobial substances: http://t.co/0TNrxR4BIK","created_at":"2013-11-22T12:10:08.000Z","author_id":"116716199","lang":"en","conversation_id":"403857929205329920","possibly_sensitive":false,"id":"403857929205329920","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":{},"mentions":[{"start":0,"end":9,"username":"DGPreece","id":"440170995"},{"start":10,"end":22,"username":"EPSA_Online","id":"104839524"},{"start":23,"end":35,"username":"emsa_europe","id":"443963165"}],"annotations":{}},"text":"@DGPreece @EPSA_Online @emsa_europe We will welcome all comments and will take all of them into account when finalising the guideline.","created_at":"2013-11-22T09:33:40.000Z","author_id":"116716199","lang":"en","conversation_id":"403813536201068544","possibly_sensitive":false,"id":"403818552433446912","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"403817906263175168"}],"in_reply_to_user_id":"440170995"},{"entities":{"hashtags":[{"start":32,"end":40,"tag":"vacancy"},{"start":76,"end":90,"tag":"antimicrobial"},{"start":91,"end":102,"tag":"resistance"},{"start":127,"end":139,"tag":"recruitment"}],"urls":[{"start":104,"end":126,"url":"http://t.co/EKlnfi2ae7","expanded_url":"http://bit.ly/HG8XKi","display_url":"bit.ly/HG8XKi"}],"mentions":{},"annotations":{}},"text":"Two weeks left to apply for our #vacancy in the secretariat for opinions on #antimicrobial #resistance: http://t.co/EKlnfi2ae7 #recruitment","created_at":"2013-11-22T09:23:33.000Z","author_id":"116716199","lang":"en","conversation_id":"403816007321812992","possibly_sensitive":false,"id":"403816007321812992","source":"bitly bitlink","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":28,"end":36,"tag":"vacancy"},{"start":76,"end":90,"tag":"Antimicrobial"},{"start":127,"end":139,"tag":"recruitment"}],"urls":[{"start":104,"end":126,"url":"http://t.co/aGjkwQSxOe","expanded_url":"http://bit.ly/19CcFPb","display_url":"bit.ly/19CcFPb"}],"mentions":{},"annotations":{}},"text":"Two weeks left to apply for #vacancy in European Surveillance of Veterinary #Antimicrobial Consumption: http://t.co/aGjkwQSxOe #recruitment","created_at":"2013-11-22T09:21:20.000Z","author_id":"116716199","lang":"en","conversation_id":"403815451769454592","possibly_sensitive":false,"id":"403815451769454592","source":"bitly bitlink","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":32,"end":40,"tag":"vacancy"},{"start":58,"end":69,"tag":"accountant"},{"start":94,"end":106,"tag":"recruitment"}],"urls":[{"start":71,"end":93,"url":"http://t.co/X4wHVdGv0k","expanded_url":"http://bit.ly/1gqZB3q","display_url":"bit.ly/1gqZB3q"}],"mentions":{},"annotations":{}},"text":"Two weeks left to apply for our #vacancy for a management #accountant: http://t.co/X4wHVdGv0k #recruitment","created_at":"2013-11-22T09:19:08.000Z","author_id":"116716199","lang":"en","conversation_id":"403814897966153728","possibly_sensitive":false,"id":"403814897966153728","source":"bitly bitlink","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":51,"end":62,"tag":"biosimilar"}],"urls":[{"start":116,"end":138,"url":"http://t.co/dXh6Fp3tLh","expanded_url":"http://bit.ly/I0SUXE","display_url":"bit.ly/I0SUXE"}],"mentions":{},"annotations":{}},"text":"One more week to comment on our draft guideline on #biosimilar medicines containing biotechnology-derived proteins: http://t.co/dXh6Fp3tLh","created_at":"2013-11-22T09:15:47.000Z","author_id":"116716199","lang":"en","conversation_id":"403814051748143104","possibly_sensitive":false,"id":"403814051748143104","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":110,"end":115,"tag":"pain"}],"urls":[{"start":117,"end":139,"url":"http://t.co/Cto5QQSUsx","expanded_url":"http://bit.ly/19yEoMs","display_url":"bit.ly/19yEoMs"}],"mentions":{},"annotations":{}},"text":"One more week to comment on our draft guideline on the clinical development of medicines for the treatment of #pain: http://t.co/Cto5QQSUsx","created_at":"2013-11-22T09:14:32.000Z","author_id":"116716199","lang":"en","conversation_id":"403813738970501120","possibly_sensitive":false,"id":"403813738970501120","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":52,"end":63,"tag":"veterinary"},{"start":85,"end":99,"tag":"antimicrobial"}],"urls":[{"start":112,"end":134,"url":"http://t.co/0TNrxR4BIK","expanded_url":"http://bit.ly/1hRrYJO","display_url":"bit.ly/1hRrYJO"}],"mentions":{},"annotations":{}},"text":"One more week to comment on our draft guideline for #veterinary medicines containing #antimicrobial substances: http://t.co/0TNrxR4BIK","created_at":"2013-11-22T09:13:44.000Z","author_id":"116716199","lang":"en","conversation_id":"403813536201068544","possibly_sensitive":false,"id":"403813536201068544","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":103,"end":125,"url":"http://t.co/tr2sTZW7Ta","expanded_url":"http://bit.ly/1fpTlc1","display_url":"bit.ly/1fpTlc1"}],"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"annotations":[{"start":40,"end":64,"probability":0.4039,"type":"Organization","normalized_text":"European Medicines Agency"}]},"text":"RT @URPLWMiPB: Position of the CHMP the European Medicines Agency on the application of metoclopramide http://t.co/tr2sTZW7Ta","created_at":"2013-11-22T09:11:23.000Z","author_id":"116716199","lang":"en","conversation_id":"403812947039756290","possibly_sensitive":false,"id":"403812947039756290","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":104,"end":126,"url":"http://t.co/YJ0q9ei6h2","expanded_url":"http://bit.ly/1fpT4FZ","display_url":"bit.ly/1fpT4FZ"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":[{"start":41,"end":65,"probability":0.5328,"type":"Organization","normalized_text":"European Medicines Agency"}]},"text":"RT @GCessak: Position of the CHMP of the European Medicines Agency on the application of metoclopramide http://t.co/YJ0q9ei6h2","created_at":"2013-11-22T09:09:56.000Z","author_id":"116716199","lang":"en","conversation_id":"403812580684091392","possibly_sensitive":false,"id":"403812580684091392","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":24,"end":28,"tag":"GMP"},{"start":33,"end":37,"tag":"GDP"}],"urls":[{"start":74,"end":96,"url":"http://t.co/B0GcBQ1SZV","expanded_url":"http://ow.ly/qokII","display_url":"ow.ly/qokII"}],"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"}],"annotations":{}},"text":"RT @MHRAgovuk: 2-4 Dec, #GMP and #GDP Symposium  &gt;&gt; see the agenda: http://t.co/B0GcBQ1SZV","created_at":"2013-11-21T13:53:46.000Z","author_id":"116716199","lang":"en","conversation_id":"403521620351803392","possibly_sensitive":false,"id":"403521620351803392","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"403497024198172672"}]},{"entities":{"hashtags":[{"start":81,"end":96,"tag":"prostatecancer"},{"start":120,"end":127,"tag":"EMUC13"}],"urls":[{"start":97,"end":119,"url":"http://t.co/UVxEBfPgJZ","expanded_url":"http://ow.ly/r2ANF","display_url":"ow.ly/r2ANF"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"annotations":{}},"text":"RT @myESMO: Clinical Predictors of Acute Urinary Symptoms after Radiotherapy for #prostatecancer http://t.co/UVxEBfPgJZ #EMUC13","created_at":"2013-11-21T11:47:18.000Z","author_id":"116716199","lang":"en","conversation_id":"403489797290721281","possibly_sensitive":false,"id":"403489797290721281","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"403469716972662784"}]},{"entities":{"hashtags":{},"urls":[{"start":115,"end":137,"url":"http://t.co/BLDgjIdxLq","expanded_url":"http://bit.ly/16dRdRD","display_url":"bit.ly/16dRdRD"}],"mentions":{},"annotations":{}},"text":"@PinkyG123 CHMP agendas are not currently public, please check MabThera EPAR or subscribe to RSS feed for updates: http://t.co/BLDgjIdxLq","created_at":"2013-11-21T10:03:01.000Z","author_id":"116716199","lang":"en","conversation_id":"403213898121506816","possibly_sensitive":false,"id":"403463552272318464","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"403213898121506816"}],"in_reply_to_user_id":"1506550260"},{"entities":{"hashtags":{},"urls":[{"start":105,"end":128,"url":"https://t.co/nCN7lp67ez","expanded_url":"https://www.gov.uk/government/consultations/proposal-to-allow-wider-access-to-naloxone-for-use-in-emergencies","display_url":"gov.uk/government/con…"}],"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"annotations":{}},"text":"RT @MHRAmedicines: MHRA seeks views on proposal to allow wider access to naloxone for use in emergencies https://t.co/nCN7lp67ez","created_at":"2013-11-20T17:28:31.000Z","author_id":"116716199","lang":"en","conversation_id":"403213276449734656","possibly_sensitive":false,"id":"403213276449734656","source":"TweetDeck","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"403212835770994688"}]},{"entities":{"hashtags":[{"start":92,"end":100,"tag":"CDCchat"}],"urls":{},"mentions":[{"start":3,"end":10,"username":"CDCgov","id":"146569971"},{"start":113,"end":124,"username":"CDC_NCEZID","id":"1262167370"}],"annotations":{}},"text":"RT @CDCgov: Antibiotic resistance—is it caused by me, the bug or the drug?  Find out during #CDCchat w/ us &amp; @CDC_NCEZID 11/22 1-2pm #SaveA…","created_at":"2013-11-20T17:27:51.000Z","author_id":"116716199","lang":"en","conversation_id":"403213111550697472","possibly_sensitive":false,"id":"403213111550697472","source":"TweetDeck","public_metrics":{"retweet_count":22,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"403207763792125953"}]},{"entities":{"hashtags":{},"urls":[{"start":112,"end":134,"url":"http://t.co/nQynwohnW1","expanded_url":"http://bit.ly/1h2QDd3","display_url":"bit.ly/1h2QDd3"}],"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"annotations":{}},"text":"RT @AEMPSGOB: Announcement of the next effective date of suspension of marketing of Pre-Par tablets (ritodrine) http://t.co/nQynwohnW1","created_at":"2013-11-20T16:41:36.000Z","author_id":"116716199","lang":"en","conversation_id":"403201471895707648","possibly_sensitive":false,"id":"403201471895707648","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":110,"end":119,"username":"eurordis","id":"26993786"}],"annotations":[{"start":26,"end":41,"probability":0.6609,"type":"Other","normalized_text":"Rare Disease Day"}]},"text":"RT @EFPIA: 100 Days until Rare Disease Day on Feb.28, 2014 ! Find out more and learn about rare diseases from @eurordis http://t.co/PFeqXwE…","created_at":"2013-11-20T14:47:14.000Z","author_id":"116716199","lang":"en","conversation_id":"403172689465974784","possibly_sensitive":false,"id":"403172689465974784","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"403160936946470912"}]},{"entities":{"hashtags":[{"start":62,"end":69,"tag":"herbal"},{"start":90,"end":95,"tag":"HMPC"}],"urls":[{"start":115,"end":137,"url":"http://t.co/64hFW3vDIB","expanded_url":"http://bit.ly/18nhMmg","display_url":"bit.ly/18nhMmg"}],"mentions":{},"annotations":[{"start":0,"end":11,"probability":0.9893,"type":"Person","normalized_text":"Werner Knöss"},{"start":17,"end":28,"probability":0.9943,"type":"Person","normalized_text":"Marisa Delbò"}]},"text":"Werner Knöss and Marisa Delbò are chair and vice-chair of our #herbal medicine committee (#HMPC) for next 3 years: http://t.co/64hFW3vDIB","created_at":"2013-11-20T12:10:32.000Z","author_id":"116716199","lang":"en","conversation_id":"403133254791741441","possibly_sensitive":false,"id":"403133254791741441","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":103,"end":125,"url":"http://t.co/wLENPxM9sW","expanded_url":"http://bit.ly/1asVK1P","display_url":"bit.ly/1asVK1P"}],"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"annotations":{}},"text":"RT @INFARMED_IP: FARMED - Forum of the medicines regulatory agencies of the Portuguese-speaking region http://t.co/wLENPxM9sW","created_at":"2013-11-20T12:08:14.000Z","author_id":"116716199","lang":"en","conversation_id":"403132674757246976","possibly_sensitive":false,"id":"403132674757246976","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":4,"end":11,"tag":"herbal"},{"start":32,"end":37,"tag":"HMPC"}],"urls":[{"start":118,"end":140,"url":"http://t.co/TTMlSKSoHx","expanded_url":"http://bit.ly/18nhMmg","display_url":"bit.ly/18nhMmg"}],"mentions":{},"annotations":[{"start":51,"end":62,"probability":0.992,"type":"Person","normalized_text":"Werner Knöss"},{"start":68,"end":79,"probability":0.9925,"type":"Person","normalized_text":"Marisa Delbò"}]},"text":"Our #herbal medicine committee (#HMPC) has elected Werner Knöss and Marisa Delbò as chair and vice-chair for 3 years: http://t.co/TTMlSKSoHx","created_at":"2013-11-20T11:18:55.000Z","author_id":"116716199","lang":"en","conversation_id":"403120265775046657","possibly_sensitive":false,"id":"403120265775046657","source":"bitly bitlink","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":108,"end":121,"tag":"WorldCOPDDay"}],"urls":[{"start":122,"end":144,"url":"http://t.co/qiOTr2gV04","expanded_url":"http://pathways.nice.org.uk/pathways/chronic-obstructive-pulmonary-disease","display_url":"pathways.nice.org.uk/pathways/chron…"}],"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"annotations":{}},"text":"RT @NICEcomms: Visit our COPD pathway for info on diagnosis, treatment &amp; management of the condition on #WorldCOPDDay http://t.co/qiOTr2gV04","created_at":"2013-11-20T11:03:41.000Z","author_id":"116716199","lang":"en","conversation_id":"403116430662438912","possibly_sensitive":false,"id":"403116430662438912","source":"TweetDeck","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"403114031814152192"}]},{"entities":{"hashtags":{},"urls":[{"start":82,"end":104,"url":"http://t.co/af5AuucTZq","expanded_url":"http://bit.ly/1aOLRHy","display_url":"bit.ly/1aOLRHy"}],"mentions":{},"annotations":[{"start":46,"end":50,"probability":0.4128,"type":"Person","normalized_text":"Roche"}]},"text":"We finalised review of medicines concerned by Roche pharmacovigilance inspection: http://t.co/af5AuucTZq","created_at":"2013-11-20T10:40:59.000Z","author_id":"116716199","lang":"en","conversation_id":"403110718049771521","possibly_sensitive":false,"id":"403110718049771521","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":44,"end":66,"url":"http://t.co/p3nM36s9K4","expanded_url":"http://bit.ly/1aOAM9m","display_url":"bit.ly/1aOAM9m"}],"mentions":[{"start":33,"end":42,"username":"EUnetHTA","id":"56493220"}],"annotations":{}},"text":"We agreed a joint work plan with @EUnetHTA: http://t.co/p3nM36s9K4","created_at":"2013-11-20T10:40:19.000Z","author_id":"116716199","lang":"en","conversation_id":"403110551800127488","possibly_sensitive":false,"id":"403110551800127488","source":"Twitter Web Client","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":88,"end":106,"tag":"pharmacovigilance"}],"urls":{},"mentions":[{"start":3,"end":13,"username":"HAIEurope","id":"3314634701"}],"annotations":[{"start":15,"end":16,"probability":0.5701,"type":"Organization","normalized_text":"EU"}]},"text":"RT @HAIEurope: EU clears Roche in drug safety investigation, but may still be fined for #pharmacovigilance non-compliance http://t.co/7N7iA…","created_at":"2013-11-20T09:41:26.000Z","author_id":"116716199","lang":"en","conversation_id":"403095734708224000","possibly_sensitive":false,"id":"403095734708224000","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"403085541903577088"}]},{"entities":{"hashtags":{},"urls":[{"start":115,"end":137,"url":"http://t.co/af5AuucTZq","expanded_url":"http://bit.ly/1aOLRHy","display_url":"bit.ly/1aOLRHy"}],"mentions":{},"annotations":{}},"text":"We've completed a review of medicines concerned by the Roche pharmacovigilance inspection; no new safety concerns: http://t.co/af5AuucTZq","created_at":"2013-11-19T16:46:53.000Z","author_id":"116716199","lang":"en","conversation_id":"402840412202606592","possibly_sensitive":false,"id":"402840412202606592","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":114,"end":136,"url":"http://t.co/p3nM36s9K4","expanded_url":"http://bit.ly/1aOAM9m","display_url":"bit.ly/1aOAM9m"}],"mentions":[{"start":36,"end":45,"username":"EUnetHTA","id":"56493220"}],"annotations":{}},"text":"We've issued a joint work plan with @EUnetHTA focused on data generation that supports regulators and HTA bodies: http://t.co/p3nM36s9K4","created_at":"2013-11-19T16:41:14.000Z","author_id":"116716199","lang":"en","conversation_id":"402838989666652160","possibly_sensitive":false,"id":"402838989666652160","source":"Twitter Web Client","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":102,"end":109,"tag":"Cancer"}],"urls":[{"start":120,"end":142,"url":"http://t.co/6BOqmnreQf","expanded_url":"http://ow.ly/qYnxk","display_url":"ow.ly/qYnxk"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"},{"start":26,"end":30,"username":"WHO","id":"14499829"},{"start":32,"end":41,"username":"EMA_News","id":"116716199"},{"start":43,"end":52,"username":"EUnetHTA","id":"56493220"}],"annotations":{}},"text":"RT @myESMO: ESMO works w/ @WHO, @EMA_News, @EUnetHTA to assure Patient Access to safe &amp; effective #Cancer medicines http://t.co/6BOqmnreQf","created_at":"2013-11-19T16:30:50.000Z","author_id":"116716199","lang":"en","conversation_id":"402836374857871360","possibly_sensitive":false,"id":"402836374857871360","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402819183878365184"}]},{"entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":11,"username":"IlaeWeb","id":"611701745"}],"annotations":{}},"text":"RT @IlaeWeb: European guideline on reporting: Standardized Computer-based Organized Reporting of EEG: SCORE. Read guidelines: http://t.co/j…","created_at":"2013-11-19T13:47:18.000Z","author_id":"116716199","lang":"en","conversation_id":"402795219898208258","possibly_sensitive":false,"id":"402795219898208258","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402789472309231616"}]},{"entities":{"hashtags":{},"urls":[{"start":85,"end":107,"url":"http://t.co/lFxApHuTwu","expanded_url":"http://bit.ly/1aOLRHy","display_url":"bit.ly/1aOLRHy"}],"mentions":{},"annotations":[{"start":49,"end":53,"probability":0.3924,"type":"Person","normalized_text":"Roche"}]},"text":"We've finalised review of medicines concerned by Roche pharmacovigilance inspection: http://t.co/lFxApHuTwu","created_at":"2013-11-19T12:07:51.000Z","author_id":"116716199","lang":"en","conversation_id":"402770191077371904","possibly_sensitive":false,"id":"402770191077371904","source":"bitly bitlink","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":47,"end":69,"url":"http://t.co/pA9fAlJQTx","expanded_url":"http://bit.ly/1aOAM9m","display_url":"bit.ly/1aOAM9m"}],"mentions":[{"start":36,"end":45,"username":"EUnetHTA","id":"56493220"}],"annotations":{}},"text":"We've agreed a joint work plan with @EUnetHTA: http://t.co/pA9fAlJQTx","created_at":"2013-11-19T10:04:55.000Z","author_id":"116716199","lang":"en","conversation_id":"402739254440513536","possibly_sensitive":false,"id":"402739254440513536","source":"bitly bitlink","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":123,"end":128,"tag":"EAAD"}],"urls":[{"start":100,"end":122,"url":"http://t.co/yRAxVn0PCd","expanded_url":"http://bitly.com/STr7dR","display_url":"bitly.com/STr7dR"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"text":"RT @ECDC_EU: There's always a personal story behind the statistics of multidrug-resistant bacteria: http://t.co/yRAxVn0PCd #EAAD  #antibiot…","created_at":"2013-11-18T17:10:00.000Z","author_id":"116716199","lang":"en","conversation_id":"402483844525199361","possibly_sensitive":false,"id":"402483844525199361","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402483781673959424"}]},{"entities":{"hashtags":[{"start":56,"end":63,"tag":"CHEM21"}],"urls":[{"start":114,"end":136,"url":"http://t.co/Rfo6fXftTC","expanded_url":"http://ow.ly/qWeNe","display_url":"ow.ly/qWeNe"}],"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":[{"start":12,"end":33,"probability":0.891,"type":"Organization","normalized_text":"University of York PhD"}]},"text":"RT @IMI_JU: University of York PhD student talks about  #CHEM21, IMI's project to make drug manufacturing cleaner http://t.co/Rfo6fXftTC @G…","created_at":"2013-11-18T17:01:23.000Z","author_id":"116716199","lang":"en","conversation_id":"402481673977090048","possibly_sensitive":false,"id":"402481673977090048","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402481219725963264"}]},{"entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":13,"username":"TOPRANEWS","id":"26739900"}],"annotations":[{"start":26,"end":46,"probability":0.2843,"type":"Organization","normalized_text":"Regulatory Rapporteur"}]},"text":"RT @TOPRANEWS: December's Regulatory Rapporteur has all the news, ideas and discussions from this year's TOPRA Annual Symposium http://t.co…","created_at":"2013-11-18T16:49:34.000Z","author_id":"116716199","lang":"en","conversation_id":"402478701205405696","possibly_sensitive":false,"id":"402478701205405696","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402478473521790976"}]},{"entities":{"hashtags":{},"urls":[{"start":73,"end":95,"url":"http://t.co/EBxzvkkSYr","expanded_url":"http://tinyurl.com/kw7usgv","display_url":"tinyurl.com/kw7usgv"}],"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"annotations":{}},"text":"RT @MHRAmedicines: Drug Safety Update, November 2013 (Volume 7, Issue 4) http://t.co/EBxzvkkSYr","created_at":"2013-11-18T16:36:49.000Z","author_id":"116716199","lang":"en","conversation_id":"402475491073863681","possibly_sensitive":false,"id":"402475491073863681","source":"TweetDeck","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402475267152556032"}]},{"entities":{"hashtags":[{"start":13,"end":18,"tag":"EAAD"}],"urls":{},"mentions":[{"start":3,"end":11,"username":"EAAD_EU","id":"1725283578"}],"annotations":[{"start":77,"end":82,"probability":0.9826,"type":"Place","normalized_text":"Europe"}]},"text":"RT @EAAD_EU: #EAAD 2013: Rapid expansion of carbapenem-resistant bacteria in Europe. Infographic on carbapenem resistance: http://t.co/0KA0…","created_at":"2013-11-18T16:27:10.000Z","author_id":"116716199","lang":"en","conversation_id":"402473063154855938","possibly_sensitive":false,"id":"402473063154855938","source":"TweetDeck","public_metrics":{"retweet_count":21,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402472930849746944"}]},{"entities":{"hashtags":[{"start":13,"end":18,"tag":"EAAD"}],"urls":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":[{"start":77,"end":82,"probability":0.9826,"type":"Place","normalized_text":"Europe"}]},"text":"RT @ECDC_EU: #EAAD 2013: Rapid expansion of carbapenem-resistant bacteria in Europe. Infographic on carbapenem resistance: http://t.co/34HV…","created_at":"2013-11-18T16:27:06.000Z","author_id":"116716199","lang":"en","conversation_id":"402473045995974656","possibly_sensitive":false,"id":"402473045995974656","source":"TweetDeck","public_metrics":{"retweet_count":46,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402472930719707136"}]},{"entities":{"hashtags":[{"start":9,"end":21,"tag":"Antibiotics"}],"urls":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"text":"RT @WHO: #Antibiotics: medicines used to treat infections caused by bacteria; they do NOT work for illnesses caused by viruses http://t.co/…","created_at":"2013-11-18T16:27:01.000Z","author_id":"116716199","lang":"en","conversation_id":"402473025137696768","possibly_sensitive":false,"id":"402473025137696768","source":"TweetDeck","public_metrics":{"retweet_count":205,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402471639402549249"}]},{"entities":{"hashtags":[{"start":14,"end":26,"tag":"antibiotics"}],"urls":[{"start":107,"end":129,"url":"http://t.co/B6NrAXrcUS","expanded_url":"http://goo.gl/K5rg8C","display_url":"goo.gl/K5rg8C"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"text":"RT @WHO: Take #antibiotics only when prescribed by a doctor for infections caused by bacteria. Infographic http://t.co/B6NrAXrcUS","created_at":"2013-11-18T16:19:54.000Z","author_id":"116716199","lang":"en","conversation_id":"402471235704983552","possibly_sensitive":false,"id":"402471235704983552","source":"TweetDeck","public_metrics":{"retweet_count":151,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402470558484271105"}]},{"entities":{"hashtags":[{"start":125,"end":129,"tag":"AMR"}],"urls":{},"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":[{"start":12,"end":33,"probability":0.5487,"type":"Person","normalized_text":"Commissioner Geoghegan"},{"start":35,"end":39,"probability":0.471,"type":"Person","normalized_text":"Quinn"}]},"text":"RT @IMI_JU: Commissioner Geoghegan-Quinn: in IMI's ND4BB, leading academics, SMEs and pharma companies join forces to tackle #AMR http://t.…","created_at":"2013-11-18T16:19:45.000Z","author_id":"116716199","lang":"en","conversation_id":"402471197822054400","possibly_sensitive":false,"id":"402471197822054400","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402469669359345665"}]},{"entities":{"hashtags":[{"start":19,"end":30,"tag":"antibiotic"}],"urls":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"text":"RT @WHO: Taking an #antibiotic unnecessarily decreases its effectiveness against bacterial infections so it might not work when really need…","created_at":"2013-11-18T16:19:36.000Z","author_id":"116716199","lang":"en","conversation_id":"402471158554959872","possibly_sensitive":false,"id":"402471158554959872","source":"TweetDeck","public_metrics":{"retweet_count":208,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402469319621103616"}]},{"entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"text":"RT @WHO: Do not take antibiotics for illnesses caused by viruses such as colds and influenza. They will not work. Infographic http://t.co/B…","created_at":"2013-11-18T16:19:22.000Z","author_id":"116716199","lang":"en","conversation_id":"402471099071356928","possibly_sensitive":false,"id":"402471099071356928","source":"TweetDeck","public_metrics":{"retweet_count":303,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402468209606942720"}]},{"entities":{"hashtags":[{"start":33,"end":45,"tag":"antibiotics"}],"urls":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"text":"RT @WHO: The number of effective #antibiotics is decreasing as bacteria change to protect themselves against an antibiotic http://t.co/B6Nr…","created_at":"2013-11-18T16:19:11.000Z","author_id":"116716199","lang":"en","conversation_id":"402471054704398336","possibly_sensitive":false,"id":"402471054704398336","source":"TweetDeck","public_metrics":{"retweet_count":120,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402467131104579585"}]},{"entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"text":"RT @WHO: Antibiotics are medicines used to treat infections caused by bacteria such as tuberculosis,  pneumonia. Infographic http://t.co/B6…","created_at":"2013-11-18T16:18:59.000Z","author_id":"116716199","lang":"en","conversation_id":"402471002984046592","possibly_sensitive":false,"id":"402471002984046592","source":"TweetDeck","public_metrics":{"retweet_count":92,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402465909593239554"}]},{"entities":{"hashtags":[{"start":110,"end":125,"tag":"clinicaltrials"},{"start":126,"end":139,"tag":"transparency"}],"urls":[{"start":44,"end":66,"url":"http://t.co/y3eugFaTi5","expanded_url":"http://bit.ly/HUMxo7","display_url":"bit.ly/HUMxo7"}],"mentions":[{"start":3,"end":13,"username":"HAIEurope","id":"3314634701"}],"annotations":[{"start":67,"end":76,"probability":0.5024,"type":"Organization","normalized_text":"EU Council"}]},"text":"RT @HAIEurope: Urgent Call for Transparency:http://t.co/y3eugFaTi5 EU Council must endorse ENVI's position on #clinicaltrials #transparency…","created_at":"2013-11-18T16:17:13.000Z","author_id":"116716199","lang":"en","conversation_id":"402470560656924673","possibly_sensitive":false,"id":"402470560656924673","source":"TweetDeck","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402460468733702144"}]},{"entities":{"hashtags":[{"start":18,"end":22,"tag":"WSJ"},{"start":45,"end":54,"tag":"Patients"},{"start":77,"end":85,"tag":"Disease"}],"urls":[{"start":106,"end":128,"url":"http://t.co/rp69r6qFdq","expanded_url":"http://projects.wsj.com/trials/#chapter=1","display_url":"projects.wsj.com/trials/#chapte…"}],"mentions":{},"annotations":{}},"text":"RT @sailinsomnia: #WSJ's Must-Read Series on #Patients Helping to Bring Rare #Disease Therapies to Market http://t.co/rp69r6qFdq","created_at":"2013-11-18T16:16:37.000Z","author_id":"116716199","lang":"en","conversation_id":"402470409259339776","possibly_sensitive":false,"id":"402470409259339776","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402459497769086976"}]},{"entities":{"hashtags":[{"start":21,"end":33,"tag":"antibiotics"},{"start":122,"end":127,"tag":"EAAD"}],"urls":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"text":"RT @ECDC_EU: Keeping #antibiotics effective is everyone’s responsibility: patients, doctors, parents. Spread the message! #EAAD","created_at":"2013-11-18T16:13:56.000Z","author_id":"116716199","lang":"en","conversation_id":"402469733645041664","possibly_sensitive":false,"id":"402469733645041664","source":"TweetDeck","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402455879767064576"}]},{"entities":{"hashtags":[{"start":21,"end":33,"tag":"antibiotics"},{"start":122,"end":127,"tag":"EAAD"}],"urls":{},"mentions":[{"start":3,"end":11,"username":"EAAD_EU","id":"1725283578"}],"annotations":{}},"text":"RT @EAAD_EU: Keeping #antibiotics effective is everyone’s responsibility: patients, doctors, parents. Spread the message! #EAAD","created_at":"2013-11-18T16:13:53.000Z","author_id":"116716199","lang":"en","conversation_id":"402469721284431872","possibly_sensitive":false,"id":"402469721284431872","source":"TweetDeck","public_metrics":{"retweet_count":17,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402455879611846656"}]},{"entities":{"hashtags":[{"start":84,"end":94,"tag":"superbugs"},{"start":126,"end":131,"tag":"EAAD"}],"urls":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"},{"start":107,"end":116,"username":"EMA_News","id":"116716199"}],"annotations":{}},"text":"RT @ECDC_EU: 25,000 Europeans/year die as direct consequence of multidrug-resistant #superbugs, ECDC &amp; @EMA_News estimate #EAAD http://t.co…","created_at":"2013-11-18T15:10:32.000Z","author_id":"116716199","lang":"en","conversation_id":"402453777354985472","possibly_sensitive":false,"id":"402453777354985472","source":"TweetDeck","public_metrics":{"retweet_count":18,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402453136461557760"}]},{"entities":{"hashtags":[{"start":18,"end":29,"tag":"Regulatory"},{"start":44,"end":48,"tag":"EMA"}],"urls":{},"mentions":{},"annotations":{}},"text":"RT @sailinsomnia: #Regulatory information - #EMA encourages companies to submit quality type-I variations for 2013 by end of November http:…","created_at":"2013-11-18T15:00:43.000Z","author_id":"116716199","lang":"en","conversation_id":"402451305802637312","possibly_sensitive":false,"id":"402451305802637312","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402451251247316992"}]},{"entities":{"hashtags":[{"start":18,"end":37,"tag":"EuropeanParliament"},{"start":70,"end":87,"tag":"Pharmcovigilance"}],"urls":[{"start":99,"end":121,"url":"http://t.co/hGhCBgsaCh","expanded_url":"http://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&reference=PE-523.004&format=PDF&language=EN&secondRef=01","display_url":"europarl.europa.eu/sides/getDoc.d…"}],"mentions":{},"annotations":{}},"text":"RT @sailinsomnia: #EuropeanParliament Proposes New User Fee Rates for #Pharmcovigilance Activities http://t.co/hGhCBgsaCh","created_at":"2013-11-18T15:00:26.000Z","author_id":"116716199","lang":"en","conversation_id":"402451237582278657","possibly_sensitive":false,"id":"402451237582278657","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402451052378607618"}]},{"entities":{"hashtags":[{"start":42,"end":63,"tag":"PersonalisedMedicine"}],"urls":[{"start":65,"end":87,"url":"http://t.co/Iyj8sF7PtB","expanded_url":"http://bit.ly/1aBge7B","display_url":"bit.ly/1aBge7B"}],"mentions":[{"start":3,"end":11,"username":"EPHA_EU","id":"184756856"},{"start":89,"end":101,"username":"EPSA_Online","id":"104839524"},{"start":102,"end":115,"username":"pharmaphorum","id":"27254739"}],"annotations":{}},"text":"RT @EPHA_EU: [European Commission report] #PersonalisedMedicine: http://t.co/Iyj8sF7PtB  @EPSA_Online @pharmaphorum @ScripMikeWard @medtech…","created_at":"2013-11-18T14:49:25.000Z","author_id":"116716199","lang":"fr","conversation_id":"402448462433632256","possibly_sensitive":false,"id":"402448462433632256","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402444199913476097"}]},{"entities":{"hashtags":[{"start":12,"end":23,"tag":"Antibiotic"},{"start":109,"end":114,"tag":"EAAD"},{"start":115,"end":123,"tag":"SaveAbx"}],"urls":{},"mentions":[{"start":3,"end":10,"username":"CDCgov","id":"146569971"}],"annotations":{}},"text":"RT @CDCgov: #Antibiotic resistance is a global public health problem. Join in keeping antibiotics effective. #EAAD #SaveAbx","created_at":"2013-11-18T14:08:28.000Z","author_id":"116716199","lang":"en","conversation_id":"402438156491841536","possibly_sensitive":false,"id":"402438156491841536","source":"TweetDeck","public_metrics":{"retweet_count":65,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402437116598423552"}]},{"entities":{"hashtags":[{"start":53,"end":58,"tag":"EAAD"}],"urls":[{"start":92,"end":114,"url":"http://t.co/uGfBFkq8k6","expanded_url":"http://bit.ly/1e7j5ql","display_url":"bit.ly/1e7j5ql"}],"mentions":[{"start":3,"end":16,"username":"ERC_Research","id":"467551928"},{"start":115,"end":123,"username":"ECDC_EU","id":"204752573"},{"start":124,"end":132,"username":"EAAD_EU","id":"1725283578"}],"annotations":{}},"text":"RT @ERC_Research: European antibiotics awareness day #EAAD. Read our selection of projects: http://t.co/uGfBFkq8k6 @ECDC_EU @EAAD_EU @EU_He…","created_at":"2013-11-18T14:06:22.000Z","author_id":"116716199","lang":"en","conversation_id":"402437627460059136","possibly_sensitive":false,"id":"402437627460059136","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402432179948371968"}]},{"entities":{"hashtags":{},"urls":[{"start":118,"end":140,"url":"http://t.co/xOC8gGN5WO","expanded_url":"http://bit.ly/18IQYJw","display_url":"bit.ly/18IQYJw"}],"mentions":[{"start":3,"end":18,"username":"Legemiddelinfo","id":"89806212"}],"annotations":[{"start":29,"end":61,"probability":0.7999,"type":"Other","normalized_text":"European Antibiotic Awareness Day"}]},"text":"RT @Legemiddelinfo: Today is European Antibiotic Awareness Day. Useful info for children's parents and doctors here:  http://t.co/xOC8gGN5WO","created_at":"2013-11-18T14:05:48.000Z","author_id":"116716199","lang":"en","conversation_id":"402437485398999040","possibly_sensitive":false,"id":"402437485398999040","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":15,"end":20,"tag":"EAAD"},{"start":67,"end":71,"tag":"AMR"}],"urls":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"text":"RT @EU_Health: #EAAD From 01/01/2014 new legislation on monitoring #AMR in food &amp; animals, data comparable with human data http://t.co/ncW2…","created_at":"2013-11-18T13:50:54.000Z","author_id":"116716199","lang":"en","conversation_id":"402433738979540992","possibly_sensitive":false,"id":"402433738979540992","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402430524909555713"}]},{"entities":{"hashtags":[{"start":54,"end":58,"tag":"AMR"},{"start":95,"end":102,"tag":"IMI_JU"},{"start":126,"end":131,"tag":"EAAD"}],"urls":[{"start":103,"end":125,"url":"http://t.co/P23jx5mK7h","expanded_url":"http://ow.ly/qVDB1","display_url":"ow.ly/qVDB1"}],"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":[{"start":16,"end":17,"probability":0.7572,"type":"Organization","normalized_text":"EU"}]},"text":"RT @IMI_JU: The EU has invested some € 800 million in #AMR-related research, including through #IMI_JU http://t.co/P23jx5mK7h #EAAD","created_at":"2013-11-18T13:50:42.000Z","author_id":"116716199","lang":"en","conversation_id":"402433688685658112","possibly_sensitive":false,"id":"402433688685658112","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402430193828364288"}]},{"entities":{"hashtags":[{"start":57,"end":62,"tag":"EAAD"}],"urls":[{"start":111,"end":133,"url":"http://t.co/vulajhnJFN","expanded_url":"http://on.fb.me/ZZ4HXC","display_url":"on.fb.me/ZZ4HXC"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":[{"start":96,"end":103,"probability":0.6212,"type":"Product","normalized_text":"Facebook"}]},"text":"RT @ECDC_EU: If you have more questions, continue to use #EAAD during today or post them in our Facebook page: http://t.co/vulajhnJFN","created_at":"2013-11-18T13:50:21.000Z","author_id":"116716199","lang":"en","conversation_id":"402433600450097152","possibly_sensitive":false,"id":"402433600450097152","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402429422151933952"}]},{"entities":{"hashtags":[{"start":70,"end":82,"tag":"antibiotics"}],"urls":[{"start":102,"end":124,"url":"http://t.co/hA6JfLmut8","expanded_url":"http://bit.ly/18IOavT","display_url":"bit.ly/18IOavT"}],"mentions":[{"start":3,"end":14,"username":"sanidadgob","id":"232124120"}],"annotations":{}},"text":"RT @sanidadgob: Remember: we are all responsible for making sure that #antibiotics remain effective.  http://t.co/hA6JfLmut8","created_at":"2013-11-18T13:48:41.000Z","author_id":"116716199","lang":"en","conversation_id":"402433178503102464","possibly_sensitive":false,"id":"402433178503102464","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":82,"end":104,"url":"http://t.co/xUr11OMDMV","expanded_url":"http://www.ilae.org/Visitors/Centre/Organization.cfm","display_url":"ilae.org/Visitors/Centr…"}],"mentions":[{"start":3,"end":11,"username":"IlaeWeb","id":"611701745"}],"annotations":{}},"text":"RT @IlaeWeb: Organization of the Epilepsies: Read proposal, add your comments at: http://t.co/xUr11OMDMV","created_at":"2013-11-18T13:46:47.000Z","author_id":"116716199","lang":"en","conversation_id":"402432699257745408","possibly_sensitive":false,"id":"402432699257745408","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402425095898927107"}]},{"entities":{"hashtags":[{"start":117,"end":127,"tag":"superbugs"},{"start":128,"end":133,"tag":"EAAD"}],"urls":{},"mentions":[{"start":3,"end":11,"username":"EAAD_EU","id":"1725283578"},{"start":24,"end":33,"username":"EMA_News","id":"116716199"}],"annotations":{}},"text":"RT @EAAD_EU: ECDC &amp; @EMA_News estimated 25,000 Europeans per yr die as direct consequence of multidrug-resistant #superbugs #EAAD http://t.…","created_at":"2013-11-18T13:45:21.000Z","author_id":"116716199","lang":"en","conversation_id":"402432342498615296","possibly_sensitive":false,"id":"402432342498615296","source":"TweetDeck","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402423434216349698"}]},{"entities":{"hashtags":[{"start":71,"end":80,"tag":"patients"},{"start":112,"end":122,"tag":"superbugs"},{"start":123,"end":128,"tag":"EAAD"}],"urls":{},"mentions":[{"start":3,"end":11,"username":"EAAD_EU","id":"1725283578"}],"annotations":{}},"text":"RT @EAAD_EU: There is always a personal story behind the statistics of #patients infected with highly resistant #superbugs #EAAD http://t.c…","created_at":"2013-11-18T13:43:57.000Z","author_id":"116716199","lang":"en","conversation_id":"402431987735990272","possibly_sensitive":false,"id":"402431987735990272","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402422435380596736"}]},{"entities":{"hashtags":[{"start":43,"end":53,"tag":"superbugs"},{"start":107,"end":115,"tag":"patient"}],"urls":{},"mentions":[{"start":3,"end":11,"username":"EAAD_EU","id":"1725283578"}],"annotations":{}},"text":"RT @EAAD_EU: What happens to patients with #superbugs resistant to many antibiotics? This video shows real #patient stories: http://t.co/xr…","created_at":"2013-11-18T12:59:06.000Z","author_id":"116716199","lang":"en","conversation_id":"402420700796833793","possibly_sensitive":false,"id":"402420700796833793","source":"TweetDeck","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402420564574220288"}]},{"entities":{"hashtags":[{"start":13,"end":18,"tag":"EAAD"},{"start":110,"end":115,"tag":"MRSA"}],"urls":{},"mentions":[{"start":3,"end":11,"username":"EAAD_EU","id":"1725283578"}],"annotations":{}},"text":"RT @EAAD_EU: #EAAD 2013 New data: growing resistance in K.pneumoniae and E.coli, first data on Acinetobacter; #MRSA decreasing http://t.co/…","created_at":"2013-11-18T12:56:42.000Z","author_id":"116716199","lang":"en","conversation_id":"402420099485011968","possibly_sensitive":false,"id":"402420099485011968","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402418960445870080"}]},{"entities":{"hashtags":[{"start":37,"end":49,"tag":"antibiotics"},{"start":113,"end":118,"tag":"EAAD"}],"urls":[{"start":90,"end":112,"url":"http://t.co/8wGIqE3JFk","expanded_url":"http://bit.ly/17vRcUf","display_url":"bit.ly/17vRcUf"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"text":"RT @ECDC_EU: Resistance to last-line #antibiotics is growing. This infographic shows more http://t.co/8wGIqE3JFk #EAAD","created_at":"2013-11-18T12:56:28.000Z","author_id":"116716199","lang":"en","conversation_id":"402420039497682944","possibly_sensitive":false,"id":"402420039497682944","source":"TweetDeck","public_metrics":{"retweet_count":30,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402418852673232897"}]},{"entities":{"hashtags":[{"start":14,"end":19,"tag":"EAAD"},{"start":70,"end":81,"tag":"antibiotic"},{"start":86,"end":107,"tag":"antibioticresistance"}],"urls":{},"mentions":[{"start":3,"end":11,"username":"EPHA_EU","id":"184756856"},{"start":108,"end":120,"username":"EPSA_Online","id":"104839524"},{"start":121,"end":133,"username":"emsa_europe","id":"443963165"}],"annotations":[{"start":20,"end":26,"probability":0.4567,"type":"Organization","normalized_text":"Twitter"},{"start":34,"end":39,"probability":0.8963,"type":"Place","normalized_text":"Europe"}]},"text":"RT @EPHA_EU: [#EAAD Twitter chat] Europe may face a return to the pre-#antibiotic era #antibioticresistance @EPSA_Online @emsa_europe @ECDC…","created_at":"2013-11-18T12:55:33.000Z","author_id":"116716199","lang":"en","conversation_id":"402419807196180480","possibly_sensitive":false,"id":"402419807196180480","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402418669621235712"}]},{"entities":{"hashtags":[{"start":34,"end":46,"tag":"antibiotics"},{"start":51,"end":72,"tag":"antibioticresistance"},{"start":112,"end":117,"tag":"EAAD"}],"urls":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"text":"RT @ECDC_EU: Do have questions on #antibiotics or  #antibioticresistance? Our experts in ECDC will answer - use #EAAD","created_at":"2013-11-18T12:55:23.000Z","author_id":"116716199","lang":"en","conversation_id":"402419764577841152","possibly_sensitive":false,"id":"402419764577841152","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402417842647072768"}]},{"entities":{"hashtags":[{"start":30,"end":42,"tag":"antibiotics"},{"start":94,"end":99,"tag":"EAAD"}],"urls":[{"start":71,"end":93,"url":"http://t.co/NDbpbUBwCh","expanded_url":"http://bit.ly/1bxSUFs","display_url":"bit.ly/1bxSUFs"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"text":"RT @ECDC_EU: Learn more about #antibiotics with this handy infographic http://t.co/NDbpbUBwCh #EAAD","created_at":"2013-11-18T12:46:11.000Z","author_id":"116716199","lang":"en","conversation_id":"402417450731327490","possibly_sensitive":false,"id":"402417450731327490","source":"TweetDeck","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402417392745070592"}]},{"entities":{"hashtags":[{"start":39,"end":42,"tag":"EU"},{"start":54,"end":65,"tag":"antibiotic"}],"urls":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"},{"start":13,"end":24,"username":"WHO_Europe","id":"125403342"},{"start":25,"end":34,"username":"jonotter","id":"215340149"}],"annotations":{}},"text":"RT @ECDC_EU: @WHO_Europe @jonotter  In #EU, community #antibiotic consumption varies 3-fold b/n highest &amp; lowest. 11-35 DDD /1000 inhabitan…","created_at":"2013-11-18T12:46:07.000Z","author_id":"116716199","lang":"en","conversation_id":"402417433421443072","possibly_sensitive":false,"id":"402417433421443072","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402417309253259265"}]},{"entities":{"hashtags":[{"start":57,"end":61,"tag":"AMR"},{"start":72,"end":83,"tag":"resistance"}],"urls":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"text":"RT @ECDC_EU: EU data on healthcare associated infections #AMR use &amp; #resistance available fr ECDC Point prevalence survey http://t.co/SVk4q…","created_at":"2013-11-18T12:45:44.000Z","author_id":"116716199","lang":"en","conversation_id":"402417337266995200","possibly_sensitive":false,"id":"402417337266995200","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402416763255922688"}]},{"entities":{"hashtags":[{"start":14,"end":19,"tag":"EAAD"},{"start":34,"end":46,"tag":"Antibiotics"}],"urls":{},"mentions":[{"start":3,"end":11,"username":"EPHA_EU","id":"184756856"}],"annotations":[{"start":20,"end":26,"probability":0.4564,"type":"Organization","normalized_text":"Twitter"}]},"text":"RT @EPHA_EU: [#EAAD Twitter chat] #Antibiotics are losing their effectiveness at a pace that was unforeseen even five years ago","created_at":"2013-11-18T12:43:29.000Z","author_id":"116716199","lang":"en","conversation_id":"402416771434438657","possibly_sensitive":false,"id":"402416771434438657","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402415251125067776"}]},{"entities":{"hashtags":[{"start":15,"end":20,"tag":"EAAD"},{"start":21,"end":24,"tag":"EU"}],"urls":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"text":"RT @EU_Health: #EAAD #EU invested some €800 million in RTD to fight AMR. 15 new research projects (more than €90 million) http://t.co/g6DcX…","created_at":"2013-11-18T12:43:07.000Z","author_id":"116716199","lang":"en","conversation_id":"402416679872778240","possibly_sensitive":false,"id":"402416679872778240","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402414969121034241"}]},{"entities":{"hashtags":[{"start":44,"end":53,"tag":"superbug"},{"start":124,"end":129,"tag":"EAAD"}],"urls":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"text":"RT @ECDC_EU: 2011 ECDC risk assessment: CPE #superbug represents risk for EU, systematic surveillance should be implemented #EAAD http://t.…","created_at":"2013-11-18T12:33:33.000Z","author_id":"116716199","lang":"en","conversation_id":"402414269456588800","possibly_sensitive":false,"id":"402414269456588800","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402414001013137408"}]},{"entities":{"hashtags":[{"start":131,"end":136,"tag":"EAAD"}],"urls":{},"mentions":[{"start":3,"end":17,"username":"WHO_Europe_TB","id":"920721606"}],"annotations":{}},"text":"RT @WHO_Europe_TB: Half of treated patients with TB in the WHO European region are resistant to first-line anti-tuberculosis drugs #EAAD","created_at":"2013-11-18T12:33:20.000Z","author_id":"116716199","lang":"en","conversation_id":"402414215429763072","possibly_sensitive":false,"id":"402414215429763072","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":13,"end":24,"tag":"antibiotic"},{"start":68,"end":77,"tag":"European"},{"start":125,"end":130,"tag":"EAAD"}],"urls":{},"mentions":[{"start":3,"end":11,"username":"EAAD_EU","id":"1725283578"}],"annotations":{}},"text":"RT @EAAD_EU: #antibiotic consumption increased in community in many #European countries in the last decade, see latest data, #EAAD http://t…","created_at":"2013-11-18T12:30:55.000Z","author_id":"116716199","lang":"en","conversation_id":"402413610271391744","possibly_sensitive":false,"id":"402413610271391744","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402413551991537665"}]},{"entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"text":"RT @ECDC_EU: Multi-drug resistant Klebsiella pneumoniae is public health concern: significant increase in EU in past years http://t.co/Xsgq…","created_at":"2013-11-18T12:30:00.000Z","author_id":"116716199","lang":"en","conversation_id":"402413379379154944","possibly_sensitive":false,"id":"402413379379154944","source":"TweetDeck","public_metrics":{"retweet_count":23,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402413074604654592"}]},{"entities":{"hashtags":[{"start":16,"end":21,"tag":"EAAD"}],"urls":{},"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"annotations":{}},"text":"RT @WHO_Europe: #EAAD Antibiotics do not help treat viral infections such as the flu or colds; only effective against bacterial infections.","created_at":"2013-11-18T12:28:55.000Z","author_id":"116716199","lang":"en","conversation_id":"402413106908770304","possibly_sensitive":false,"id":"402413106908770304","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":62,"end":66,"tag":"MDR"},{"start":121,"end":128,"tag":"TBChat"},{"start":131,"end":136,"tag":"EAAD"}],"urls":{},"mentions":[{"start":3,"end":17,"username":"WHO_Europe_TB","id":"920721606"}],"annotations":[{"start":112,"end":117,"probability":0.9381,"type":"Place","normalized_text":"Europe"}]},"text":"RT @WHO_Europe_TB: Over 1/2 of the countries with the highest #MDR rates in the world are in the eastern of the Europe | #TBChat 4 #EAAD ht…","created_at":"2013-11-18T12:23:34.000Z","author_id":"116716199","lang":"en","conversation_id":"402411757517275138","possibly_sensitive":false,"id":"402411757517275138","source":"TweetDeck","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402410936683601921"}]},{"entities":{"hashtags":[{"start":29,"end":34,"tag":"EAAD"},{"start":70,"end":79,"tag":"patients"},{"start":85,"end":95,"tag":"superbugs"}],"urls":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"},{"start":15,"end":28,"username":"gavin_barlow","id":"1273595630"}],"annotations":{}},"text":"RT @ECDC_EU: . @gavin_barlow #EAAD patient stories: read 3 stories of #patients with #superbugs resistant to many antibiotics http://t.co/s…","created_at":"2013-11-18T12:23:07.000Z","author_id":"116716199","lang":"en","conversation_id":"402411647123210240","possibly_sensitive":false,"id":"402411647123210240","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402410712112177152"}]},{"entities":{"hashtags":[{"start":13,"end":18,"tag":"EAAD"},{"start":102,"end":112,"tag":"hospitals"},{"start":119,"end":127,"tag":"patient"}],"urls":{},"mentions":[{"start":3,"end":11,"username":"EAAD_EU","id":"1725283578"}],"annotations":[{"start":77,"end":82,"probability":0.9822,"type":"Place","normalized_text":"Europe"}]},"text":"RT @EAAD_EU: #EAAD 2013: Rapid expansion of carbapenem-resistant bacteria in Europe– future threat to #hospitals &amp; #patient safety http://t…","created_at":"2013-11-18T12:20:55.000Z","author_id":"116716199","lang":"en","conversation_id":"402411093672222720","possibly_sensitive":false,"id":"402411093672222720","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402409699451998208"}]},{"entities":{"hashtags":[{"start":43,"end":48,"tag":"COPD"},{"start":118,"end":130,"tag":"EUCOPDBrx13"}],"urls":{},"mentions":[{"start":3,"end":16,"username":"EFA_Patients","id":"1299643704"},{"start":131,"end":139,"username":"EU_COPD","id":"886504362"}],"annotations":{}},"text":"RT @EFA_Patients: What's the best care for #COPD &amp; how can research improve standards of care? Come discuss 28Nov #EUCOPDBrx13 @EU_COPD htt…","created_at":"2013-11-18T12:13:59.000Z","author_id":"116716199","lang":"en","conversation_id":"402409348904669185","possibly_sensitive":false,"id":"402409348904669185","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402408863473086464"}]},{"entities":{"hashtags":[{"start":50,"end":61,"tag":"variations"}],"urls":[{"start":95,"end":117,"url":"http://t.co/iGVFLay6ED","expanded_url":"http://bit.ly/1d9KXgt","display_url":"bit.ly/1d9KXgt"}],"mentions":{},"annotations":{}},"text":"Reminder: companies need to submit quality type-I #variations for 2013 by the end of November: http://t.co/iGVFLay6ED","created_at":"2013-11-18T12:10:38.000Z","author_id":"116716199","lang":"en","conversation_id":"402408504293466112","possibly_sensitive":false,"id":"402408504293466112","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":128,"end":133,"tag":"CHMP"}],"urls":[{"start":105,"end":127,"url":"http://t.co/mHIFIP0jU1","expanded_url":"http://bit.ly/1inAlKW","display_url":"bit.ly/1inAlKW"}],"mentions":{},"annotations":{}},"text":"Our human medicines committee's plenary meeting is this week. We're publishing the highlights on Friday: http://t.co/mHIFIP0jU1 #CHMP","created_at":"2013-11-18T12:09:51.000Z","author_id":"116716199","lang":"en","conversation_id":"402408306292973568","possibly_sensitive":false,"id":"402408306292973568","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":94,"end":105,"tag":"resistance"},{"start":130,"end":135,"tag":"EAAD"}],"urls":[{"start":107,"end":129,"url":"http://t.co/GdvaaWIXLs","expanded_url":"http://bit.ly/1fO9ci1","display_url":"bit.ly/1fO9ci1"}],"mentions":{},"annotations":[{"start":17,"end":49,"probability":0.8648,"type":"Other","normalized_text":"European Antibiotic Awareness Day"}]},"text":"We're supporting European Antibiotic Awareness Day. Find out how we support the fight against #resistance: http://t.co/GdvaaWIXLs #EAAD","created_at":"2013-11-18T12:08:04.000Z","author_id":"116716199","lang":"en","conversation_id":"402407857758289921","possibly_sensitive":false,"id":"402407857758289921","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":127,"end":132,"tag":"EAAD"}],"urls":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"text":"RT @ECDC_EU: We cannot provide advice, diagnosis on specific conditions but we will talk about how to use antibiotics properly #EAAD","created_at":"2013-11-18T12:06:23.000Z","author_id":"116716199","lang":"en","conversation_id":"402407435974877184","possibly_sensitive":false,"id":"402407435974877184","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402407374948171776"}]},{"entities":{"hashtags":[{"start":52,"end":63,"tag":"biosimilar"}],"urls":[{"start":117,"end":139,"url":"http://t.co/dXh6Fp3tLh","expanded_url":"http://bit.ly/I0SUXE","display_url":"bit.ly/I0SUXE"}],"mentions":{},"annotations":{}},"text":"Two weeks left to comment on our draft guideline on #biosimilar medicines containing biotechnology-derived proteins: http://t.co/dXh6Fp3tLh","created_at":"2013-11-18T12:05:51.000Z","author_id":"116716199","lang":"en","conversation_id":"402407300993789952","possibly_sensitive":false,"id":"402407300993789952","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"text":"RT @ECDC_EU: ECDC experts Anna-Pelagia Magiorakos, Liselotte Diaz Högberg, Barbara Albiger &amp; Ole Heuer ready to answer your questions on #a…","created_at":"2013-11-18T12:04:59.000Z","author_id":"116716199","lang":"de","conversation_id":"402407083456212992","possibly_sensitive":false,"id":"402407083456212992","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402406943740153856"}]},{"entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"annotations":[{"start":80,"end":96,"probability":0.3993,"type":"Person","normalized_text":"Danilo Lo Fo Wong"},{"start":99,"end":117,"probability":0.5054,"type":"Person","normalized_text":"Nienke van de Sande"},{"start":123,"end":138,"probability":0.8863,"type":"Person","normalized_text":"Ganna Bolokhovet"}]},"text":"RT @WHO_Europe: Answering your questions today from WHO are Hanne Bak Pedersen, Danilo Lo Fo Wong, Nienke van de Sande and Ganna Bolokhovet…","created_at":"2013-11-18T12:04:56.000Z","author_id":"116716199","lang":"en","conversation_id":"402407068893597696","possibly_sensitive":false,"id":"402407068893597696","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402406930351542272"}]},{"entities":{"hashtags":[{"start":111,"end":116,"tag":"pain"}],"urls":[{"start":118,"end":140,"url":"http://t.co/Cto5QQSUsx","expanded_url":"http://bit.ly/19yEoMs","display_url":"bit.ly/19yEoMs"}],"mentions":{},"annotations":{}},"text":"Two weeks left to comment on our draft guideline on the clinical development of medicines for the treatment of #pain: http://t.co/Cto5QQSUsx","created_at":"2013-11-18T12:04:24.000Z","author_id":"116716199","lang":"en","conversation_id":"402406933694386176","possibly_sensitive":false,"id":"402406933694386176","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":53,"end":64,"tag":"veterinary"},{"start":86,"end":100,"tag":"antimicrobial"}],"urls":[{"start":113,"end":135,"url":"http://t.co/0TNrxR4BIK","expanded_url":"http://bit.ly/1hRrYJO","display_url":"bit.ly/1hRrYJO"}],"mentions":{},"annotations":{}},"text":"Two weeks left to comment on our draft guideline for #veterinary medicines containing #antimicrobial substances: http://t.co/0TNrxR4BIK","created_at":"2013-11-18T12:03:46.000Z","author_id":"116716199","lang":"en","conversation_id":"402406777351700480","possibly_sensitive":false,"id":"402406777351700480","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":41,"end":46,"tag":"EAAD"}],"urls":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"text":"RT @ECDC_EU: To post question please use #EAAD","created_at":"2013-11-18T12:02:59.000Z","author_id":"116716199","lang":"en","conversation_id":"402406580160692225","possibly_sensitive":false,"id":"402406580160692225","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402406537760870402"}]},{"entities":{"hashtags":[{"start":96,"end":101,"tag":"EAAD"}],"urls":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"},{"start":105,"end":116,"username":"WHO_Europe","id":"125403342"},{"start":117,"end":127,"username":"EU_Health","id":"606325697"}],"annotations":[{"start":62,"end":94,"probability":0.8853,"type":"Other","normalized_text":"European Antibiotic Awareness Day"}]},"text":"RT @ECDC_EU: Welcome to our joint chat on the occasion of the European Antibiotic Awareness Day #EAAD w/ @WHO_Europe @EU_Health @innovation…","created_at":"2013-11-18T12:02:31.000Z","author_id":"116716199","lang":"en","conversation_id":"402406461197647872","possibly_sensitive":false,"id":"402406461197647872","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402406412846116864"}]},{"entities":{"hashtags":[{"start":40,"end":52,"tag":"twitterchat"},{"start":56,"end":67,"tag":"antibiotic"},{"start":113,"end":118,"tag":"EAAD"}],"urls":{},"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"annotations":{}},"text":"RT @WHO_Europe: Starting in 5 minutes - #twitterchat on #antibiotic resistance...ask our experts questions using #EAAD","created_at":"2013-11-18T12:01:57.000Z","author_id":"116716199","lang":"en","conversation_id":"402406317781831680","possibly_sensitive":false,"id":"402406317781831680","source":"TweetDeck","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402404785703235584"}]},{"entities":{"hashtags":[{"start":51,"end":65,"tag":"antimicrobial"}],"urls":{},"mentions":[{"start":3,"end":13,"username":"beuctweet","id":"3061421219"}],"annotations":[{"start":15,"end":48,"probability":0.4126,"type":"Other","normalized_text":"European Antibiotics Awareness Day"}]},"text":"RT @beuctweet: European Antibiotics Awareness Day: #antimicrobial resistance in food will be high on BEUC’s agenda in 2014. Stay tuned. #EA…","created_at":"2013-11-18T11:55:49.000Z","author_id":"116716199","lang":"en","conversation_id":"402404777595654144","possibly_sensitive":false,"id":"402404777595654144","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402402344844791809"}]},{"entities":{"hashtags":[{"start":42,"end":54,"tag":"antibiotics"}],"urls":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":82,"end":90,"username":"ECDC_EU","id":"204752573"},{"start":91,"end":101,"username":"EU_Health","id":"606325697"},{"start":102,"end":118,"username":"innovationunion","id":"786508396245639172"},{"start":119,"end":130,"username":"WHO_Europe","id":"125403342"}],"annotations":{}},"text":"RT @EU_Health: Starting in 20': Join our  #antibiotics chat,  13:00-14:30 CET, w. @ECDC_EU @EU_Health @innovationunion @WHO_Europe experts.…","created_at":"2013-11-18T11:40:05.000Z","author_id":"116716199","lang":"en","conversation_id":"402400817619013632","possibly_sensitive":false,"id":"402400817619013632","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402400753626521600"}]},{"entities":{"hashtags":[{"start":22,"end":29,"tag":"Europe"},{"start":45,"end":56,"tag":"Antibiotic"}],"urls":{},"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"annotations":[{"start":81,"end":87,"probability":0.5386,"type":"Product","normalized_text":"Twitter"}]},"text":"RT @WHO_Europe: Today #Europe marks European #Antibiotic Awareness Day. Join our Twitter chat at 13:00 CET &amp; help promote prudent use of an…","created_at":"2013-11-18T11:28:29.000Z","author_id":"116716199","lang":"en","conversation_id":"402397896038813696","possibly_sensitive":false,"id":"402397896038813696","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402397855488286720"}]},{"entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":11,"username":"borgton","id":"1605512862"}],"annotations":[{"start":84,"end":85,"probability":0.4972,"type":"Place","normalized_text":"EU"}]},"text":"RT @borgton: Today Anti Microbial Resistance AMR Awareness Day 25000 persons die in EU each year because of infections  as direct result of…","created_at":"2013-11-18T11:28:22.000Z","author_id":"116716199","lang":"en","conversation_id":"402397866749988864","possibly_sensitive":false,"id":"402397866749988864","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402397740002717696"}]},{"entities":{"hashtags":[{"start":51,"end":62,"tag":"variations"}],"urls":[{"start":96,"end":118,"url":"http://t.co/9xJWPWklog","expanded_url":"http://bit.ly/1d9KXgt","display_url":"bit.ly/1d9KXgt"}],"mentions":{},"annotations":{}},"text":"We're reminding companies to submit quality type-I #variations for 2013 by the end of November: http://t.co/9xJWPWklog","created_at":"2013-11-18T11:20:12.000Z","author_id":"116716199","lang":"en","conversation_id":"402395812418027520","possibly_sensitive":false,"id":"402395812418027520","source":"bitly bitlink","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":100,"end":121,"tag":"antibioticresistance"}],"urls":{},"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"annotations":{}},"text":"RT @NICEcomms: Find out how our guidance can help to cut down on unnecessary antibiotic prescribing #antibioticresistance \nhttp://t.co/ms4C…","created_at":"2013-11-18T11:14:29.000Z","author_id":"116716199","lang":"en","conversation_id":"402394374983536640","possibly_sensitive":false,"id":"402394374983536640","source":"TweetDeck","public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402393903715741696"}]},{"entities":{"hashtags":[{"start":27,"end":38,"tag":"Antibiotic"},{"start":115,"end":119,"tag":"amr"},{"start":120,"end":125,"tag":"eaad"}],"urls":[{"start":92,"end":114,"url":"http://t.co/iaGpDl0GOf","expanded_url":"http://bit.ly/HZ6Ukl","display_url":"bit.ly/HZ6Ukl"}],"mentions":[{"start":3,"end":11,"username":"EPHA_EU","id":"184756856"},{"start":54,"end":62,"username":"ECDC_EU","id":"204752573"},{"start":127,"end":136,"username":"EMA_News","id":"116716199"}],"annotations":{}},"text":"RT @EPHA_EU: [6th European #Antibiotic Awareness Day] @ECDC_EU' s event - Summary (Nov. 15):http://t.co/iaGpDl0GOf #amr #eaad  @EMA_News @E…","created_at":"2013-11-18T11:13:31.000Z","author_id":"116716199","lang":"en","conversation_id":"402394132187852800","possibly_sensitive":false,"id":"402394132187852800","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402392912459075584"}]},{"entities":{"hashtags":[{"start":87,"end":99,"tag":"antibiotics"}],"urls":[{"start":113,"end":135,"url":"http://t.co/myb8BgB3nP","expanded_url":"http://bit.ly/17D5AtF","display_url":"bit.ly/17D5AtF"}],"mentions":[{"start":3,"end":14,"username":"sanidadgob","id":"232124120"}],"annotations":{}},"text":"RT @sanidadgob: Antibiotics are not effective against colds or the flu. Remember: take #antibiotics responsibly. http://t.co/myb8BgB3nP","created_at":"2013-11-18T11:12:34.000Z","author_id":"116716199","lang":"en","conversation_id":"402393893255139329","possibly_sensitive":false,"id":"402393893255139329","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":19,"username":"Martinharvey100","id":"113148426"},{"start":21,"end":31,"username":"MHRApress","id":"330990243"},{"start":129,"end":138,"username":"EMA_News","id":"116716199"}],"annotations":{}},"text":"RT @Martinharvey100: @MHRApress Expert group calls for earlier patient access to medicines including adaptive licensing pilot at @EMA_News …","created_at":"2013-11-18T10:59:26.000Z","author_id":"116716199","lang":"en","conversation_id":"402390585329213442","possibly_sensitive":false,"id":"402390585329213442","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402390159272202240"}]},{"entities":{"hashtags":[{"start":79,"end":94,"tag":"bioequivalence"}],"urls":[{"start":115,"end":137,"url":"http://t.co/ojXivn0vSz","expanded_url":"http://bit.ly/1ifPXQq","display_url":"bit.ly/1ifPXQq"}],"mentions":{},"annotations":{}},"text":"On Friday we published 16 product-specific guidance documents on demonstrating #bioequivalence, open for comments: http://t.co/ojXivn0vSz","created_at":"2013-11-18T10:56:31.000Z","author_id":"116716199","lang":"en","conversation_id":"402389852039032832","possibly_sensitive":false,"id":"402389852039032832","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":100,"end":105,"tag":"EAAD"}],"urls":[{"start":106,"end":128,"url":"http://t.co/RUcaWpBzMe","expanded_url":"http://bit.ly/1bmXg5S","display_url":"bit.ly/1bmXg5S"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"},{"start":14,"end":25,"username":"WHO_Europe","id":"125403342"}],"annotations":{}},"text":"RT @WHO: Join @WHO_Europe later today for a twitterchat on antibiotics 13:00-14:30 CET. Use hashtag #EAAD http://t.co/RUcaWpBzMe","created_at":"2013-11-18T10:55:06.000Z","author_id":"116716199","lang":"en","conversation_id":"402389496072658944","possibly_sensitive":false,"id":"402389496072658944","source":"TweetDeck","public_metrics":{"retweet_count":42,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402389214756470784"}]},{"entities":{"hashtags":[{"start":112,"end":117,"tag":"EAAD"}],"urls":{},"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"},{"start":118,"end":126,"username":"ECDC_EU","id":"204752573"}],"annotations":[{"start":15,"end":47,"probability":0.6674,"type":"Other","normalized_text":"European Antibiotic Awareness Day"}]},"text":"RT @IMI_JU: On European Antibiotic Awareness Day read how IMI is addressing the urgent need for new antibiotics #EAAD @ECDC_EU http://t.co/…","created_at":"2013-11-18T10:54:38.000Z","author_id":"116716199","lang":"en","conversation_id":"402389376543387648","possibly_sensitive":false,"id":"402389376543387648","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402387922227568640"}]},{"entities":{"hashtags":[{"start":91,"end":112,"tag":"AntibioticResistance"},{"start":114,"end":119,"tag":"EAAD"}],"urls":{},"mentions":[{"start":3,"end":11,"username":"EAAD_EU","id":"1725283578"},{"start":74,"end":87,"username":"frontlinepbs","id":"16016427"}],"annotations":[{"start":13,"end":42,"probability":0.5182,"type":"Other","normalized_text":"Hunting the Nightmare Bacteria"}]},"text":"RT @EAAD_EU: Hunting the Nightmare Bacteria: informative documentary from @frontlinePBS on #AntibioticResistance. #EAAD http://t.co/EP6RHBZ…","created_at":"2013-11-18T10:54:23.000Z","author_id":"116716199","lang":"en","conversation_id":"402389315067457536","possibly_sensitive":false,"id":"402389315067457536","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402386415696109569"}]},{"entities":{"hashtags":[{"start":17,"end":22,"tag":"EAAD"},{"start":38,"end":52,"tag":"antimicrobial"},{"start":71,"end":82,"tag":"antibiotic"}],"urls":[{"start":106,"end":128,"url":"http://t.co/Hj1JxJE8Es","expanded_url":"http://bit.ly/1bxSUFs","display_url":"bit.ly/1bxSUFs"}],"mentions":[{"start":3,"end":11,"username":"EAAD_EU","id":"1725283578"}],"annotations":[{"start":94,"end":99,"probability":0.9929,"type":"Place","normalized_text":"Europe"}]},"text":"RT @EAAD_EU: New #EAAD infographic on #antimicrobial resistance &amp;  #antibiotic consumption in Europe. http://t.co/Hj1JxJE8Es http://t.co/8T…","created_at":"2013-11-18T10:53:56.000Z","author_id":"116716199","lang":"en","conversation_id":"402389203419295744","possibly_sensitive":false,"id":"402389203419295744","source":"TweetDeck","public_metrics":{"retweet_count":58,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402386060304318464"}]},{"entities":{"hashtags":[{"start":124,"end":129,"tag":"EAAD"}],"urls":{},"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"},{"start":102,"end":113,"username":"WHO_Europe","id":"125403342"}],"annotations":[{"start":25,"end":31,"probability":0.4863,"type":"Product","normalized_text":"twitter"}]},"text":"RT @WHO_Europe: Join the twitter chat on antibiotic resistance today. Send in questions to experts to @WHO_Europe w/hashtag #EAAD http://t.…","created_at":"2013-11-18T10:53:52.000Z","author_id":"116716199","lang":"en","conversation_id":"402389183735427072","possibly_sensitive":false,"id":"402389183735427072","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402385632598568960"}]},{"entities":{"hashtags":{},"urls":[{"start":115,"end":137,"url":"http://t.co/BteCcdG2L4","expanded_url":"http://bit.ly/1atRfTM","display_url":"bit.ly/1atRfTM"}],"mentions":{},"annotations":[{"start":30,"end":32,"probability":0.6403,"type":"Organization","normalized_text":"EMA"}]},"text":"Article co-authored by senior EMA staff states that excessive risk aversion not in best interest of public health: http://t.co/BteCcdG2L4","created_at":"2013-11-18T10:53:06.000Z","author_id":"116716199","lang":"en","conversation_id":"402388994295472128","possibly_sensitive":false,"id":"402388994295472128","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":68,"end":75,"tag":"stroke"}],"urls":[{"start":114,"end":136,"url":"http://t.co/LFOsRFFLno","expanded_url":"http://bit.ly/17vmF90","display_url":"bit.ly/17vmF90"}],"mentions":{},"annotations":{}},"text":"Send us your comments on our draft guidance on medicines to prevent #stroke in patients with atrial fibrillation: http://t.co/LFOsRFFLno","created_at":"2013-11-18T10:47:25.000Z","author_id":"116716199","lang":"en","conversation_id":"402387563622567936","possibly_sensitive":false,"id":"402387563622567936","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":53,"end":64,"tag":"veterinary"},{"start":86,"end":100,"tag":"antimicrobial"}],"urls":[{"start":113,"end":135,"url":"http://t.co/zKrWhyOELU","expanded_url":"http://bit.ly/1hRrYJO","display_url":"bit.ly/1hRrYJO"}],"mentions":{},"annotations":{}},"text":"Two more weeks to comment on our draft guideline for #veterinary medicines containing #antimicrobial substances: http://t.co/zKrWhyOELU","created_at":"2013-11-18T10:40:14.000Z","author_id":"116716199","lang":"en","conversation_id":"402385754208616448","possibly_sensitive":false,"id":"402385754208616448","source":"bitly bitlink","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":111,"end":116,"tag":"pain"}],"urls":[{"start":118,"end":140,"url":"http://t.co/jd3uH4Auhx","expanded_url":"http://bit.ly/19yEoMs","display_url":"bit.ly/19yEoMs"}],"mentions":{},"annotations":{}},"text":"Two more weeks to comment on our draft guideline on the clinical development of medicines for the treatment of #pain: http://t.co/jd3uH4Auhx","created_at":"2013-11-18T10:37:54.000Z","author_id":"116716199","lang":"en","conversation_id":"402385167308062720","possibly_sensitive":false,"id":"402385167308062720","source":"bitly bitlink","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":52,"end":63,"tag":"biosimilar"}],"urls":[{"start":117,"end":139,"url":"http://t.co/aT2FCQIVZH","expanded_url":"http://bit.ly/I0SUXE","display_url":"bit.ly/I0SUXE"}],"mentions":{},"annotations":{}},"text":"Two more weeks to comment on our draft guideline on #biosimilar medicines containing biotechnology-derived proteins: http://t.co/aT2FCQIVZH","created_at":"2013-11-18T10:36:05.000Z","author_id":"116716199","lang":"en","conversation_id":"402384708161789952","possibly_sensitive":false,"id":"402384708161789952","source":"bitly bitlink","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":30,"end":35,"tag":"CHMP"}],"urls":[{"start":85,"end":107,"url":"http://t.co/a1EAgaKgMt","expanded_url":"http://bit.ly/1inAlKW","display_url":"bit.ly/1inAlKW"}],"mentions":{},"annotations":{}},"text":"Our human medicines committee #CHMP meets this week. Highlights published on Friday: http://t.co/a1EAgaKgMt","created_at":"2013-11-18T10:29:52.000Z","author_id":"116716199","lang":"en","conversation_id":"402383145464762368","possibly_sensitive":false,"id":"402383145464762368","source":"bitly bitlink","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"annotations":{}},"text":"RT @FrancoisMaignen: Assessing the extent and impact of the masking effect of disproportionality analyses on two spontaneous reporting sy…h…","created_at":"2013-11-18T10:27:27.000Z","author_id":"116716199","lang":"en","conversation_id":"402382538032676864","possibly_sensitive":false,"id":"402382538032676864","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402381192089337856"}]},{"entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"annotations":[{"start":99,"end":114,"probability":0.8213,"type":"Person","normalized_text":"Francois Maignen"},{"start":117,"end":130,"probability":0.9285,"type":"Person","normalized_text":"Manfred Hauben"},{"start":133,"end":135,"probability":0.7491,"type":"Person","normalized_text":"Eri"}]},"text":"RT @FrancoisMaignen: A conceptual approach to the masking effect of measures of disproportionality\nFrancois Maignen, Manfred Hauben, Eri…ht…","created_at":"2013-11-18T10:27:03.000Z","author_id":"116716199","lang":"en","conversation_id":"402382436236926976","possibly_sensitive":false,"id":"402382436236926976","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402380945334226944"}]},{"entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"annotations":[{"start":35,"end":73,"probability":0.3402,"type":"Other","normalized_text":"European Antibiotics Awareness Day 2013"}]},"text":"RT @URPLWMiPB: Our Office supports European Antibiotics Awareness Day 2013, which is taking place on Monday 18 November 2013 http://t.co/BK…","created_at":"2013-11-18T10:25:31.000Z","author_id":"116716199","lang":"en","conversation_id":"402382051942203392","possibly_sensitive":false,"id":"402382051942203392","source":"TweetDeck","public_metrics":{"retweet_count":18,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402379837131612160"}]},{"entities":{"hashtags":[{"start":95,"end":106,"tag":"resistance"},{"start":134,"end":139,"tag":"EAAD"}],"urls":[{"start":111,"end":133,"url":"http://t.co/s6wmjyA9fM","expanded_url":"http://bit.ly/1fO9ci1","display_url":"bit.ly/1fO9ci1"}],"mentions":{},"annotations":[{"start":17,"end":49,"probability":0.7062,"type":"Other","normalized_text":"European Antibiotic Awareness Day"}]},"text":"We're supporting European Antibiotic Awareness Day today. Find out how we're helping to combat #resistance:  http://t.co/s6wmjyA9fM #EAAD","created_at":"2013-11-18T10:23:42.000Z","author_id":"116716199","lang":"en","conversation_id":"402381595468124160","possibly_sensitive":false,"id":"402381595468124160","source":"bitly bitlink","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":2,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":74,"end":96,"url":"http://t.co/a63vZYXVeC","expanded_url":"http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON336726","display_url":"mhra.gov.uk/NewsCentre/Pre…"}],"mentions":[{"start":3,"end":13,"username":"MHRApress","id":"330990243"}],"annotations":{}},"text":"RT @MHRApress: Expert group calls for earlier patient access to medicines http://t.co/a63vZYXVeC","created_at":"2013-11-18T10:05:56.000Z","author_id":"116716199","lang":"en","conversation_id":"402377120812261376","possibly_sensitive":false,"id":"402377120812261376","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402376577645690880"}]},{"entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":13,"username":"HAIEurope","id":"3314634701"}],"annotations":[{"start":15,"end":16,"probability":0.8832,"type":"Place","normalized_text":"UK"}]},"text":"RT @HAIEurope: UK’s Expert Group on Innovation in the Reg. of Healthcare urges for early access to unlicensed &amp; innovative medicines http:/…","created_at":"2013-11-18T10:05:48.000Z","author_id":"116716199","lang":"en","conversation_id":"402377088906166272","possibly_sensitive":false,"id":"402377088906166272","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402364563611348992"}]},{"entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":19,"username":"Martinharvey100","id":"113148426"},{"start":21,"end":36,"username":"NatRevDrugDisc","id":"36066745"},{"start":37,"end":46,"username":"EMA_News","id":"116716199"}],"annotations":{}},"text":"RT @Martinharvey100: @NatRevDrugDisc @EMA_News suggests being too risk-averse in drug regulation can actually harm not help public health h…","created_at":"2013-11-18T10:04:30.000Z","author_id":"116716199","lang":"en","conversation_id":"402376761968586754","possibly_sensitive":false,"id":"402376761968586754","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402376375098945536"}]},{"entities":{"hashtags":[{"start":59,"end":64,"tag":"EAAD"}],"urls":[{"start":93,"end":115,"url":"http://t.co/GyrApeTVOm","expanded_url":"http://bit.ly/18hstH2","display_url":"bit.ly/18hstH2"}],"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"annotations":[{"start":25,"end":57,"probability":0.7638,"type":"Other","normalized_text":"European Antibiotic Awareness Day"}]},"text":"RT @WHO_Europe: Today is European Antibiotic Awareness Day #EAAD Use antibiotics responsibly http://t.co/GyrApeTVOm","created_at":"2013-11-18T09:42:24.000Z","author_id":"116716199","lang":"en","conversation_id":"402371199654588416","possibly_sensitive":false,"id":"402371199654588416","source":"TweetDeck","public_metrics":{"retweet_count":34,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402371122831687681"}]},{"entities":{"hashtags":[{"start":22,"end":34,"tag":"Antibiotics"},{"start":49,"end":54,"tag":"EAAD"}],"urls":{},"mentions":[{"start":3,"end":11,"username":"EPHA_EU","id":"184756856"}],"annotations":{}},"text":"RT @EPHA_EU: European #Antibiotics Awareness day #EAAD | [Press release] The clock is at five-to-twelve for antibiotic resistance: http://t…","created_at":"2013-11-18T09:38:14.000Z","author_id":"116716199","lang":"en","conversation_id":"402370150088712192","possibly_sensitive":false,"id":"402370150088712192","source":"TweetDeck","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402370034682458112"}]},{"entities":{"hashtags":[{"start":49,"end":63,"tag":"antimicrobial"},{"start":76,"end":81,"tag":"EFSA"},{"start":82,"end":87,"tag":"ECDC"}],"urls":[{"start":89,"end":111,"url":"http://t.co/uYQ9dbnjod","expanded_url":"http://bit.ly/17fUuxJ","display_url":"bit.ly/17fUuxJ"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":[{"start":26,"end":31,"probability":0.9596,"type":"Place","normalized_text":"Europe"}]},"text":"RT @EFSA_EU: Infographic: Europe’s fight against #antimicrobial resistance. #EFSA #ECDC  http://t.co/uYQ9dbnjod","created_at":"2013-11-18T09:34:43.000Z","author_id":"116716199","lang":"en","conversation_id":"402369266810241024","possibly_sensitive":false,"id":"402369266810241024","source":"TweetDeck","public_metrics":{"retweet_count":23,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402367424877453314"}]},{"entities":{"hashtags":[{"start":58,"end":63,"tag":"EAAD"}],"urls":{},"mentions":[{"start":3,"end":11,"username":"EAAD_EU","id":"1725283578"},{"start":104,"end":114,"username":"EU_Health","id":"606325697"},{"start":116,"end":132,"username":"innovationunion","id":"786508396245639172"}],"annotations":[{"start":18,"end":50,"probability":0.5047,"type":"Other","normalized_text":"European Antibiotic Awareness Day"}]},"text":"RT @EAAD_EU: It's European Antibiotic Awareness Day! Join #EAAD Twitter chat: 13:00-14:30 CET, w/ ECDC, @EU_Health, @innovationunion, @WHO_…","created_at":"2013-11-18T09:32:58.000Z","author_id":"116716199","lang":"en","conversation_id":"402368827079393281","possibly_sensitive":false,"id":"402368827079393281","source":"TweetDeck","public_metrics":{"retweet_count":18,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402363464384905216"}]},{"entities":{"hashtags":[{"start":58,"end":63,"tag":"EAAD"}],"urls":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"},{"start":104,"end":114,"username":"EU_Health","id":"606325697"},{"start":116,"end":132,"username":"innovationunion","id":"786508396245639172"}],"annotations":[{"start":18,"end":50,"probability":0.5047,"type":"Other","normalized_text":"European Antibiotic Awareness Day"}]},"text":"RT @ECDC_EU: It's European Antibiotic Awareness Day! Join #EAAD Twitter chat: 13:00-14:30 CET, w/ ECDC, @EU_Health, @innovationunion, @WHO_…","created_at":"2013-11-18T09:32:54.000Z","author_id":"116716199","lang":"en","conversation_id":"402368811254296576","possibly_sensitive":false,"id":"402368811254296576","source":"TweetDeck","public_metrics":{"retweet_count":19,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402363464355573762"}]},{"entities":{"hashtags":[{"start":58,"end":62,"tag":"AMR"}],"urls":{},"mentions":[{"start":3,"end":15,"username":"CPME_EUROPA","id":"440810430"}],"annotations":{}},"text":"RT @CPME_EUROPA: doctor’s role is important in containing #AMR by promoting good practices on prudent use of antibiotics &amp; providing input …","created_at":"2013-11-18T09:32:21.000Z","author_id":"116716199","lang":"en","conversation_id":"402368671995011072","possibly_sensitive":false,"id":"402368671995011072","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"402360364764913664"}]},{"entities":{"hashtags":[{"start":72,"end":87,"tag":"bioequivalence"}],"urls":[{"start":112,"end":134,"url":"http://t.co/LFE1dwRYqR","expanded_url":"http://bit.ly/1ifPXQq","display_url":"bit.ly/1ifPXQq"}],"mentions":{},"annotations":{}},"text":"We've published 16 product-specific guidance documents on demonstrating #bioequivalence, open for consultation: http://t.co/LFE1dwRYqR","created_at":"2013-11-15T14:21:38.000Z","author_id":"116716199","lang":"en","conversation_id":"401354309168013312","possibly_sensitive":false,"id":"401354309168013312","source":"bitly bitlink","public_metrics":{"retweet_count":7,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":40,"end":54,"tag":"Eurobarometer"},{"start":127,"end":132,"tag":"EAAD"},{"start":133,"end":137,"tag":"AMR"}],"urls":[{"start":104,"end":126,"url":"http://t.co/I9eDXfGKHx","expanded_url":"http://bit.ly/1bsCa2z","display_url":"bit.ly/1bsCa2z"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"text":"RT @EU_Health: Antimicrobial resistance #Eurobarometer November 2013 - summary &amp; country factsheets http://t.co/I9eDXfGKHx #EAAD #AMR #anti…","created_at":"2013-11-15T14:17:02.000Z","author_id":"116716199","lang":"en","conversation_id":"401353150222721024","possibly_sensitive":false,"id":"401353150222721024","source":"TweetDeck","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"401352704292700160"}]},{"entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"},{"start":59,"end":70,"username":"WHO_Europe","id":"125403342"},{"start":83,"end":93,"username":"EU_Health","id":"606325697"},{"start":94,"end":110,"username":"innovationunion","id":"786508396245639172"}],"annotations":{}},"text":"RT @ECDC_EU: What do new EU data on antibiotics mean? ECDC @WHO_Europe, jpiamr.eu, @EU_Health @innovationunion  discuss at 2pm.Follow  #EAA…","created_at":"2013-11-15T12:49:51.000Z","author_id":"116716199","lang":"en","conversation_id":"401331208887361536","possibly_sensitive":false,"id":"401331208887361536","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"401327801368084480"}]},{"entities":{"hashtags":[{"start":47,"end":58,"tag":"spirometry"},{"start":77,"end":82,"tag":"COPD"},{"start":83,"end":89,"tag":"h2020"},{"start":93,"end":105,"tag":"EUCOPDBrx13"}],"urls":{},"mentions":[{"start":3,"end":16,"username":"EFA_Patients","id":"1299643704"}],"annotations":{}},"text":"RT @EFA_Patients: Test your lung capacity with #spirometry and learn more on #COPD #h2020 at #EUCOPDBrx13 event on 28 Nov http://t.co/MVuaS…","created_at":"2013-11-15T12:49:35.000Z","author_id":"116716199","lang":"en","conversation_id":"401331141220651008","possibly_sensitive":false,"id":"401331141220651008","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"401330130951618560"}]},{"entities":{"hashtags":[{"start":50,"end":61,"tag":"regulation"}],"urls":[{"start":118,"end":140,"url":"http://t.co/9bqYDKK8r9","expanded_url":"http://bit.ly/1atRfTM","display_url":"bit.ly/1atRfTM"}],"mentions":{},"annotations":[{"start":85,"end":87,"probability":0.6983,"type":"Organization","normalized_text":"EMA"}]},"text":"New article on the risks of risk aversion in drug #regulation, co-authored by senior EMA staff and committee members: http://t.co/9bqYDKK8r9","created_at":"2013-11-15T11:44:15.000Z","author_id":"116716199","lang":"en","conversation_id":"401314703114522624","possibly_sensitive":false,"id":"401314703114522624","source":"bitly bitlink","public_metrics":{"retweet_count":4,"reply_count":3,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":70,"end":77,"tag":"stroke"}],"urls":[{"start":116,"end":138,"url":"http://t.co/L1GlxTAm8n","expanded_url":"http://bit.ly/17vmF90","display_url":"bit.ly/17vmF90"}],"mentions":{},"annotations":{}},"text":"We're consulting on draft guidance on developing medicines to prevent #stroke in patients with atrial fibrillation: http://t.co/L1GlxTAm8n","created_at":"2013-11-15T10:05:48.000Z","author_id":"116716199","lang":"en","conversation_id":"401289926836506625","possibly_sensitive":false,"id":"401289926836506625","source":"bitly bitlink","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":69,"end":91,"url":"http://t.co/L5zzshOPR7","expanded_url":"http://bit.ly/1j8Sl9r","display_url":"bit.ly/1j8Sl9r"},{"start":116,"end":138,"url":"http://t.co/PXIKAo9uV4","expanded_url":"http://bit.ly/176ZhkW","display_url":"bit.ly/176ZhkW"}],"mentions":{},"annotations":{}},"text":"@BOXINGBENZILLA Please check our website for details including FAQs: http://t.co/L5zzshOPR7. Or send us a question: http://t.co/PXIKAo9uV4","created_at":"2013-11-15T09:48:32.000Z","author_id":"116716199","lang":"en","conversation_id":"401073246596268032","possibly_sensitive":false,"id":"401285581386182656","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"401073246596268032"}],"in_reply_to_user_id":"24148158"},{"entities":{"hashtags":[{"start":27,"end":40,"tag":"rarediseases"}],"urls":[{"start":101,"end":123,"url":"http://t.co/q5CWxkRYNt","expanded_url":"http://bit.ly/1crj0M4","display_url":"bit.ly/1crj0M4"}],"mentions":{},"annotations":[{"start":93,"end":98,"probability":0.9881,"type":"Place","normalized_text":"Berlin"}]},"text":"The European conference on #rarediseases and orphan products takes place on 8-10 May 2014 in Berlin: http://t.co/q5CWxkRYNt","created_at":"2013-11-14T16:45:56.000Z","author_id":"116716199","lang":"en","conversation_id":"401028233212067841","possibly_sensitive":false,"id":"401028233212067841","source":"Twitter Web Client","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":110,"end":132,"url":"http://t.co/WjECFTKOn2","expanded_url":"http://bit.ly/1e5fCbX","display_url":"bit.ly/1e5fCbX"}],"mentions":{},"annotations":[{"start":102,"end":107,"probability":0.9926,"type":"Place","normalized_text":"London"}]},"text":"Registration is open for the annual EMA review of the year and outlook for 2014, on 28-29 November in London: http://t.co/WjECFTKOn2","created_at":"2013-11-14T16:40:35.000Z","author_id":"116716199","lang":"en","conversation_id":"401026888480460800","possibly_sensitive":false,"id":"401026888480460800","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":46,"end":55,"tag":"diabetes"}],"urls":[{"start":111,"end":133,"url":"http://t.co/t9kkMKjWmo","expanded_url":"http://bit.ly/1j6AoIx","display_url":"bit.ly/1j6AoIx"}],"mentions":{},"annotations":[{"start":11,"end":28,"probability":0.8468,"type":"Other","normalized_text":"World Diabetes Day"}]},"text":"We support World Diabetes Day. Read about the #diabetes medicines recently recommended for approval in the EU: http://t.co/t9kkMKjWmo","created_at":"2013-11-14T16:35:07.000Z","author_id":"116716199","lang":"en","conversation_id":"401025512002162688","possibly_sensitive":false,"id":"401025512002162688","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":92,"end":106,"tag":"pyrrolizidine"}],"urls":[{"start":118,"end":140,"url":"http://t.co/vlikiAtv9y","expanded_url":"http://bit.ly/1crVrCP","display_url":"bit.ly/1crVrCP"}],"mentions":{},"annotations":{}},"text":"We're consulting on a 2nd draft statement on herbal medicines containing toxic, unsaturated #pyrrolizidine alkaloids: http://t.co/vlikiAtv9y","created_at":"2013-11-14T14:48:57.000Z","author_id":"116716199","lang":"en","conversation_id":"400998795905093632","possibly_sensitive":false,"id":"400998795905093632","source":"bitly bitlink","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":18,"end":22,"tag":"WDD"},{"start":80,"end":90,"tag":"hepatitis"}],"urls":{},"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"annotations":{}},"text":"RT @Hep_Alliance: #WDD what better day to learn about the risks of diabetes for #hepatitis C patients and the precautions you can take! htt…","created_at":"2013-11-14T12:05:23.000Z","author_id":"116716199","lang":"en","conversation_id":"400957629633003521","possibly_sensitive":false,"id":"400957629633003521","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"400953718750724096"}]},{"entities":{"hashtags":[{"start":48,"end":61,"tag":"rarediseases"}],"urls":[{"start":110,"end":132,"url":"http://t.co/TghTPTRAf2","expanded_url":"http://bit.ly/1crj0M4","display_url":"bit.ly/1crj0M4"}],"mentions":{},"annotations":[{"start":102,"end":107,"probability":0.989,"type":"Place","normalized_text":"Berlin"}]},"text":"We're taking part in the European conference on #rarediseases and orphan products on 8-10 May 2014 in Berlin: http://t.co/TghTPTRAf2","created_at":"2013-11-14T11:26:50.000Z","author_id":"116716199","lang":"en","conversation_id":"400947931551129600","possibly_sensitive":false,"id":"400947931551129600","source":"bitly bitlink","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":96,"end":118,"url":"http://t.co/FToe2jiGg2","expanded_url":"http://bit.ly/1e5fCbX","display_url":"bit.ly/1e5fCbX"}],"mentions":{},"annotations":[{"start":88,"end":93,"probability":0.9918,"type":"Place","normalized_text":"London"}]},"text":"The annual EMA review of the year and outlook for 2014 takes place on 28-29 November in London: http://t.co/FToe2jiGg2","created_at":"2013-11-14T11:21:00.000Z","author_id":"116716199","lang":"en","conversation_id":"400946463574069248","possibly_sensitive":false,"id":"400946463574069248","source":"bitly bitlink","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":113,"end":120,"tag":"ctdata"}],"urls":[{"start":89,"end":111,"url":"http://t.co/pVZWUx4ubB","expanded_url":"http://bit.ly/18ra6LY","display_url":"bit.ly/18ra6LY"}],"mentions":{},"annotations":{}},"text":"Yesterday we provided an update on our policy on the publication of clinical-trial data: http://t.co/pVZWUx4ubB  #ctdata","created_at":"2013-11-14T11:09:55.000Z","author_id":"116716199","lang":"en","conversation_id":"400943672839004160","possibly_sensitive":false,"id":"400943672839004160","source":"Twitter Web Client","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":47,"end":56,"tag":"diabetes"}],"urls":[{"start":111,"end":133,"url":"http://t.co/AOX3zdIJyp","expanded_url":"http://bit.ly/1j6AoIx","display_url":"bit.ly/1j6AoIx"}],"mentions":{},"annotations":[{"start":17,"end":34,"probability":0.8103,"type":"Other","normalized_text":"World Diabetes Day"}]},"text":"We're supporting World Diabetes Day. Eight new #diabetes medicines recommended for approval in past 18 months: http://t.co/AOX3zdIJyp","created_at":"2013-11-14T11:05:15.000Z","author_id":"116716199","lang":"en","conversation_id":"400942498291666944","possibly_sensitive":false,"id":"400942498291666944","source":"bitly bitlink","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":118,"end":122,"tag":"WDD"}],"urls":[{"start":95,"end":117,"url":"http://t.co/i9RTVTKrMe","expanded_url":"http://www.imi-summit.eu","display_url":"imi-summit.eu"}],"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{}},"text":"RT @IMI_JU: IMI project SUMMIT is creating the largest ever database on diabetic complications http://t.co/i9RTVTKrMe #WDD","created_at":"2013-11-14T10:32:15.000Z","author_id":"116716199","lang":"en","conversation_id":"400934192009064448","possibly_sensitive":false,"id":"400934192009064448","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"400930784309018625"}]},{"entities":{"hashtags":[{"start":65,"end":73,"tag":"anaemia"},{"start":110,"end":121,"tag":"commitment"},{"start":122,"end":126,"tag":"fp7"}],"urls":[{"start":87,"end":109,"url":"http://t.co/S2wGTw3u0q","expanded_url":"http://cordis.europa.eu/fetch?CALLER=EN_NEWS&ACTION=D&SESSION=&RCN=36245","display_url":"cordis.europa.eu/fetch?CALLER=E…"}],"mentions":[{"start":3,"end":12,"username":"myCORDIS","id":"818505470608572416"}],"annotations":{}},"text":"RT @myCORDIS: EU red blood cell research project to advance rare #anaemia patient care http://t.co/S2wGTw3u0q #commitment #fp7","created_at":"2013-11-14T09:27:57.000Z","author_id":"116716199","lang":"en","conversation_id":"400918010753335296","possibly_sensitive":false,"id":"400918010753335296","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"400917790120357888"}]},{"entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"}],"annotations":[{"start":40,"end":82,"probability":0.6825,"type":"Other","normalized_text":"Therapeutic Innovation & Regulatory Science"}]},"text":"RT @DrugInfoAssn: The November issue of Therapeutic Innovation &amp; Regulatory Science features 2 interesting articles on collaboration. http:…","created_at":"2013-11-13T17:17:36.000Z","author_id":"116716199","lang":"en","conversation_id":"400673815744634880","possibly_sensitive":false,"id":"400673815744634880","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"400669557997592576"}]},{"entities":{"hashtags":[{"start":71,"end":76,"tag":"MERS"}],"urls":{},"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"},{"start":84,"end":88,"username":"WHO","id":"14499829"}],"annotations":{}},"text":"RT @ECDC_Flu: Excellent overview on what we know and do not know about #MERS-CoV by @WHO MERSCoV Research group @PLOSCurrentsOut: http://t.…","created_at":"2013-11-13T17:13:16.000Z","author_id":"116716199","lang":"en","conversation_id":"400672725707919360","possibly_sensitive":false,"id":"400672725707919360","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"400660266997673984"}]},{"entities":{"hashtags":{},"urls":[{"start":116,"end":138,"url":"http://t.co/DqMS4YToGv","expanded_url":"http://bit.ly/1aEtIMw","display_url":"bit.ly/1aEtIMw"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":[{"start":85,"end":96,"probability":0.7845,"type":"Place","normalized_text":"Parma, Italy"}]},"text":"RT @EFSA_EU: Vacancy: Executive Director of EFSA, (Temporary Agent - Grade AD 14) in Parma, Italy - COM/2013/10342. http://t.co/DqMS4YToGv","created_at":"2013-11-13T17:07:38.000Z","author_id":"116716199","lang":"en","conversation_id":"400671307013967872","possibly_sensitive":false,"id":"400671307013967872","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"400651617046777856"}]},{"entities":{"hashtags":[{"start":50,"end":54,"tag":"GMP"},{"start":61,"end":65,"tag":"GDP"}],"urls":[{"start":114,"end":136,"url":"http://t.co/usnxgnG79u","expanded_url":"http://ow.ly/qokzH","display_url":"ow.ly/qokzH"}],"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"}],"annotations":[{"start":22,"end":36,"probability":0.9864,"type":"Person","normalized_text":"Richard Andrews"}]},"text":"RT @MHRAgovuk: MHRA's Richard Andrews to speak at #GMP &amp; #GDP Symposium. 17+ years pharmaceutical experience: http://t.co/usnxgnG79u","created_at":"2013-11-13T17:05:51.000Z","author_id":"116716199","lang":"en","conversation_id":"400670860467376128","possibly_sensitive":false,"id":"400670860467376128","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"400643503480643584"}]},{"entities":{"hashtags":[{"start":41,"end":45,"tag":"WDD"}],"urls":[{"start":85,"end":107,"url":"http://t.co/tic9YRBtaq","expanded_url":"http://bit.ly/HR4Mek","display_url":"bit.ly/HR4Mek"}],"mentions":[{"start":3,"end":7,"username":"WDD","id":"15179874"}],"annotations":{}},"text":"RT @WDD: Only 1 day to go! Check out the #WDD newsletter for the latest information! http://t.co/tic9YRBtaq","created_at":"2013-11-13T17:04:36.000Z","author_id":"116716199","lang":"en","conversation_id":"400670543998775296","possibly_sensitive":false,"id":"400670543998775296","source":"TweetDeck","public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"400638275339038720"}]},{"entities":{"hashtags":[{"start":59,"end":68,"tag":"clinical"}],"urls":{},"mentions":[{"start":3,"end":14,"username":"europarltv","id":"1038025055433904128"},{"start":108,"end":123,"username":"GlenisWillmott","id":"106110469"}],"annotations":{}},"text":"RT @europarltv: \"I think we should know the results of all #clinical trials even if they're not successful\" @GlenisWillmott http://t.co/XiW…","created_at":"2013-11-13T17:04:24.000Z","author_id":"116716199","lang":"en","conversation_id":"400670493037965312","possibly_sensitive":false,"id":"400670493037965312","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"400637959038570496"}]},{"entities":{"hashtags":[{"start":25,"end":36,"tag":"antibiotic"}],"urls":[{"start":71,"end":93,"url":"http://t.co/0WIYnBiWwK","expanded_url":"http://bit.ly/1fBDUuu","display_url":"bit.ly/1fBDUuu"}],"mentions":[{"start":3,"end":12,"username":"agesnews","id":"223456379"},{"start":94,"end":102,"username":"meyerar","id":"264210776"},{"start":103,"end":114,"username":"Gerdbillen","id":"43111409"},{"start":115,"end":126,"username":"LambrechtO","id":"299212398"},{"start":127,"end":133,"username":"BfRde","id":"51214982"}],"annotations":{}},"text":"RT @agesnews: Veterinary #antibiotic sale volumes in Austria 2010-2012 http://t.co/0WIYnBiWwK @meyerar @Gerdbillen @LambrechtO @BfRde","created_at":"2013-11-13T16:59:51.000Z","author_id":"116716199","lang":"et","conversation_id":"400669350928990208","possibly_sensitive":false,"id":"400669350928990208","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":106,"end":117,"tag":"palliative"}],"urls":[{"start":118,"end":140,"url":"http://t.co/1lvoSjtd2h","expanded_url":"http://ow.ly/qM7lX","display_url":"ow.ly/qM7lX"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"},{"start":93,"end":99,"username":"EORTC","id":"414752636"}],"annotations":{}},"text":"RT @myESMO: Prognostic value of baseline QOL data for survival in different types of cancer: @EORTC study #palliative http://t.co/1lvoSjtd2h","created_at":"2013-11-13T13:39:09.000Z","author_id":"116716199","lang":"en","conversation_id":"400618840934989824","possibly_sensitive":false,"id":"400618840934989824","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"400618682130649088"}]},{"entities":{"hashtags":[{"start":126,"end":133,"tag":"ctdata"}],"urls":[{"start":103,"end":125,"url":"http://t.co/ozzMT5QREE","expanded_url":"http://bit.ly/HXGxut","display_url":"bit.ly/HXGxut"}],"mentions":[{"start":3,"end":13,"username":"HAIEurope","id":"3314634701"},{"start":15,"end":28,"username":"DrDavidHealy","id":"455904453"}],"annotations":{}},"text":"RT @HAIEurope: @DrDavidHealy features our new policy paper on Clinical Trial transparency in his blog: http://t.co/ozzMT5QREE #ctdata","created_at":"2013-11-13T13:33:33.000Z","author_id":"116716199","lang":"en","conversation_id":"400617430851940352","possibly_sensitive":false,"id":"400617430851940352","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":29,"end":41,"tag":"antibiotics"}],"urls":{},"mentions":[{"start":3,"end":11,"username":"EAAD_EU","id":"1725283578"},{"start":98,"end":106,"username":"ECDC_EU","id":"204752573"},{"start":107,"end":117,"username":"EU_Health","id":"606325697"},{"start":118,"end":134,"username":"innovationunion","id":"786508396245639172"}],"annotations":[{"start":42,"end":48,"probability":0.4027,"type":"Product","normalized_text":"Twitter"}]},"text":"RT @EAAD_EU: Please RT: Join #antibiotics Twitter chat on 18 Nov 13:00-14:30 CET, w/ experts from @ECDC_EU @EU_Health @innovationunion @WHO…","created_at":"2013-11-13T13:32:31.000Z","author_id":"116716199","lang":"en","conversation_id":"400617171119652864","possibly_sensitive":false,"id":"400617171119652864","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"400605156766916608"}]},{"entities":{"hashtags":[{"start":71,"end":80,"tag":"Diabetes"},{"start":136,"end":140,"tag":"WDD"}],"urls":{},"mentions":[{"start":3,"end":18,"username":"IntDiabetesFed","id":"38393473"}],"annotations":[{"start":38,"end":55,"probability":0.9371,"type":"Other","normalized_text":"World Diabetes Day"}]},"text":"RT @IntDiabetesFed: One day away from World Diabetes Day!Check out new #Diabetes Atlas website &amp; new statistics going live tomorrow #WDD ht…","created_at":"2013-11-13T13:30:39.000Z","author_id":"116716199","lang":"en","conversation_id":"400616702284541952","possibly_sensitive":false,"id":"400616702284541952","source":"TweetDeck","public_metrics":{"retweet_count":41,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"400601776023298048"}]},{"entities":{"hashtags":[{"start":39,"end":49,"tag":"medicines"},{"start":103,"end":108,"tag":"AIFA"}],"urls":[{"start":109,"end":131,"url":"http://t.co/TaIIxlHZo1","expanded_url":"http://bit.ly/1gJghTN","display_url":"bit.ly/1gJghTN"}],"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"annotations":{}},"text":"RT @Aifa_ufficiale: All information on #medicines just a click away. We present the Medicines Databank #AIFA http://t.co/TaIIxlHZo1","created_at":"2013-11-13T12:21:59.000Z","author_id":"116716199","lang":"en","conversation_id":"400599420137259008","possibly_sensitive":false,"id":"400599420137259008","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":27,"end":36,"tag":"Diabetes"},{"start":73,"end":77,"tag":"WDD"}],"urls":[{"start":91,"end":113,"url":"http://t.co/nbNCNL64mR","expanded_url":"http://bit.ly/16jyPEp","display_url":"bit.ly/16jyPEp"}],"mentions":[{"start":3,"end":7,"username":"WDD","id":"15179874"}],"annotations":{}},"text":"RT @WDD: Tomorrow is World #Diabetes Day. We need your support, join the #WDD thunderclap: http://t.co/nbNCNL64mR","created_at":"2013-11-13T12:17:12.000Z","author_id":"116716199","lang":"en","conversation_id":"400598216741109760","possibly_sensitive":false,"id":"400598216741109760","source":"TweetDeck","public_metrics":{"retweet_count":29,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"400575702199586816"}]},{"entities":{"hashtags":{},"urls":{},"mentions":[{"start":0,"end":16,"username":"ScripRegMaureen","id":"552617924"}],"annotations":{}},"text":"@ScripRegMaureen We will provide an update following our next Management Board meeting on 11-12 December at the latest.","created_at":"2013-11-13T10:41:03.000Z","author_id":"116716199","lang":"en","conversation_id":"400572507893161984","possibly_sensitive":false,"id":"400574018836656128","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"400572507893161984"}],"in_reply_to_user_id":"552617924"},{"entities":{"hashtags":[{"start":104,"end":111,"tag":"ctdata"}],"urls":[{"start":81,"end":103,"url":"http://t.co/pVZWUx4ubB","expanded_url":"http://bit.ly/18ra6LY","display_url":"bit.ly/18ra6LY"}],"mentions":{},"annotations":{}},"text":"We've provided an update on our policy on the publication of clinical-trial data http://t.co/pVZWUx4ubB #ctdata","created_at":"2013-11-13T10:22:46.000Z","author_id":"116716199","lang":"en","conversation_id":"400569418544971776","possibly_sensitive":false,"id":"400569418544971776","source":"Twitter Web Client","public_metrics":{"retweet_count":10,"reply_count":2,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":123,"end":128,"tag":"EEAD"}],"urls":{},"mentions":[{"start":3,"end":11,"username":"EPHA_EU","id":"184756856"}],"annotations":[{"start":13,"end":19,"probability":0.5697,"type":"Organization","normalized_text":"Twitter"},{"start":89,"end":121,"probability":0.5796,"type":"Other","normalized_text":"European Antibiotic Awareness Day"}]},"text":"RT @EPHA_EU: Twitter chat: ask experts questions on Antibiotic Resistance: 18 Nov on the European Antibiotic Awareness Day #EEAD http://t.c…","created_at":"2013-11-13T09:50:28.000Z","author_id":"116716199","lang":"en","conversation_id":"400561290227101696","possibly_sensitive":false,"id":"400561290227101696","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"400557896536055808"}]},{"entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"text":"RT @GCessak: EMA Human medicines highlights - October 2013 | Key information for patients, consumers and healthcare professionals http://t.…","created_at":"2013-11-13T09:46:47.000Z","author_id":"116716199","lang":"en","conversation_id":"400560363151712256","possibly_sensitive":false,"id":"400560363151712256","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"400555880531234816"}]},{"entities":{"hashtags":[{"start":13,"end":23,"tag":"Grastofil"},{"start":25,"end":36,"tag":"filgrastim"},{"start":41,"end":52,"tag":"biosimilar"},{"start":56,"end":65,"tag":"Neupogen"}],"urls":[{"start":100,"end":122,"url":"http://t.co/eKecKf0ZYZ","expanded_url":"http://bit.ly/HJ7jqK","display_url":"bit.ly/HJ7jqK"}],"mentions":{},"annotations":{}},"text":"The EPAR for #Grastofil (#filgrastim), a #biosimilar of #Neupogen, is now available on our website: http://t.co/eKecKf0ZYZ","created_at":"2013-11-12T11:55:31.000Z","author_id":"116716199","lang":"en","conversation_id":"400230371981152257","possibly_sensitive":false,"id":"400230371981152257","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":18,"end":33,"tag":"ClinicalTrials"},{"start":61,"end":67,"tag":"India"}],"urls":[{"start":68,"end":90,"url":"http://t.co/vQJxSxHfqi","expanded_url":"http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/pharmaceuticals/clinical-trials-to-get-more-challenging/articleshow/25467694.cms?intenttarget=no","display_url":"economictimes.indiatimes.com/news/news-by-i…"}],"mentions":[{"start":95,"end":109,"username":"ArchiveDigger","id":"21736388"}],"annotations":{}},"text":"RT @sailinsomnia: #ClinicalTrials to get more challenging in #India http://t.co/vQJxSxHfqi via @ArchiveDigger","created_at":"2013-11-11T16:43:32.000Z","author_id":"116716199","lang":"en","conversation_id":"399940468416327682","possibly_sensitive":false,"id":"399940468416327682","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"399933777108930560"}]},{"entities":{"hashtags":{},"urls":[{"start":108,"end":130,"url":"http://t.co/S7OpQet1Hh","expanded_url":"http://bit.ly/17s234O","display_url":"bit.ly/17s234O"}],"mentions":[{"start":3,"end":13,"username":"TOPRANEWS","id":"26739900"}],"annotations":[{"start":76,"end":82,"probability":0.9812,"type":"Place","normalized_text":"America"}]},"text":"RT @TOPRANEWS: November's Regulatory Rapporteur offers our annual update on America’s regulatory landscape:.http://t.co/S7OpQet1Hh #regaffa…","created_at":"2013-11-11T15:14:25.000Z","author_id":"116716199","lang":"en","conversation_id":"399918039711227906","possibly_sensitive":false,"id":"399918039711227906","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"399917498897686528"}]},{"entities":{"hashtags":[{"start":42,"end":52,"tag":"Grastofil"},{"start":54,"end":65,"tag":"filgrastim"},{"start":70,"end":81,"tag":"biosimilar"},{"start":85,"end":94,"tag":"Neupogen"}],"urls":[{"start":96,"end":118,"url":"http://t.co/Xt0yOlOMnl","expanded_url":"http://bit.ly/HJ7jqK","display_url":"bit.ly/HJ7jqK"}],"mentions":{},"annotations":{}},"text":"We've published the assessment report for #Grastofil (#filgrastim), a #biosimilar of #Neupogen: http://t.co/Xt0yOlOMnl","created_at":"2013-11-11T15:05:39.000Z","author_id":"116716199","lang":"en","conversation_id":"399915834627616768","possibly_sensitive":false,"id":"399915834627616768","source":"bitly bitlink","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":18,"end":22,"tag":"FDA"},{"start":34,"end":41,"tag":"safety"},{"start":53,"end":60,"tag":"Sanofi"},{"start":69,"end":78,"tag":"Lemtrada"}],"urls":[{"start":79,"end":101,"url":"http://t.co/mi1iA1zed5","expanded_url":"http://reut.rs/1foBPls","display_url":"reut.rs/1foBPls"}],"mentions":[{"start":106,"end":114,"username":"Reuters","id":"1652541"}],"annotations":{}},"text":"RT @sailinsomnia: #FDA staff flag #safety fears over #Sanofi MS drug #Lemtrada http://t.co/mi1iA1zed5 via @reuters","created_at":"2013-11-11T15:03:23.000Z","author_id":"116716199","lang":"en","conversation_id":"399915264512258048","possibly_sensitive":false,"id":"399915264512258048","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"399914316419198977"}]},{"entities":{"hashtags":[{"start":15,"end":21,"tag":"Women"},{"start":50,"end":65,"tag":"clinicaltrials"},{"start":115,"end":130,"tag":"cancerresearch"}],"urls":[{"start":92,"end":114,"url":"http://t.co/gbeLHOQKLM","expanded_url":"http://bit.ly/1bo6ZZB","display_url":"bit.ly/1bo6ZZB"}],"mentions":[{"start":3,"end":13,"username":"HAIEurope","id":"3314634701"}],"annotations":{}},"text":"RT @HAIEurope: #Women under-represented in cancer #clinicaltrials studies, research reveals http://t.co/gbeLHOQKLM #cancerresearch @NatureN…","created_at":"2013-11-11T15:02:07.000Z","author_id":"116716199","lang":"en","conversation_id":"399914944465874944","possibly_sensitive":false,"id":"399914944465874944","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"399913469337554944"}]},{"entities":{"hashtags":[{"start":87,"end":92,"tag":"MERS"}],"urls":[{"start":64,"end":86,"url":"http://t.co/5jNnGRGagJ","expanded_url":"http://goo.gl/9Xt2f7","display_url":"goo.gl/9Xt2f7"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":[{"start":19,"end":29,"probability":0.3621,"type":"Place","normalized_text":"Middle East"}]},"text":"RT @WHO: Update on Middle East respiratory syndrome coronavirus http://t.co/5jNnGRGagJ #MERS","created_at":"2013-11-11T15:01:44.000Z","author_id":"116716199","lang":"en","conversation_id":"399914846851825664","possibly_sensitive":false,"id":"399914846851825664","source":"TweetDeck","public_metrics":{"retweet_count":47,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"399913241272254465"}]},{"entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"}],"annotations":[{"start":40,"end":82,"probability":0.4638,"type":"Other","normalized_text":"Therapeutic Innovation & Regulatory Science"}]},"text":"RT @DrugInfoAssn: The November issue of Therapeutic Innovation &amp; Regulatory Science features two interesting articles on... http://t.co/Hib…","created_at":"2013-11-11T15:00:59.000Z","author_id":"116716199","lang":"en","conversation_id":"399914660612157440","possibly_sensitive":false,"id":"399914660612157440","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"399910614044528640"}]},{"entities":{"hashtags":{},"urls":[{"start":100,"end":122,"url":"http://t.co/BaNPxqa13p","expanded_url":"http://www.washingtonpost.com/business/fda-policy-shift-would-allow-generic-drugmakers-to-quickly-update-drug-labels-to-warn-patients/2013/11/08/d31f8c7c-48ae-11e3-95a9-3f15b5618ba8_story.html","display_url":"washingtonpost.com/business/fda-p…"}],"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"}],"annotations":{}},"text":"RT @DrugInfoAssn: Proposed FDA Rule Would Allow Generic Drugmakers To Update Warning Labels Quickly.http://t.co/BaNPxqa13p","created_at":"2013-11-11T14:59:30.000Z","author_id":"116716199","lang":"en","conversation_id":"399914284894810112","possibly_sensitive":false,"id":"399914284894810112","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"399906374206779393"}]},{"entities":{"hashtags":[{"start":22,"end":34,"tag":"antibiotics"},{"start":124,"end":129,"tag":"EAAD"}],"urls":{},"mentions":[{"start":3,"end":11,"username":"EAAD_EU","id":"1725283578"},{"start":107,"end":115,"username":"EAAD_EU","id":"1725283578"}],"annotations":[{"start":35,"end":41,"probability":0.4779,"type":"Product","normalized_text":"Twitter"}]},"text":"RT @EAAD_EU: Join the #antibiotics Twitter chat ‘Everyone’s responsible’, Nov 18 13:00 – 14:30 CET, follow @EAAD_eu and use #EAAD http://t.…","created_at":"2013-11-11T14:33:59.000Z","author_id":"116716199","lang":"en","conversation_id":"399907865206333441","possibly_sensitive":false,"id":"399907865206333441","source":"TweetDeck","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"399893497429643264"}]},{"entities":{"hashtags":{},"urls":[{"start":54,"end":76,"url":"http://t.co/5nsRo5TzvN","expanded_url":"http://bit.ly/HFvuXu","display_url":"bit.ly/HFvuXu"}],"mentions":{},"annotations":{}},"text":"Last Friday we published the CVMP meeting highlights: http://t.co/5nsRo5TzvN","created_at":"2013-11-11T12:57:51.000Z","author_id":"116716199","lang":"en","conversation_id":"399883671605219328","possibly_sensitive":false,"id":"399883671605219328","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":23,"end":32,"tag":"acipimox"}],"urls":[{"start":112,"end":134,"url":"http://t.co/OmM1jplUZv","expanded_url":"http://bit.ly/1hpIsZh","display_url":"bit.ly/1hpIsZh"}],"mentions":{},"annotations":{}},"text":"PRAC recommended using #acipimox only as additional or alternative treatment to lower high triglyceride levels: http://t.co/OmM1jplUZv","created_at":"2013-11-11T12:56:49.000Z","author_id":"116716199","lang":"en","conversation_id":"399883413731041280","possibly_sensitive":false,"id":"399883413731041280","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":43,"end":53,"tag":"diacerein"}],"urls":[{"start":76,"end":98,"url":"http://t.co/KnrrKova2W","expanded_url":"http://bit.ly/HCA0Wn","display_url":"bit.ly/HCA0Wn"}],"mentions":{},"annotations":{}},"text":"Last Friday PRAC recommended suspension of #diacerein-containing medicines: http://t.co/KnrrKova2W","created_at":"2013-11-11T12:56:16.000Z","author_id":"116716199","lang":"en","conversation_id":"399883273226047488","possibly_sensitive":false,"id":"399883273226047488","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":79,"end":86,"tag":"cancer"},{"start":96,"end":104,"tag":"Iclusig"}],"urls":[{"start":106,"end":128,"url":"http://t.co/pF5uVapTTZ","expanded_url":"http://bit.ly/1fonUvG","display_url":"bit.ly/1fonUvG"}],"mentions":{},"annotations":{}},"text":"PRAC updates on the risks of serious vascular occlusive events associated with #cancer medicine #Iclusig: http://t.co/pF5uVapTTZ","created_at":"2013-11-11T12:55:24.000Z","author_id":"116716199","lang":"en","conversation_id":"399883056225337344","possibly_sensitive":false,"id":"399883056225337344","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":54,"end":76,"url":"http://t.co/1rVJWDEDuN","expanded_url":"http://bit.ly/1hpHTyO","display_url":"bit.ly/1hpHTyO"}],"mentions":{},"annotations":{}},"text":"Last Friday we published the PRAC meeting highlights: http://t.co/1rVJWDEDuN","created_at":"2013-11-11T12:53:03.000Z","author_id":"116716199","lang":"en","conversation_id":"399882462630670336","possibly_sensitive":false,"id":"399882462630670336","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":24,"end":28,"tag":"GMP"},{"start":33,"end":37,"tag":"GDP"}],"urls":[{"start":65,"end":87,"url":"http://t.co/6HGQGePuwb","expanded_url":"http://ow.ly/qokrJ","display_url":"ow.ly/qokrJ"}],"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"}],"annotations":{}},"text":"RT @MHRAgovuk: 2-4 Dec, #GMP and #GDP Symposium. Don't miss out! http://t.co/6HGQGePuwb","created_at":"2013-11-11T12:13:38.000Z","author_id":"116716199","lang":"en","conversation_id":"399872543210745856","possibly_sensitive":false,"id":"399872543210745856","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"399871815994318848"}]},{"entities":{"hashtags":[{"start":60,"end":67,"tag":"herbal"},{"start":81,"end":87,"tag":"Fucus"},{"start":101,"end":114,"tag":"bladderwrack"}],"urls":[{"start":117,"end":139,"url":"http://t.co/3c18b5y6BY","expanded_url":"http://bit.ly/1aKmxq9","display_url":"bit.ly/1aKmxq9"}],"mentions":{},"annotations":{}},"text":"Just a few more days left to comment on our draft Community #herbal monograph on #Fucus vesiculosus (#bladderwrack): http://t.co/3c18b5y6BY","created_at":"2013-11-11T12:03:04.000Z","author_id":"116716199","lang":"en","conversation_id":"399869885578104832","possibly_sensitive":false,"id":"399869885578104832","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":60,"end":67,"tag":"herbal"},{"start":81,"end":92,"tag":"Eucalyptus"}],"urls":[{"start":98,"end":120,"url":"http://t.co/nUqjVyhdQs","expanded_url":"http://bit.ly/1ge8iOu","display_url":"bit.ly/1ge8iOu"}],"mentions":{},"annotations":{}},"text":"Just a few more days left to comment on our draft Community #herbal monograph on #Eucalyptus oil: http://t.co/nUqjVyhdQs","created_at":"2013-11-11T12:02:41.000Z","author_id":"116716199","lang":"en","conversation_id":"399869790593904640","possibly_sensitive":false,"id":"399869790593904640","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":53,"end":68,"tag":"osteoarthritis"},{"start":69,"end":79,"tag":"Alzheimer"},{"start":82,"end":89,"tag":"cancer"},{"start":90,"end":99,"tag":"zoonoses"},{"start":110,"end":122,"tag":"antibiotics"}],"urls":{},"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{}},"text":"RT @IMI_JU: IMI 11th Call indicative text now online #osteoarthritis #Alzheimer's #cancer #zoonoses, ecorisks #antibiotics http://t.co/g20w…","created_at":"2013-11-11T11:20:39.000Z","author_id":"116716199","lang":"en","conversation_id":"399859210038427648","possibly_sensitive":false,"id":"399859210038427648","source":"TweetDeck","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"399859059693592576"}]},{"entities":{"hashtags":{},"urls":[{"start":96,"end":118,"url":"http://t.co/6Ybvd71Nfm","expanded_url":"http://bit.ly/HPC8ea","display_url":"bit.ly/HPC8ea"}],"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"annotations":{}},"text":"RT @AEMPSGOB: Presentation day on the action plan on antimicrobial resistance, 18 November 2013 http://t.co/6Ybvd71Nfm","created_at":"2013-11-11T11:09:34.000Z","author_id":"116716199","lang":"en","conversation_id":"399856419416981505","possibly_sensitive":false,"id":"399856419416981505","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":44,"end":51,"tag":"herbal"},{"start":65,"end":71,"tag":"Fucus"},{"start":85,"end":98,"tag":"bladderwrack"}],"urls":[{"start":101,"end":123,"url":"http://t.co/3c18b5y6BY","expanded_url":"http://bit.ly/1aKmxq9","display_url":"bit.ly/1aKmxq9"}],"mentions":{},"annotations":{}},"text":"Last week to comment on our draft Community #herbal monograph on #Fucus vesiculosus (#bladderwrack): http://t.co/3c18b5y6BY","created_at":"2013-11-11T09:44:15.000Z","author_id":"116716199","lang":"en","conversation_id":"399834952096694272","possibly_sensitive":false,"id":"399834952096694272","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":44,"end":51,"tag":"herbal"},{"start":65,"end":76,"tag":"Eucalyptus"}],"urls":[{"start":82,"end":104,"url":"http://t.co/nUqjVyhdQs","expanded_url":"http://bit.ly/1ge8iOu","display_url":"bit.ly/1ge8iOu"}],"mentions":{},"annotations":{}},"text":"Last week to comment on our draft Community #herbal monograph on #Eucalyptus oil: http://t.co/nUqjVyhdQs","created_at":"2013-11-11T09:44:00.000Z","author_id":"116716199","lang":"en","conversation_id":"399834888649453569","possibly_sensitive":false,"id":"399834888649453569","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":130,"end":135,"tag":"EAAD"}],"urls":{},"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"annotations":[{"start":49,"end":55,"probability":0.5709,"type":"Product","normalized_text":"Twitter"}]},"text":"RT @WHO_Europe: There will be a live antibiotics Twitter Chat Nov 18 13:00-14:30 CET.  Join the chat &amp; ask experts questions! #EAAD http://…","created_at":"2013-11-11T09:22:40.000Z","author_id":"116716199","lang":"en","conversation_id":"399829519327969280","possibly_sensitive":false,"id":"399829519327969280","source":"TweetDeck","public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"399824466093428737"}]},{"entities":{"hashtags":{},"urls":[{"start":50,"end":72,"url":"http://t.co/t8LlnAhd2K","expanded_url":"http://bit.ly/HFvuXu","display_url":"bit.ly/HFvuXu"}],"mentions":{},"annotations":{}},"text":"We've just published the CVMP meeting highlights: http://t.co/t8LlnAhd2K","created_at":"2013-11-08T16:49:49.000Z","author_id":"116716199","lang":"en","conversation_id":"398854885963481089","possibly_sensitive":false,"id":"398854885963481089","source":"bitly bitlink","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":{},"mentions":[{"start":0,"end":15,"username":"xOneStepBehind","id":"40722651"}],"annotations":{}},"text":"@xOneStepBehind We currently have ongoing programme of server upgrades before moving offices. Restricting downtime to weekends. Apologies!","created_at":"2013-11-08T16:10:09.000Z","author_id":"116716199","lang":"en","conversation_id":"398842309665517568","possibly_sensitive":false,"id":"398844901321752576","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"398842851250823168"}],"in_reply_to_user_id":"40722651"},{"entities":{"hashtags":[{"start":29,"end":40,"tag":"veterinary"},{"start":70,"end":81,"tag":"Innovation"}],"urls":[{"start":112,"end":134,"url":"http://t.co/UfK6SH358H","expanded_url":"http://bit.ly/HKPmIW","display_url":"bit.ly/HKPmIW"}],"mentions":{},"annotations":{}},"text":"Companies developing certain #veterinary medicines can now access our #Innovation Task Force briefing meetings: http://t.co/UfK6SH358H","created_at":"2013-11-08T16:01:40.000Z","author_id":"116716199","lang":"en","conversation_id":"398842768392335360","possibly_sensitive":false,"id":"398842768392335360","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":104,"end":126,"url":"http://t.co/b0a7p9EaWx","expanded_url":"http://bit.ly/17RiKXB","display_url":"bit.ly/17RiKXB"}],"mentions":{},"annotations":{}},"text":"Remember the EMA website will be unavailable from 09:00 to 18:00 tomorrow Sat 9 Nov due to maintenance: http://t.co/b0a7p9EaWx","created_at":"2013-11-08T15:59:51.000Z","author_id":"116716199","lang":"en","conversation_id":"398842309665517568","possibly_sensitive":false,"id":"398842309665517568","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":97,"end":103,"tag":"drugs"},{"start":108,"end":121,"tag":"technologies"}],"urls":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"text":"RT @WHO: Countries in the WHO African Region choose 4 innovative projects for the development of #drugs and #technologies http://t.co/R9rwr…","created_at":"2013-11-08T15:51:30.000Z","author_id":"116716199","lang":"en","conversation_id":"398840207568424961","possibly_sensitive":false,"id":"398840207568424961","source":"TweetDeck","public_metrics":{"retweet_count":18,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"398832195327913984"}]},{"entities":{"hashtags":[{"start":35,"end":44,"tag":"ISO13485"}],"urls":{},"mentions":[{"start":3,"end":16,"username":"isostandards","id":"54819839"}],"annotations":[{"start":111,"end":117,"probability":0.987,"type":"Place","normalized_text":"Germany"},{"start":120,"end":122,"probability":0.8754,"type":"Place","normalized_text":"USA"},{"start":125,"end":129,"probability":0.8594,"type":"Place","normalized_text":"Italy"}]},"text":"RT @isostandards: Certificates for #ISO13485 (quality medical devices) increased by 12% in 2012- top countries Germany, USA, Italy http://t…","created_at":"2013-11-08T15:50:34.000Z","author_id":"116716199","lang":"en","conversation_id":"398839973660463104","possibly_sensitive":false,"id":"398839973660463104","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"398835466159783936"}]},{"entities":{"hashtags":[{"start":22,"end":31,"tag":"acipimox"}],"urls":[{"start":111,"end":133,"url":"http://t.co/OmM1jplUZv","expanded_url":"http://bit.ly/1hpIsZh","display_url":"bit.ly/1hpIsZh"}],"mentions":{},"annotations":{}},"text":"PRAC recommends using #acipimox only as additional or alternative treatment to lower high triglyceride levels: http://t.co/OmM1jplUZv","created_at":"2013-11-08T12:27:44.000Z","author_id":"116716199","lang":"en","conversation_id":"398788929379254272","possibly_sensitive":false,"id":"398788929379254272","source":"bitly bitlink","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":30,"end":40,"tag":"diacerein"}],"urls":[{"start":63,"end":85,"url":"http://t.co/vLptpM8Fnu","expanded_url":"http://bit.ly/HCA0Wn","display_url":"bit.ly/HCA0Wn"}],"mentions":{},"annotations":{}},"text":"PRAC recommends suspension of #diacerein-containing medicines: http://t.co/vLptpM8Fnu","created_at":"2013-11-08T12:26:33.000Z","author_id":"116716199","lang":"en","conversation_id":"398788629373661184","possibly_sensitive":false,"id":"398788629373661184","source":"bitly bitlink","public_metrics":{"retweet_count":9,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":79,"end":86,"tag":"cancer"},{"start":96,"end":104,"tag":"Iclusig"}],"urls":[{"start":106,"end":128,"url":"http://t.co/TazbZtgL1s","expanded_url":"http://bit.ly/1fonUvG","display_url":"bit.ly/1fonUvG"}],"mentions":{},"annotations":{}},"text":"PRAC updates on the risks of serious vascular occlusive events associated with #cancer medicine #Iclusig: http://t.co/TazbZtgL1s","created_at":"2013-11-08T12:25:34.000Z","author_id":"116716199","lang":"en","conversation_id":"398788384992534528","possibly_sensitive":false,"id":"398788384992534528","source":"bitly bitlink","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":50,"end":72,"url":"http://t.co/8dYKItD7zr","expanded_url":"http://bit.ly/1hpHTyO","display_url":"bit.ly/1hpHTyO"}],"mentions":{},"annotations":{}},"text":"We've just published the PRAC meeting highlights: http://t.co/8dYKItD7zr","created_at":"2013-11-08T12:24:02.000Z","author_id":"116716199","lang":"en","conversation_id":"398787999913484288","possibly_sensitive":false,"id":"398787999913484288","source":"bitly bitlink","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":103,"end":125,"url":"http://t.co/CvqqpN5KMV","expanded_url":"http://bit.ly/HKPmIW","display_url":"bit.ly/HKPmIW"}],"mentions":{},"annotations":{}},"text":"Our Innovation Task Force briefing meetings are now open to companies developing veterinary medicines: http://t.co/CvqqpN5KMV","created_at":"2013-11-08T11:43:48.000Z","author_id":"116716199","lang":"en","conversation_id":"398777872015704064","possibly_sensitive":false,"id":"398777872015704064","source":"bitly bitlink","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":87,"end":106,"tag":"multidrugresistant"}],"urls":[{"start":118,"end":140,"url":"http://t.co/FlQzprOu14","expanded_url":"http://bit.ly/1dPzSy7","display_url":"bit.ly/1dPzSy7"}],"mentions":{},"annotations":{}},"text":"Yesterday we published our new guidance on development of antibacterials to help fight #multidrugresistant pathogens: http://t.co/FlQzprOu14","created_at":"2013-11-08T10:35:25.000Z","author_id":"116716199","lang":"en","conversation_id":"398760663943630848","possibly_sensitive":false,"id":"398760663943630848","source":"Twitter Web Client","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":111,"end":133,"url":"http://t.co/SgaO5hFfFZ","expanded_url":"http://bit.ly/17RiKXB","display_url":"bit.ly/17RiKXB"}],"mentions":{},"annotations":{}},"text":"Our website will be unavailable tomorrow Sat 9 Nov, due to essential maintenance. Back to normal the next day: http://t.co/SgaO5hFfFZ","created_at":"2013-11-08T09:41:03.000Z","author_id":"116716199","lang":"en","conversation_id":"398746980530532352","possibly_sensitive":false,"id":"398746980530532352","source":"bitly bitlink","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":84,"end":98,"tag":"antimicrobial"}],"urls":[{"start":111,"end":133,"url":"http://t.co/Ki98UjaF8N","expanded_url":"http://bit.ly/1hS09OZ","display_url":"bit.ly/1hS09OZ"}],"mentions":{},"annotations":{}},"text":"Watch the live broadcast of our workshop on regulatory options in the fight against #antimicrobial resistance: http://t.co/Ki98UjaF8N","created_at":"2013-11-08T09:24:32.000Z","author_id":"116716199","lang":"en","conversation_id":"398742826055651328","possibly_sensitive":false,"id":"398742826055651328","source":"bitly bitlink","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":16,"end":31,"tag":"Clinicaltrials"},{"start":73,"end":80,"tag":"Health"},{"start":132,"end":139,"tag":"ctdata"}],"urls":[{"start":109,"end":131,"url":"http://t.co/V6LkU8Lmb2","expanded_url":"http://bit.ly/HAp8rT","display_url":"bit.ly/HAp8rT"}],"mentions":{},"annotations":{}},"text":"RT @HAI_Global: #Clinicaltrials data can't be commercially confidential. #Health overriding public interest. http://t.co/V6LkU8Lmb2 #ctdata","created_at":"2013-11-07T16:30:00.000Z","author_id":"116716199","lang":"en","conversation_id":"398487507546808321","possibly_sensitive":false,"id":"398487507546808321","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":103,"end":125,"url":"http://t.co/HaJq4C25U1","expanded_url":"http://www.esf.org/fileadmin/Public_documents/Publications/HumanStemCellResearch.pdf","display_url":"esf.org/fileadmin/Publ…"}],"mentions":[{"start":3,"end":19,"username":"EU_ScienceChief","id":"2743488442"},{"start":29,"end":38,"username":"ESF_news","id":"143039587"}],"annotations":{}},"text":"RT @EU_ScienceChief: See new @esf_news report on human stem cell research and regenerative medicine at http://t.co/HaJq4C25U1","created_at":"2013-11-07T16:27:28.000Z","author_id":"116716199","lang":"en","conversation_id":"398486874106249216","possibly_sensitive":false,"id":"398486874106249216","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"398486472497827840"}]},{"entities":{"hashtags":[{"start":30,"end":35,"tag":"MERS"}],"urls":[{"start":92,"end":114,"url":"http://t.co/M9kP3RuovN","expanded_url":"http://bit.ly/Hzzzfj","display_url":"bit.ly/Hzzzfj"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":[{"start":85,"end":89,"probability":0.9795,"type":"Place","normalized_text":"Spain"}]},"text":"RT @ECDC_EU: ECDC updates its #MERS-CoV risk assessment following a case reported by Spain: http://t.co/M9kP3RuovN","created_at":"2013-11-07T14:21:03.000Z","author_id":"116716199","lang":"en","conversation_id":"398455058594926592","possibly_sensitive":false,"id":"398455058594926592","source":"TweetDeck","public_metrics":{"retweet_count":19,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"398421656357441536"}]},{"entities":{"hashtags":[{"start":56,"end":71,"tag":"antibacterials"},{"start":86,"end":105,"tag":"multidrugresistant"}],"urls":[{"start":117,"end":139,"url":"http://t.co/3zZTrb3Kh9","expanded_url":"http://bit.ly/1dPzSy7","display_url":"bit.ly/1dPzSy7"}],"mentions":{},"annotations":{}},"text":"We've just published our new guidance on development of #antibacterials to help fight #multidrugresistant pathogens: http://t.co/3zZTrb3Kh9","created_at":"2013-11-07T12:04:09.000Z","author_id":"116716199","lang":"en","conversation_id":"398420605630160896","possibly_sensitive":false,"id":"398420605630160896","source":"bitly bitlink","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":70,"end":74,"tag":"GMP"},{"start":79,"end":83,"tag":"GDP"}],"urls":[{"start":106,"end":128,"url":"http://t.co/yYooGVdnRD","expanded_url":"http://ow.ly/qojHn","display_url":"ow.ly/qojHn"}],"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"}],"annotations":[{"start":15,"end":24,"probability":0.9517,"type":"Person","normalized_text":"Mark Birse"}]},"text":"RT @MHRAgovuk: Mark Birse, Group Manager GMDP Inspections to speak at #GMP and #GDP Symposium on 2-4 Dec: http://t.co/yYooGVdnRD","created_at":"2013-11-07T11:47:14.000Z","author_id":"116716199","lang":"en","conversation_id":"398416347069034496","possibly_sensitive":false,"id":"398416347069034496","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"398416134225281024"}]},{"entities":{"hashtags":[{"start":24,"end":33,"tag":"guidance"},{"start":48,"end":63,"tag":"antibacterials"},{"start":86,"end":105,"tag":"multidrugresistant"},{"start":106,"end":116,"tag":"pathogens"}],"urls":[{"start":118,"end":140,"url":"http://t.co/3zZTrb3Kh9","expanded_url":"http://bit.ly/1dPzSy7","display_url":"bit.ly/1dPzSy7"}],"mentions":{},"annotations":{}},"text":"We've published further #guidance on developing #antibacterials to help fight against #multidrugresistant #pathogens: http://t.co/3zZTrb3Kh9","created_at":"2013-11-07T11:43:40.000Z","author_id":"116716199","lang":"en","conversation_id":"398415450738290688","possibly_sensitive":false,"id":"398415450738290688","source":"bitly bitlink","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":117,"end":130,"tag":"RareDiseases"}],"urls":{},"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"annotations":{}},"text":"RT @eurordis: Abstract submission to The Patient (peer-reviewed journal focused on patient needs): \nSpecial Issue on #RareDiseases \nhttp://…","created_at":"2013-11-07T10:43:23.000Z","author_id":"116716199","lang":"en","conversation_id":"398400281873874944","possibly_sensitive":false,"id":"398400281873874944","source":"TweetDeck","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"398398646699696128"}]},{"entities":{"hashtags":{},"urls":[{"start":57,"end":79,"url":"http://t.co/lvHr5fMRUt","expanded_url":"http://bit.ly/HBv3gF","display_url":"bit.ly/HBv3gF"}],"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"annotations":[{"start":17,"end":22,"probability":0.4422,"type":"Organization","normalized_text":"Status"}]},"text":"RT @INFARMED_IP: Status update on marketing of medicines http://t.co/lvHr5fMRUt","created_at":"2013-11-07T10:13:01.000Z","author_id":"116716199","lang":"en","conversation_id":"398392637322846208","possibly_sensitive":false,"id":"398392637322846208","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":117,"end":139,"url":"http://t.co/XLwYDhZmML","expanded_url":"http://bit.ly/1flCQe5","display_url":"bit.ly/1flCQe5"}],"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"annotations":[{"start":76,"end":115,"probability":0.9298,"type":"Organization","normalized_text":"EU Management Board Telematics Committee"}]},"text":"RT @Aifa_ufficiale: Director of Italian medicines agency at the helm of the EU Management Board Telematics Committee http://t.co/XLwYDhZmML","created_at":"2013-11-07T10:12:05.000Z","author_id":"116716199","lang":"en","conversation_id":"398392404761272320","possibly_sensitive":false,"id":"398392404761272320","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":30,"end":41,"tag":"accountant"},{"start":63,"end":71,"tag":"finance"}],"urls":[{"start":105,"end":127,"url":"http://t.co/evNlWFZo96","expanded_url":"http://bit.ly/1gqZB3q","display_url":"bit.ly/1gqZB3q"}],"mentions":{},"annotations":{}},"text":"We're recruiting a management #accountant to work in the EMA's #finance department. Apply by 6 December: http://t.co/evNlWFZo96","created_at":"2013-11-06T17:16:16.000Z","author_id":"116716199","lang":"en","conversation_id":"398136764822347776","possibly_sensitive":false,"id":"398136764822347776","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":41,"end":46,"tag":"data"},{"start":80,"end":91,"tag":"veterinary"},{"start":92,"end":107,"tag":"antimicrobials"}],"urls":[{"start":109,"end":131,"url":"http://t.co/8cI1saLeFn","expanded_url":"http://bit.ly/19CcFPb","display_url":"bit.ly/19CcFPb"}],"mentions":{},"annotations":{}},"text":"We have a vacancy to support our work on #data collection on the consumption of #veterinary #antimicrobials: http://t.co/8cI1saLeFn","created_at":"2013-11-06T17:14:34.000Z","author_id":"116716199","lang":"en","conversation_id":"398136336810389504","possibly_sensitive":false,"id":"398136336810389504","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":25,"end":36,"tag":"veterinary"},{"start":92,"end":106,"tag":"antimicrobial"}],"urls":[{"start":115,"end":137,"url":"http://t.co/yiOIu2kduF","expanded_url":"http://bit.ly/HG8XKi","display_url":"bit.ly/HG8XKi"}],"mentions":{},"annotations":{}},"text":"We have a vacancy in our #veterinary medicines department to support our work on the use of #antimicrobial agents: http://t.co/yiOIu2kduF","created_at":"2013-11-06T17:08:24.000Z","author_id":"116716199","lang":"en","conversation_id":"398134783806414849","possibly_sensitive":false,"id":"398134783806414849","source":"Twitter Web Client","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":77,"end":99,"url":"http://t.co/wQGvoupB0A","expanded_url":"http://bit.ly/HG8zLT","display_url":"bit.ly/HG8zLT"}],"mentions":{},"annotations":{}},"text":"We're recruiting a Head of Human Resources at the EMA. Apply by 20 December: http://t.co/wQGvoupB0A","created_at":"2013-11-06T17:02:06.000Z","author_id":"116716199","lang":"en","conversation_id":"398133200142073856","possibly_sensitive":false,"id":"398133200142073856","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":86,"end":108,"url":"http://t.co/z63t2E7hrW","expanded_url":"http://bit.ly/1iMhB4Z","display_url":"bit.ly/1iMhB4Z"}],"mentions":{},"annotations":{}},"text":"We're recruiting a Head of IT Operations Department at the EMA. Apply by 20 December: http://t.co/z63t2E7hrW","created_at":"2013-11-06T17:01:07.000Z","author_id":"116716199","lang":"en","conversation_id":"398132952837525505","possibly_sensitive":false,"id":"398132952837525505","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":45,"end":49,"tag":"FDA"},{"start":69,"end":87,"tag":"SickleCellDisease"}],"urls":[{"start":106,"end":128,"url":"http://t.co/QiKWjxGUwN","expanded_url":"http://1.usa.gov/HJndBg","display_url":"1.usa.gov/HJndBg"}],"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"annotations":{}},"text":"RT @FDA_Drug_Info: Register for Feb. 7, 2014 #FDA Public Meeting on  #SickleCellDisease by Jan. 27, 2014. http://t.co/QiKWjxGUwN","created_at":"2013-11-06T13:16:20.000Z","author_id":"116716199","lang":"en","conversation_id":"398076383110238208","possibly_sensitive":false,"id":"398076383110238208","source":"TweetDeck","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"398073054795804673"}]},{"entities":{"hashtags":[{"start":59,"end":70,"tag":"accountant"},{"start":78,"end":86,"tag":"finance"}],"urls":[{"start":99,"end":121,"url":"http://t.co/X4wHVdGv0k","expanded_url":"http://bit.ly/1gqZB3q","display_url":"bit.ly/1gqZB3q"}],"mentions":{},"annotations":{}},"text":"We are recruiting for the long-term position of management #accountant in our #finance department: http://t.co/X4wHVdGv0k","created_at":"2013-11-06T12:08:15.000Z","author_id":"116716199","lang":"en","conversation_id":"398059249450098688","possibly_sensitive":false,"id":"398059249450098688","source":"bitly bitlink","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":44,"end":49,"tag":"data"},{"start":64,"end":75,"tag":"veterinary"},{"start":76,"end":90,"tag":"antimicrobial"}],"urls":[{"start":104,"end":126,"url":"http://t.co/aGjkwQSxOe","expanded_url":"http://bit.ly/19CcFPb","display_url":"bit.ly/19CcFPb"}],"mentions":{},"annotations":{}},"text":"We have a short-term vacancy in the area of #data collection on #veterinary #antimicrobial consumption: http://t.co/aGjkwQSxOe","created_at":"2013-11-06T12:01:20.000Z","author_id":"116716199","lang":"en","conversation_id":"398057511158550528","possibly_sensitive":false,"id":"398057511158550528","source":"bitly bitlink","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":36,"end":47,"tag":"veterinary"},{"start":92,"end":106,"tag":"antimicrobial"}],"urls":[{"start":116,"end":138,"url":"http://t.co/EKlnfi2ae7","expanded_url":"http://bit.ly/HG8XKi","display_url":"bit.ly/HG8XKi"}],"mentions":{},"annotations":{}},"text":"We have a short-term vacancy in the #veterinary medicines department to support our work on #antimicrobial agents:  http://t.co/EKlnfi2ae7","created_at":"2013-11-06T11:48:35.000Z","author_id":"116716199","lang":"en","conversation_id":"398054302977363968","possibly_sensitive":false,"id":"398054302977363968","source":"bitly bitlink","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":79,"end":101,"url":"http://t.co/cl7tW1hx6o","expanded_url":"http://bit.ly/HG8zLT","display_url":"bit.ly/HG8zLT"}],"mentions":{},"annotations":{}},"text":"We are recruiting a Head of Human Resources, application deadline 20 December: http://t.co/cl7tW1hx6o","created_at":"2013-11-06T11:36:07.000Z","author_id":"116716199","lang":"en","conversation_id":"398051162248974336","possibly_sensitive":false,"id":"398051162248974336","source":"bitly bitlink","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":42,"end":45,"tag":"IT"}],"urls":[{"start":103,"end":125,"url":"http://t.co/yc9Ba29XxB","expanded_url":"http://bit.ly/1iMhB4Z","display_url":"bit.ly/1iMhB4Z"}],"mentions":{},"annotations":{}},"text":"We are recruiting for the post of Head of #IT Operations Department, application deadline 20 December: http://t.co/yc9Ba29XxB","created_at":"2013-11-06T11:32:57.000Z","author_id":"116716199","lang":"en","conversation_id":"398050365649985536","possibly_sensitive":false,"id":"398050365649985536","source":"bitly bitlink","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":20,"end":36,"tag":"qualitybydesign"}],"urls":[{"start":118,"end":140,"url":"http://t.co/mzsDbkeygX","expanded_url":"http://bit.ly/17C3tvY","display_url":"bit.ly/17C3tvY"}],"mentions":{},"annotations":[{"start":85,"end":87,"probability":0.4942,"type":"Organization","normalized_text":"EMA"},{"start":93,"end":95,"probability":0.8199,"type":"Organization","normalized_text":"FDA"}]},"text":"Get guidance on the #qualitybydesign concept from the second Q&amp;A produced jointly by EMA and FDA, just published: http://t.co/mzsDbkeygX","created_at":"2013-11-05T12:33:27.000Z","author_id":"116716199","lang":"en","conversation_id":"397703203518558208","possibly_sensitive":false,"id":"397703203518558208","source":"Twitter Web Client","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":4,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":24,"end":34,"tag":"shortages"}],"urls":[{"start":113,"end":135,"url":"http://t.co/Sm1KaVlMkA","expanded_url":"http://bit.ly/1fePjQU","display_url":"bit.ly/1fePjQU"}],"mentions":{},"annotations":[{"start":51,"end":53,"probability":0.4482,"type":"Organization","normalized_text":"EMA"}]},"text":"A catalogue of medicine #shortages assessed by the EMA is now available on our website and will be kept updated: http://t.co/Sm1KaVlMkA","created_at":"2013-11-05T12:30:09.000Z","author_id":"116716199","lang":"en","conversation_id":"397702375768469505","possibly_sensitive":false,"id":"397702375768469505","source":"Twitter Web Client","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":2,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":42,"end":52,"tag":"shortages"}],"urls":[{"start":113,"end":135,"url":"http://t.co/iX5mKr6xl5","expanded_url":"http://bit.ly/1fePjQU","display_url":"bit.ly/1fePjQU"}],"mentions":{},"annotations":{}},"text":"We have published a catalogue of medicine #shortages assessed by the EMA. Check here for the latest information: http://t.co/iX5mKr6xl5","created_at":"2013-11-04T17:45:50.000Z","author_id":"116716199","lang":"en","conversation_id":"397419428226539521","possibly_sensitive":false,"id":"397419428226539521","source":"bitly bitlink","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":86,"end":102,"tag":"qualitybydesign"}],"urls":[{"start":112,"end":134,"url":"http://t.co/k0m6aP6wJU","expanded_url":"http://bit.ly/17C3tvY","display_url":"bit.ly/17C3tvY"}],"mentions":{},"annotations":[{"start":4,"end":6,"probability":0.4231,"type":"Organization","normalized_text":"EMA"},{"start":12,"end":14,"probability":0.8896,"type":"Organization","normalized_text":"FDA"}]},"text":"The EMA and FDA have published a second joint Q&amp;A document giving guidance on the #qualitybydesign concept: http://t.co/k0m6aP6wJU","created_at":"2013-11-04T17:40:53.000Z","author_id":"116716199","lang":"en","conversation_id":"397418184619593728","possibly_sensitive":false,"id":"397418184619593728","source":"bitly bitlink","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":5,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":48,"end":52,"tag":"GMP"},{"start":86,"end":90,"tag":"GDP"}],"urls":[{"start":122,"end":144,"url":"http://t.co/AHOEu0U4Jc","expanded_url":"http://ow.ly/qogQm","display_url":"ow.ly/qogQm"}],"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"}],"annotations":{}},"text":"RT @MHRAgovuk: MHRA Good Manufacturing Practice #GMP &amp; Good Distribution Practice #GDP Symposia, 2 - 4 December 2013. http://t.co/AHOEu0U4Jc","created_at":"2013-11-04T16:44:23.000Z","author_id":"116716199","lang":"en","conversation_id":"397403963642757120","possibly_sensitive":false,"id":"397403963642757120","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"397386705533407232"}]},{"entities":{"hashtags":[{"start":54,"end":58,"tag":"flu"},{"start":126,"end":134,"tag":"ESCAIDE"}],"urls":{},"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"},{"start":45,"end":53,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"text":"RT @ECDC_Flu: Reusable campaign materials in @ECDC_EU #flu comms toolkit  targeting health care workers&amp; risk groups, pre #ESCAIDE: http://…","created_at":"2013-11-04T16:42:08.000Z","author_id":"116716199","lang":"en","conversation_id":"397403400528080897","possibly_sensitive":false,"id":"397403400528080897","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"397379876891529216"}]},{"entities":{"hashtags":{},"urls":[{"start":73,"end":95,"url":"http://t.co/qm4FKWQNxT","expanded_url":"http://bit.ly/1gn8v1W","display_url":"bit.ly/1gn8v1W"}],"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"annotations":{}},"text":"RT @LV_MPA: New pharmacovigilance system at the Swedish medicines agency http://t.co/qm4FKWQNxT","created_at":"2013-11-04T16:41:43.000Z","author_id":"116716199","lang":"en","conversation_id":"397403295800520704","possibly_sensitive":false,"id":"397403295800520704","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":104,"end":126,"url":"http://t.co/Zp7NbkKMnZ","expanded_url":"http://bit.ly/HFl1KM","display_url":"bit.ly/HFl1KM"}],"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"annotations":{}},"text":"RT @URPLWMiPB: Communication to healthcare professionals on the medicinal product Jevtana (cabazitaxel) http://t.co/Zp7NbkKMnZ","created_at":"2013-11-04T16:39:47.000Z","author_id":"116716199","lang":"en","conversation_id":"397402809080901632","possibly_sensitive":false,"id":"397402809080901632","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":106,"end":128,"url":"http://t.co/ufh1B8ulcv","expanded_url":"http://www.alz.co.uk/world-alzheimers-month-2013","display_url":"alz.co.uk/world-alzheime…"}],"mentions":[{"start":3,"end":13,"username":"AlzDisInt","id":"198970635"}],"annotations":[{"start":50,"end":64,"probability":0.6395,"type":"Other","normalized_text":"World Alzheimer"}]},"text":"RT @AlzDisInt: Here's our round up of this year's World Alzheimer's Month news - bring on September 2014! http://t.co/ufh1B8ulcv #alzheimer…","created_at":"2013-11-04T14:42:32.000Z","author_id":"116716199","lang":"en","conversation_id":"397373302114492416","possibly_sensitive":false,"id":"397373302114492416","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"397368880273707008"}]},{"entities":{"hashtags":[{"start":93,"end":104,"tag":"Alzheimers"}],"urls":[{"start":116,"end":138,"url":"http://t.co/aML13gJ1TU","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2013/10/WC500153464.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"}],"mentions":[{"start":3,"end":19,"username":"AlzheimerEurope","id":"1536274003"},{"start":47,"end":56,"username":"EMA_News","id":"116716199"}],"annotations":{}},"text":"RT @AlzheimerEurope: European Medicines Agency @EMA_News asks for comments on need to revise #Alzheimers guideline: http://t.co/aML13gJ1TU","created_at":"2013-11-04T13:55:18.000Z","author_id":"116716199","lang":"en","conversation_id":"397361413963804672","possibly_sensitive":false,"id":"397361413963804672","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"397359716411531264"}]},{"entities":{"hashtags":{},"urls":[{"start":58,"end":80,"url":"http://t.co/nIRaXm4YtD","expanded_url":"http://bit.ly/HqESh3","display_url":"bit.ly/HqESh3"}],"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"annotations":{}},"text":"RT @LV_MPA: Knowledge of medicines for children improving http://t.co/nIRaXm4YtD","created_at":"2013-11-04T13:21:58.000Z","author_id":"116716199","lang":"en","conversation_id":"397353027167731712","possibly_sensitive":false,"id":"397353027167731712","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":19,"end":23,"tag":"FDA"},{"start":46,"end":54,"tag":"Iclusig"}],"urls":[{"start":111,"end":133,"url":"http://t.co/ffwgAvC14t","expanded_url":"http://bit.ly/HqEgYP","display_url":"bit.ly/HqEgYP"}],"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"annotations":{}},"text":"RT @FDA_Drug_Info: #FDA asks the manufacturer #Iclusig (ponatinib) for leukaemia to suspend marketing and sale http://t.co/ffwgAvC14t","created_at":"2013-11-04T13:18:06.000Z","author_id":"116716199","lang":"en","conversation_id":"397352051811692545","possibly_sensitive":false,"id":"397352051811692545","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":67,"end":89,"url":"http://t.co/JeTHyedxhU","expanded_url":"http://bbc.in/HvQShQ","display_url":"bbc.in/HvQShQ"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"text":"RT @EFPIA: \"Blood test could detect serious skin cancer spread\" -- http://t.co/JeTHyedxhU","created_at":"2013-11-04T11:42:57.000Z","author_id":"116716199","lang":"en","conversation_id":"397328108279193600","possibly_sensitive":false,"id":"397328108279193600","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"397326940475899904"}]},{"entities":{"hashtags":[{"start":103,"end":111,"tag":"ESCAIDE"},{"start":112,"end":116,"tag":"flu"}],"urls":{},"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"annotations":{}},"text":"RT @ECDC_Flu: Flu vaccine types, effectiveness vs efficacy &amp; safety concerns being reviewed at pre #ESCAIDE #flu workshop. More: http://t.c…","created_at":"2013-11-04T11:42:24.000Z","author_id":"116716199","lang":"en","conversation_id":"397327969246400513","possibly_sensitive":false,"id":"397327969246400513","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"397324646413922305"}]},{"entities":{"hashtags":[{"start":17,"end":31,"tag":"Blacktriangle"}],"urls":[{"start":110,"end":132,"url":"http://t.co/j9MtIwjc0h","expanded_url":"http://bit.ly/HELYhV","display_url":"bit.ly/HELYhV"}],"mentions":[{"start":3,"end":15,"username":"EUneurology","id":"619868597"}],"annotations":{}},"text":"RT @EUneurology: #Blacktriangle appearing on product information to encourage reporting of adverse reactions: http://t.co/j9MtIwjc0h","created_at":"2013-11-04T11:39:12.000Z","author_id":"116716199","lang":"en","conversation_id":"397327165634519040","possibly_sensitive":false,"id":"397327165634519040","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":19,"end":34,"tag":"clinicaltrials"},{"start":133,"end":140,"tag":"ctdata"}],"urls":[{"start":93,"end":115,"url":"http://t.co/Ffaoeb6KAG","expanded_url":"http://bit.ly/HwbnLk","display_url":"bit.ly/HwbnLk"}],"mentions":[{"start":3,"end":13,"username":"HAIEurope","id":"3314634701"},{"start":116,"end":132,"username":"TheConversation","id":"255869083"}],"annotations":{}},"text":"RT @HAIEurope: Why #clinicaltrials data must be made publicly available, without the jargon: http://t.co/Ffaoeb6KAG @TheConversation #ctdata","created_at":"2013-11-04T11:37:38.000Z","author_id":"116716199","lang":"en","conversation_id":"397326770556268544","possibly_sensitive":false,"id":"397326770556268544","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":2,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":64,"end":76,"tag":"antibiotics"},{"start":117,"end":122,"tag":"EAAD"}],"urls":[{"start":94,"end":116,"url":"http://t.co/Fobt8RdEEZ","expanded_url":"http://bit.ly/HELAjw","display_url":"bit.ly/HELAjw"}],"mentions":[{"start":3,"end":11,"username":"EAAD_EU","id":"1725283578"}],"annotations":{}},"text":"RT @EAAD_EU: Remember: we are all responsible for ensuring that #antibiotics remain effective http://t.co/Fobt8RdEEZ #EAAD","created_at":"2013-11-04T11:35:44.000Z","author_id":"116716199","lang":"en","conversation_id":"397326291780640768","possibly_sensitive":false,"id":"397326291780640768","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":35,"end":50,"tag":"clinicaltrials"},{"start":51,"end":64,"tag":"transparency"},{"start":128,"end":135,"tag":"ctdata"}],"urls":[{"start":90,"end":112,"url":"http://t.co/18ZBCM88Q6","expanded_url":"http://bit.ly/HELeJE","display_url":"bit.ly/HELeJE"}],"mentions":[{"start":3,"end":13,"username":"HAIEurope","id":"3314634701"},{"start":113,"end":127,"username":"pharmabiznews","id":"116717533"}],"annotations":{}},"text":"RT @HAIEurope: HAI Policy Paper on #clinicaltrials #transparency covered by Indian press: http://t.co/18ZBCM88Q6 @pharmabiznews #ctdata","created_at":"2013-11-04T11:32:11.000Z","author_id":"116716199","lang":"en","conversation_id":"397325397596971008","possibly_sensitive":false,"id":"397325397596971008","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":63,"end":73,"tag":"medicines"},{"start":81,"end":99,"tag":"pharmacovigilance"}],"urls":[{"start":113,"end":135,"url":"http://t.co/UlAMK3tn5o","expanded_url":"http://bit.ly/17vuWPP","display_url":"bit.ly/17vuWPP"}],"mentions":{},"annotations":{}},"text":"Companies now have new notification requirements for withdrawn #medicines - 2012 #pharmacovigilance law updates: http://t.co/UlAMK3tn5o","created_at":"2013-11-04T10:01:36.000Z","author_id":"116716199","lang":"en","conversation_id":"397302600325804032","possibly_sensitive":false,"id":"397302600325804032","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":[{"start":59,"end":65,"probability":0.4835,"type":"Organization","normalized_text":"Twitter"}]},"text":"RT @ECDC_EU: ESCAIDE 2013 starting tomorrow - follow us on Twitter. Get updates from all plenary sessions and satellite events. Follow #ESC…","created_at":"2013-11-04T09:58:47.000Z","author_id":"116716199","lang":"en","conversation_id":"397301891274522624","possibly_sensitive":false,"id":"397301891274522624","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"397295220473094144"}]},{"entities":{"hashtags":[{"start":83,"end":87,"tag":"flu"}],"urls":{},"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"annotations":[{"start":112,"end":117,"probability":0.9935,"type":"Place","normalized_text":"Europe"}]},"text":"RT @ECDC_Flu: New ECDC report reviews evidence on barriers and drivers of seasonal #flu vaccination coverage in Europe http://t.co/uZj0pUPS…","created_at":"2013-11-04T09:58:10.000Z","author_id":"116716199","lang":"en","conversation_id":"397301739012882432","possibly_sensitive":false,"id":"397301739012882432","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"397293009441529856"}]},{"entities":{"hashtags":[{"start":18,"end":36,"tag":"pharmacovigilance"}],"urls":[{"start":112,"end":134,"url":"http://t.co/rfZQqXqJQw","expanded_url":"http://bit.ly/17vuWPP","display_url":"bit.ly/17vuWPP"}],"mentions":{},"annotations":{}},"text":"Amendments to the #pharmacovigilance legislation now in force with new notification requirements for companies: http://t.co/rfZQqXqJQw","created_at":"2013-10-31T18:29:33.000Z","author_id":"116716199","lang":"en","conversation_id":"395980880550064129","possibly_sensitive":false,"id":"395980880550064129","source":"bitly bitlink","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":3,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":95,"end":105,"tag":"Alzheimer"}],"urls":[{"start":117,"end":139,"url":"http://t.co/UAOvVQ2EJk","expanded_url":"http://bit.ly/19V2hkG","display_url":"bit.ly/19V2hkG"}],"mentions":{},"annotations":{}},"text":"We're seeking comments on a concept paper on the need to revise the guideline on medicines for #Alzheimer's disease: http://t.co/UAOvVQ2EJk","created_at":"2013-10-31T15:28:38.000Z","author_id":"116716199","lang":"en","conversation_id":"395935350155407360","possibly_sensitive":false,"id":"395935350155407360","source":"bitly bitlink","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":103,"end":125,"url":"http://t.co/BHy9otJ7Ld","expanded_url":"http://bit.ly/16OV9mu","display_url":"bit.ly/16OV9mu"}],"mentions":{},"annotations":{}},"text":"We're closed tomorrow. We have an emergency out-of-hours telephone number for problems with medicines: http://t.co/BHy9otJ7Ld","created_at":"2013-10-31T12:10:08.000Z","author_id":"116716199","lang":"en","conversation_id":"395885398640971776","possibly_sensitive":false,"id":"395885398640971776","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":4,"end":22,"tag":"pharmacovigilance"},{"start":27,"end":38,"tag":"veterinary"}],"urls":[{"start":92,"end":114,"url":"http://t.co/eP2TDfaD1n","expanded_url":"http://bit.ly/1aGHPDi","display_url":"bit.ly/1aGHPDi"},{"start":116,"end":138,"url":"http://t.co/QqmWIvK832","expanded_url":"http://bit.ly/1bFkWjN","display_url":"bit.ly/1bFkWjN"}],"mentions":{},"annotations":{}},"text":"Our #pharmacovigilance and #veterinary committees meet next week. Highlights out on Friday: http://t.co/eP2TDfaD1n  http://t.co/QqmWIvK832","created_at":"2013-10-31T12:09:53.000Z","author_id":"116716199","lang":"en","conversation_id":"395885334191280128","possibly_sensitive":false,"id":"395885334191280128","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":49,"end":56,"tag":"herbal"},{"start":70,"end":76,"tag":"Fucus"},{"start":90,"end":103,"tag":"bladderwrack"}],"urls":[{"start":106,"end":128,"url":"http://t.co/3c18b5y6BY","expanded_url":"http://bit.ly/1aKmxq9","display_url":"bit.ly/1aKmxq9"}],"mentions":{},"annotations":{}},"text":"Two more weeks to comment on our draft Community #herbal monograph on #Fucus vesiculosus (#bladderwrack): http://t.co/3c18b5y6BY","created_at":"2013-10-31T12:08:56.000Z","author_id":"116716199","lang":"en","conversation_id":"395885096680443906","possibly_sensitive":false,"id":"395885096680443906","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":49,"end":56,"tag":"herbal"},{"start":70,"end":81,"tag":"Eucalyptus"}],"urls":[{"start":87,"end":109,"url":"http://t.co/nUqjVyhdQs","expanded_url":"http://bit.ly/1ge8iOu","display_url":"bit.ly/1ge8iOu"}],"mentions":{},"annotations":{}},"text":"Two more weeks to comment on our draft Community #herbal monograph on #Eucalyptus oil: http://t.co/nUqjVyhdQs","created_at":"2013-10-31T12:05:59.000Z","author_id":"116716199","lang":"en","conversation_id":"395884352896126976","possibly_sensitive":false,"id":"395884352896126976","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":111,"end":133,"url":"http://t.co/KZBpNukA5S","expanded_url":"http://bit.ly/16OV9mu","display_url":"bit.ly/16OV9mu"}],"mentions":{},"annotations":{}},"text":"Our office is closed tomorrow. We have an emergency out-of-hours telephone number for problems with medicines: http://t.co/KZBpNukA5S","created_at":"2013-10-31T10:42:06.000Z","author_id":"116716199","lang":"en","conversation_id":"395863244638019584","possibly_sensitive":false,"id":"395863244638019584","source":"bitly bitlink","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":23,"end":35,"tag":"biosimilars"}],"urls":[{"start":72,"end":94,"url":"http://t.co/SidoCUhosq","expanded_url":"http://bit.ly/1f5yt6W","display_url":"bit.ly/1f5yt6W"}],"mentions":{},"annotations":{}},"text":"Follow our workshop on #biosimilars, broadcast live on the EMA website: http://t.co/SidoCUhosq","created_at":"2013-10-31T10:21:46.000Z","author_id":"116716199","lang":"en","conversation_id":"395858126345617408","possibly_sensitive":false,"id":"395858126345617408","source":"bitly bitlink","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":3,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":14,"end":32,"tag":"pharmacovigilance"},{"start":37,"end":48,"tag":"veterinary"}],"urls":[{"start":92,"end":114,"url":"http://t.co/eP2TDfaD1n","expanded_url":"http://bit.ly/1aGHPDi","display_url":"bit.ly/1aGHPDi"},{"start":115,"end":137,"url":"http://t.co/QqmWIvK832","expanded_url":"http://bit.ly/1bFkWjN","display_url":"bit.ly/1bFkWjN"}],"mentions":{},"annotations":{}},"text":"Next week our #pharmacovigilance and #veterinary committees meet. Highlights out on Friday: http://t.co/eP2TDfaD1n http://t.co/QqmWIvK832","created_at":"2013-10-31T09:30:36.000Z","author_id":"116716199","lang":"en","conversation_id":"395845250767273984","possibly_sensitive":false,"id":"395845250767273984","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":49,"end":56,"tag":"herbal"},{"start":70,"end":76,"tag":"Fucus"},{"start":90,"end":103,"tag":"bladderwrack"}],"urls":[{"start":106,"end":128,"url":"http://t.co/3c18b5y6BY","expanded_url":"http://bit.ly/1aKmxq9","display_url":"bit.ly/1aKmxq9"}],"mentions":{},"annotations":{}},"text":"Two weeks left to comment on our draft Community #herbal monograph on #Fucus vesiculosus (#bladderwrack): http://t.co/3c18b5y6BY","created_at":"2013-10-31T09:26:15.000Z","author_id":"116716199","lang":"en","conversation_id":"395844155642884097","possibly_sensitive":false,"id":"395844155642884097","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":49,"end":56,"tag":"herbal"},{"start":70,"end":81,"tag":"Eucalyptus"}],"urls":[{"start":87,"end":109,"url":"http://t.co/sZ8CNRDwTw","expanded_url":"http://bit.ly/1ge8iOu","display_url":"bit.ly/1ge8iOu"}],"mentions":{},"annotations":{}},"text":"Two weeks left to comment on our draft Community #herbal monograph on #Eucalyptus oil: http://t.co/sZ8CNRDwTw","created_at":"2013-10-31T09:23:39.000Z","author_id":"116716199","lang":"en","conversation_id":"395843500283269120","possibly_sensitive":false,"id":"395843500283269120","source":"bitly bitlink","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":66,"end":88,"url":"http://t.co/sxhSMG5lVl","expanded_url":"http://bit.ly/1clGxyC","display_url":"bit.ly/1clGxyC"}],"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"annotations":[{"start":50,"end":64,"probability":0.4834,"type":"Organization","normalized_text":"Meloxicam Mylan"}]},"text":"RT @INFARMED_IP: Voluntary recall of the medicine Meloxicam Mylan http://t.co/sxhSMG5lVl","created_at":"2013-10-30T16:08:54.000Z","author_id":"116716199","lang":"en","conversation_id":"395583096533172224","possibly_sensitive":false,"id":"395583096533172224","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":67,"end":76,"tag":"oncology"},{"start":77,"end":86,"tag":"research"}],"urls":[{"start":94,"end":116,"url":"http://t.co/jHxJoZ0uvY","expanded_url":"http://bbc.in/17WPMls","display_url":"bbc.in/17WPMls"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"text":"RT @EFPIA: \"Seven classes of breast cancer test 'offers new hope'\" #oncology #research news - http://t.co/jHxJoZ0uvY","created_at":"2013-10-30T14:35:02.000Z","author_id":"116716199","lang":"en","conversation_id":"395559473424498690","possibly_sensitive":false,"id":"395559473424498690","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"395559262581039104"}]},{"entities":{"hashtags":{},"urls":[{"start":74,"end":96,"url":"http://t.co/PCDBhzXHek","expanded_url":"http://bit.ly/1h0mVq2","display_url":"bit.ly/1h0mVq2"}],"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"annotations":[{"start":49,"end":51,"probability":0.541,"type":"Organization","normalized_text":"FDA"}]},"text":"RT @Aifa_ufficiale: New recommendations from the FDA on fentanyl patches: http://t.co/PCDBhzXHek","created_at":"2013-10-30T14:02:33.000Z","author_id":"116716199","lang":"en","conversation_id":"395551299355152385","possibly_sensitive":false,"id":"395551299355152385","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":18,"end":23,"tag":"EAAD"},{"start":24,"end":32,"tag":"patient"},{"start":59,"end":70,"tag":"clinicians"},{"start":101,"end":113,"tag":"antibiotics"}],"urls":[{"start":115,"end":137,"url":"http://t.co/IkXkOYLeN9","expanded_url":"http://bit.ly/OEMyPq","display_url":"bit.ly/OEMyPq"}],"mentions":[{"start":3,"end":11,"username":"EAAD_EU","id":"1725283578"}],"annotations":{}},"text":"RT @EAAD_EU: Read #EAAD #patient dialogue: useful tool for #clinicians to discuss appropriate use of #antibiotics. http://t.co/IkXkOYLeN9 #…","created_at":"2013-10-30T13:00:46.000Z","author_id":"116716199","lang":"en","conversation_id":"395535752735387648","possibly_sensitive":false,"id":"395535752735387648","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"395532541119066112"}]},{"entities":{"hashtags":[{"start":96,"end":103,"tag":"cancer"}],"urls":[{"start":115,"end":137,"url":"http://t.co/5dbmJU4yMi","expanded_url":"http://bit.ly/1etgd7d","display_url":"bit.ly/1etgd7d"}],"mentions":{},"annotations":{}},"text":"One day left to comment on need to revise condition–specific guidance on the evaluation of anti-#cancer medicines: http://t.co/5dbmJU4yMi","created_at":"2013-10-30T12:06:20.000Z","author_id":"116716199","lang":"en","conversation_id":"395522053295443968","possibly_sensitive":false,"id":"395522053295443968","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":81,"end":85,"tag":"flu"},{"start":86,"end":95,"tag":"vaccines"}],"urls":[{"start":97,"end":119,"url":"http://t.co/KE1DvoRtdJ","expanded_url":"http://bit.ly/16htHxA","display_url":"bit.ly/16htHxA"}],"mentions":{},"annotations":{}},"text":"One day left to comment on our explanatory note on the withdrawal of guidance on #flu #vaccines: http://t.co/KE1DvoRtdJ","created_at":"2013-10-30T12:05:32.000Z","author_id":"116716199","lang":"en","conversation_id":"395521850148540417","possibly_sensitive":false,"id":"395521850148540417","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":83,"end":95,"tag":"biosimilars"}],"urls":[{"start":98,"end":120,"url":"http://t.co/eP6eLuld9g","expanded_url":"http://bit.ly/1etg4k0","display_url":"bit.ly/1etg4k0"}],"mentions":{},"annotations":{}},"text":"One day left to comment on our guideline on similar biological medicinal products (#biosimilars): http://t.co/eP6eLuld9g","created_at":"2013-10-30T12:05:18.000Z","author_id":"116716199","lang":"en","conversation_id":"395521791315017728","possibly_sensitive":false,"id":"395521791315017728","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":62,"end":71,"tag":"parabens"}],"urls":[{"start":111,"end":133,"url":"http://t.co/X7nXdWRWMD","expanded_url":"http://bit.ly/15KxJkS","display_url":"bit.ly/15KxJkS"}],"mentions":{},"annotations":{}},"text":"One day left to comment on our reflection paper on the use of #parabens as excipients in oral human medicines: http://t.co/X7nXdWRWMD","created_at":"2013-10-30T12:05:04.000Z","author_id":"116716199","lang":"en","conversation_id":"395521734893268992","possibly_sensitive":false,"id":"395521734893268992","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":55,"end":66,"tag":"phthalates"}],"urls":[{"start":101,"end":123,"url":"http://t.co/slqCKReqR4","expanded_url":"http://bit.ly/174dVvR","display_url":"bit.ly/174dVvR"}],"mentions":{},"annotations":{}},"text":"One day left to comment on our guideline on the use of #phthalates as excipients in human medicines: http://t.co/slqCKReqR4","created_at":"2013-10-30T12:04:51.000Z","author_id":"116716199","lang":"en","conversation_id":"395521681168416768","possibly_sensitive":false,"id":"395521681168416768","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":58,"end":62,"tag":"flu"},{"start":63,"end":72,"tag":"vaccines"}],"urls":{},"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{}},"text":"RT @IMI_JU: IMI’s October newsletter is out! 10th Call on #flu #vaccines, IMI in the FT, &amp; news from our fantastic projects http://t.co/ory…","created_at":"2013-10-30T11:36:07.000Z","author_id":"116716199","lang":"en","conversation_id":"395514450599370753","possibly_sensitive":false,"id":"395514450599370753","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"395514259108417536"}]},{"entities":{"hashtags":{},"urls":[{"start":114,"end":136,"url":"http://t.co/0e6QRiz8hv","expanded_url":"http://www.infarmed.pt/portal/page/portal/INFARMED/MAIS_NOVIDADES/DETALHE_NOVIDADE?itemid=8658643","display_url":"infarmed.pt/portal/page/po…"}],"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"annotations":{}},"text":"RT @INFARMED_IP: Submission of marketing-authorisation applications - Instructions for applicants from 21/10/2013 http://t.co/0e6QRiz8hv","created_at":"2013-10-30T11:31:55.000Z","author_id":"116716199","lang":"en","conversation_id":"395513389998280704","possibly_sensitive":false,"id":"395513389998280704","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":112,"end":134,"url":"http://t.co/YNeileKn1j","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/10/news_detail_001929.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"},{"start":97,"end":111,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"text":"RT @GCessak: Revision of paediatric-investigation-plan guideline: stakeholder comments sought by @EU_Commission http://t.co/YNeileKn1j","created_at":"2013-10-30T11:24:05.000Z","author_id":"116716199","lang":"en","conversation_id":"395511420999049216","possibly_sensitive":false,"id":"395511420999049216","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"395511328971829248"}]},{"entities":{"hashtags":[{"start":31,"end":39,"tag":"patient"}],"urls":[{"start":109,"end":131,"url":"http://t.co/78cGGDvtxX","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Report/2013/10/WC500153276.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"}],"mentions":[{"start":3,"end":19,"username":"AlzheimerEurope","id":"1536274003"},{"start":90,"end":99,"username":"EMA_News","id":"116716199"}],"annotations":{}},"text":"RT @AlzheimerEurope: Report on #patient involvement in medicines' evaluation available on @EMA_News website: http://t.co/78cGGDvtxX","created_at":"2013-10-30T11:04:22.000Z","author_id":"116716199","lang":"en","conversation_id":"395506458474708992","possibly_sensitive":false,"id":"395506458474708992","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"395501794605813762"}]},{"entities":{"hashtags":[{"start":97,"end":101,"tag":"PIP"}],"urls":[{"start":114,"end":136,"url":"http://t.co/DD3mBVtWZr","expanded_url":"http://bit.ly/1dlzJlS","display_url":"bit.ly/1dlzJlS"}],"mentions":[{"start":4,"end":18,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"text":"The @EU_Commission has launched a consultation on revision of the paediatric-investigation-plan (#PIP) guideline: http://t.co/DD3mBVtWZr","created_at":"2013-10-30T10:34:36.000Z","author_id":"116716199","lang":"en","conversation_id":"395498968295043072","possibly_sensitive":false,"id":"395498968295043072","source":"Twitter Web Client","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":2,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":81,"end":85,"tag":"flu"},{"start":86,"end":95,"tag":"vaccines"}],"urls":[{"start":97,"end":119,"url":"http://t.co/KE1DvoRtdJ","expanded_url":"http://bit.ly/16htHxA","display_url":"bit.ly/16htHxA"}],"mentions":{},"annotations":{}},"text":"One more day to comment on our explanatory note on the withdrawal of guidance on #flu #vaccines: http://t.co/KE1DvoRtdJ","created_at":"2013-10-30T10:33:41.000Z","author_id":"116716199","lang":"en","conversation_id":"395498736836542464","possibly_sensitive":false,"id":"395498736836542464","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":96,"end":103,"tag":"cancer"}],"urls":[{"start":115,"end":137,"url":"http://t.co/5dbmJU4yMi","expanded_url":"http://bit.ly/1etgd7d","display_url":"bit.ly/1etgd7d"}],"mentions":{},"annotations":{}},"text":"One more day to comment on need to revise condition–specific guidance on the evaluation of anti-#cancer medicines: http://t.co/5dbmJU4yMi","created_at":"2013-10-30T10:32:36.000Z","author_id":"116716199","lang":"en","conversation_id":"395498463875448833","possibly_sensitive":false,"id":"395498463875448833","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":83,"end":95,"tag":"biosimilars"}],"urls":[{"start":98,"end":120,"url":"http://t.co/eP6eLuld9g","expanded_url":"http://bit.ly/1etg4k0","display_url":"bit.ly/1etg4k0"}],"mentions":{},"annotations":{}},"text":"One more day to comment on our guideline on similar biological medicinal products (#biosimilars): http://t.co/eP6eLuld9g","created_at":"2013-10-30T10:32:04.000Z","author_id":"116716199","lang":"en","conversation_id":"395498331226382336","possibly_sensitive":false,"id":"395498331226382336","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":62,"end":71,"tag":"parabens"}],"urls":[{"start":111,"end":133,"url":"http://t.co/X7nXdWRWMD","expanded_url":"http://bit.ly/15KxJkS","display_url":"bit.ly/15KxJkS"}],"mentions":{},"annotations":{}},"text":"One more day to comment on our reflection paper on the use of #parabens as excipients in oral human medicines: http://t.co/X7nXdWRWMD","created_at":"2013-10-30T10:31:29.000Z","author_id":"116716199","lang":"en","conversation_id":"395498184715169792","possibly_sensitive":false,"id":"395498184715169792","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":55,"end":66,"tag":"phthalates"}],"urls":[{"start":101,"end":123,"url":"http://t.co/slqCKReqR4","expanded_url":"http://bit.ly/174dVvR","display_url":"bit.ly/174dVvR"}],"mentions":{},"annotations":{}},"text":"One more day to comment on our guideline on the use of #phthalates as excipients in human medicines: http://t.co/slqCKReqR4","created_at":"2013-10-30T10:31:16.000Z","author_id":"116716199","lang":"en","conversation_id":"395498128918335488","possibly_sensitive":false,"id":"395498128918335488","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":104,"end":126,"url":"http://t.co/NOA81ykbhr","expanded_url":"http://www.urpl.gov.pl/aktualnosci/rekomendacji-cmdh-dotyczacych-ograniczenia-stosowania-krotko-dzialajacych-beta-agonistow-w-poloznictwie","display_url":"urpl.gov.pl/aktualnosci/re…"}],"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"annotations":{}},"text":"RT @URPLWMiPB: CMDh position on the restriction of the use of short-acting beta-agonists in obstetrics  http://t.co/NOA81ykbhr","created_at":"2013-10-30T10:29:07.000Z","author_id":"116716199","lang":"en","conversation_id":"395497589061062656","possibly_sensitive":false,"id":"395497589061062656","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":115,"end":137,"url":"http://t.co/NOA81ykbhr","expanded_url":"http://www.urpl.gov.pl/aktualnosci/rekomendacji-cmdh-dotyczacych-ograniczenia-stosowania-krotko-dzialajacych-beta-agonistow-w-poloznictwie","display_url":"urpl.gov.pl/aktualnosci/re…"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"text":"RT @GCessak: Information on position of the CMDh on restriction of use of short-acting beta-agonists in obstetrics http://t.co/NOA81ykbhr","created_at":"2013-10-30T10:07:46.000Z","author_id":"116716199","lang":"en","conversation_id":"395492213917904896","possibly_sensitive":false,"id":"395492213917904896","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":75,"end":90,"tag":"ClinicalTrials"},{"start":130,"end":137,"tag":"ctdata"}],"urls":[{"start":107,"end":129,"url":"http://t.co/pNKBNLcjAi","expanded_url":"http://bit.ly/1a9Xrga","display_url":"bit.ly/1a9Xrga"}],"mentions":[{"start":3,"end":13,"username":"HAIEurope","id":"3314634701"}],"annotations":{}},"text":"RT @HAIEurope: Policy Paper: 'Protecting Citizens' Health: Transparency of #ClinicalTrials Data in the EU' http://t.co/pNKBNLcjAi #ctdata","created_at":"2013-10-30T10:04:03.000Z","author_id":"116716199","lang":"en","conversation_id":"395491279347261440","possibly_sensitive":false,"id":"395491279347261440","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":100,"end":110,"tag":"medicines"}],"urls":[{"start":112,"end":134,"url":"http://t.co/WsPaVGCDz8","expanded_url":"http://bit.ly/18yrVaY","display_url":"bit.ly/18yrVaY"}],"mentions":{},"annotations":{}},"text":"See the report and slides from our workshop on involving patients in the benefit-risk assessment of #medicines: http://t.co/WsPaVGCDz8","created_at":"2013-10-30T09:35:28.000Z","author_id":"116716199","lang":"en","conversation_id":"395484084413009921","possibly_sensitive":false,"id":"395484084413009921","source":"Twitter Web Client","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":27,"end":33,"tag":"polio"}],"urls":[{"start":95,"end":117,"url":"http://t.co/Emz5LLiHcG","expanded_url":"http://bit.ly/1itgvLv","display_url":"bit.ly/1itgvLv"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"},{"start":13,"end":17,"username":"WHO","id":"14499829"}],"annotations":[{"start":43,"end":47,"probability":0.9596,"type":"Place","normalized_text":"Syria"}]},"text":"RT @ECDC_EU: @WHO confirms #polio cases in Syria; ECDC risk assessment still valid.See update  http://t.co/Emz5LLiHcG &amp; assessment http://t…","created_at":"2013-10-30T09:23:41.000Z","author_id":"116716199","lang":"en","conversation_id":"395481120034156544","possibly_sensitive":false,"id":"395481120034156544","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"395479753744187392"}]},{"entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"annotations":[{"start":127,"end":128,"probability":0.415,"type":"Place","normalized_text":"UK"}]},"text":"RT @MHRAmedicines: Drug Alerts: Class 2 Medicines Recall (action within 48 hours): Imigran Injection/Subject - GlaxoSmithKline UK... http:/…","created_at":"2013-10-29T14:40:54.000Z","author_id":"116716199","lang":"en","conversation_id":"395198562096513024","possibly_sensitive":false,"id":"395198562096513024","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"395196938460487680"}]},{"entities":{"hashtags":[{"start":105,"end":115,"tag":"medicines"}],"urls":[{"start":117,"end":139,"url":"http://t.co/QuNgugyuVY","expanded_url":"http://bit.ly/18yrVaY","display_url":"bit.ly/18yrVaY"}],"mentions":{},"annotations":{}},"text":"We've published a report of our workshop on further involving patients in the benefit-risk assessment of #medicines: http://t.co/QuNgugyuVY","created_at":"2013-10-29T14:39:40.000Z","author_id":"116716199","lang":"en","conversation_id":"395198251882008577","possibly_sensitive":false,"id":"395198251882008577","source":"bitly bitlink","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":93,"end":97,"tag":"PIP"}],"urls":[{"start":110,"end":132,"url":"http://t.co/li3jQNVYvy","expanded_url":"http://bit.ly/1dlzJlS","display_url":"bit.ly/1dlzJlS"}],"mentions":[{"start":4,"end":18,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"text":"The @EU_Commission is looking for comments on the revision of paediatric-investigation-plan (#PIP) guideline: http://t.co/li3jQNVYvy","created_at":"2013-10-29T13:53:24.000Z","author_id":"116716199","lang":"en","conversation_id":"395186607135133696","possibly_sensitive":false,"id":"395186607135133696","source":"bitly bitlink","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":111,"end":115,"tag":"flu"},{"start":116,"end":125,"tag":"vaccines"}],"urls":{},"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":[{"start":12,"end":14,"probability":0.4606,"type":"Organization","normalized_text":"IMI"}]},"text":"RT @IMI_JU: IMI launches €12m 10th Call, goal to improve tests used to evaluate level of protection offered by #flu #vaccines http://t.co/B…","created_at":"2013-10-29T11:35:18.000Z","author_id":"116716199","lang":"en","conversation_id":"395151854251700226","possibly_sensitive":false,"id":"395151854251700226","source":"TweetDeck","public_metrics":{"retweet_count":18,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"395131418986033152"}]},{"entities":{"hashtags":[{"start":14,"end":28,"tag":"blacktriangle"}],"urls":[{"start":108,"end":130,"url":"http://t.co/ZzDNIqm0Nk","expanded_url":"http://bit.ly/10EQUGI","display_url":"bit.ly/10EQUGI"}],"mentions":{},"annotations":{}},"text":"What does the #blacktriangle mean? Find out about additional monitoring of medicines by watching our video: http://t.co/ZzDNIqm0Nk","created_at":"2013-10-29T09:48:47.000Z","author_id":"116716199","lang":"en","conversation_id":"395125047498526720","possibly_sensitive":false,"id":"395125047498526720","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":100,"end":122,"url":"http://t.co/qxzLRlmXqY","expanded_url":"http://www.esmo.org/Oncology-News/European-Medicines-Agency-Warning-on-Risk-of-Arterial-Thrombosis-with-Ponatinib#.Um6Wv2GzJQQ.twitter","display_url":"esmo.org/Oncology-News/…"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"text":"RT @GCessak: European Medicines Agency Warning on Risk of Arterial Thrombosis with Ponatinib | ESMO http://t.co/qxzLRlmXqY","created_at":"2013-10-29T09:45:17.000Z","author_id":"116716199","lang":"en","conversation_id":"395124169547206656","possibly_sensitive":false,"id":"395124169547206656","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"394869833201754112"}]},{"entities":{"hashtags":[{"start":76,"end":84,"tag":"measles"}],"urls":{},"mentions":[{"start":3,"end":18,"username":"WHO_Europe_VPI","id":"561122363"}],"annotations":[{"start":98,"end":103,"probability":0.9874,"type":"Place","normalized_text":"Europe"}]},"text":"RT @WHO_Europe_VPI: 2/2 Need for accelerated action is clear amidst ongoing #measles outbreaks in Europe //bit.ly/1gVvX7C","created_at":"2013-10-28T16:27:42.000Z","author_id":"116716199","lang":"en","conversation_id":"394863053923028992","possibly_sensitive":false,"id":"394863053923028992","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"394862923031392256"}]},{"entities":{"hashtags":[{"start":98,"end":106,"tag":"measles"}],"urls":{},"mentions":[{"start":3,"end":18,"username":"WHO_Europe_VPI","id":"561122363"}],"annotations":[{"start":122,"end":127,"probability":0.9541,"type":"Place","normalized_text":"Europe"}]},"text":"RT @WHO_Europe_VPI: 1/2 Regional Verification Commission meets this wk to review progress towards #measles elimination in Europe http://t.c…","created_at":"2013-10-28T16:27:39.000Z","author_id":"116716199","lang":"en","conversation_id":"394863040174120961","possibly_sensitive":false,"id":"394863040174120961","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"394862543279112193"}]},{"entities":{"hashtags":[{"start":24,"end":31,"tag":"Pharma"},{"start":66,"end":72,"tag":"Drugs"},{"start":77,"end":85,"tag":"Malaria"},{"start":87,"end":90,"tag":"TB"},{"start":104,"end":113,"tag":"Diseases"}],"urls":[{"start":116,"end":138,"url":"http://t.co/MFaVLRh44U","expanded_url":"http://onforb.es/1atLqGu","display_url":"onforb.es/1atLqGu"}],"mentions":{},"annotations":{}},"text":"RT @sailinsomnia: Is It #Pharma's Fault That We Don't Have Better #Drugs For #Malaria, #TB And Tropical #Diseases?  http://t.co/MFaVLRh44U …","created_at":"2013-10-28T16:25:55.000Z","author_id":"116716199","lang":"en","conversation_id":"394862605396738048","possibly_sensitive":false,"id":"394862605396738048","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"394860076516663296"}]},{"entities":{"hashtags":{},"urls":[{"start":69,"end":91,"url":"http://t.co/nQKMxB0pYR","expanded_url":"http://bit.ly/1bvw5nf","display_url":"bit.ly/1bvw5nf"}],"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"annotations":{}},"text":"RT @AEMPSGOB: New electronic office for the Spanish medicines agency\nhttp://t.co/nQKMxB0pYR","created_at":"2013-10-28T16:24:47.000Z","author_id":"116716199","lang":"en","conversation_id":"394862320234401794","possibly_sensitive":false,"id":"394862320234401794","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":82,"end":104,"url":"http://t.co/qJhzeVMxBL","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/10/news_detail_001933.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":{},"annotations":[{"start":75,"end":80,"probability":0.9914,"type":"Place","normalized_text":"Europe"}]},"text":"RT @sailinsomnia: Novo Nordisk recalls some NovoMix 30 insulin products in Europe http://t.co/qJhzeVMxBL","created_at":"2013-10-28T16:21:58.000Z","author_id":"116716199","lang":"en","conversation_id":"394861610935664640","possibly_sensitive":false,"id":"394861610935664640","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"394859236112338944"}]},{"entities":{"hashtags":[{"start":18,"end":22,"tag":"FDA"},{"start":32,"end":44,"tag":"Painkillers"}],"urls":[{"start":69,"end":91,"url":"http://t.co/iUMyVw0jFL","expanded_url":"http://nyti.ms/Hq8ZFd","display_url":"nyti.ms/Hq8ZFd"}],"mentions":{},"annotations":{}},"text":"RT @sailinsomnia: #FDA Shift on #Painkillers Was Years in the Making http://t.co/iUMyVw0jFL","created_at":"2013-10-28T16:21:08.000Z","author_id":"116716199","lang":"en","conversation_id":"394861399488217088","possibly_sensitive":false,"id":"394861399488217088","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"394858267093921793"}]},{"entities":{"hashtags":[{"start":67,"end":74,"tag":"safety"},{"start":99,"end":106,"tag":"health"}],"urls":[{"start":76,"end":98,"url":"http://t.co/C3FwSaLdyp","expanded_url":"http://bit.ly/17TAoq0","display_url":"bit.ly/17TAoq0"}],"mentions":[{"start":3,"end":16,"username":"HealthCanada","id":"928334374256472064"}],"annotations":[{"start":18,"end":34,"probability":0.5527,"type":"Organization","normalized_text":"Harper Government"}]},"text":"RT @HealthCanada: Harper Government takes steps to improve patient #safety: http://t.co/C3FwSaLdyp #health","created_at":"2013-10-28T15:48:36.000Z","author_id":"116716199","lang":"en","conversation_id":"394853211497955328","possibly_sensitive":false,"id":"394853211497955328","source":"TweetDeck","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"394849006091644928"}]},{"entities":{"hashtags":[{"start":77,"end":90,"tag":"transparency"},{"start":94,"end":108,"tag":"clinicaltrial"}],"urls":{},"mentions":[{"start":3,"end":13,"username":"HAIEurope","id":"3314634701"}],"annotations":{}},"text":"RT @HAIEurope: Just published: HAI Policy Paper\n'Protecting citizens’ health:#transparency of #clinicaltrial data on meds in the EU' http:/…","created_at":"2013-10-28T15:32:15.000Z","author_id":"116716199","lang":"en","conversation_id":"394849097238052864","possibly_sensitive":false,"id":"394849097238052864","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"394838399388901377"}]},{"entities":{"hashtags":{},"urls":[{"start":110,"end":132,"url":"http://t.co/VhoLBLDFYo","expanded_url":"http://bit.ly/18u9fJJ","display_url":"bit.ly/18u9fJJ"}],"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"annotations":{}},"text":"RT @Aifa_ufficiale: Influenza vaccination of elderly effective: reinterpretation of data from Cochrane review http://t.co/VhoLBLDFYo","created_at":"2013-10-28T11:58:09.000Z","author_id":"116716199","lang":"en","conversation_id":"394795217426976768","possibly_sensitive":false,"id":"394795217426976768","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":76,"end":98,"url":"http://t.co/wHznK5tXrO","expanded_url":"http://ow.ly/qeIuJ","display_url":"ow.ly/qeIuJ"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"},{"start":12,"end":21,"username":"EMA_News","id":"116716199"}],"annotations":[{"start":41,"end":59,"probability":0.4338,"type":"Other","normalized_text":"Arterial Thrombosis"}]},"text":"RT @myESMO: @EMA_News warning on risk of Arterial Thrombosis with Ponatinib http://t.co/wHznK5tXrO","created_at":"2013-10-28T11:44:03.000Z","author_id":"116716199","lang":"en","conversation_id":"394791669310038018","possibly_sensitive":false,"id":"394791669310038018","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"394791256465080320"}]},{"entities":{"hashtags":{},"urls":[{"start":109,"end":131,"url":"http://t.co/U9MTGPVglO","expanded_url":"http://bit.ly/HotGC9","display_url":"bit.ly/HotGC9"}],"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"annotations":{}},"text":"RT @INFARMED_IP: Falsified medicine - Pegasys, solution for injection in prefilled syringe, 0.18 mg / 0.5 ml http://t.co/U9MTGPVglO","created_at":"2013-10-28T11:41:25.000Z","author_id":"116716199","lang":"en","conversation_id":"394791004613509120","possibly_sensitive":false,"id":"394791004613509120","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":60,"end":72,"tag":"nicardipine"}],"urls":[{"start":74,"end":96,"url":"http://t.co/dpVqz0KpKM","expanded_url":"http://bit.ly/19DEndl","display_url":"bit.ly/19DEndl"}],"mentions":{},"annotations":{}},"text":"On Friday we gave recommendations on the use of intravenous #nicardipine: http://t.co/dpVqz0KpKM","created_at":"2013-10-28T11:37:25.000Z","author_id":"116716199","lang":"en","conversation_id":"394789999628926976","possibly_sensitive":false,"id":"394789999628926976","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":52,"end":74,"url":"http://t.co/K2VuSWS55e","expanded_url":"http://bit.ly/168zqJ5","display_url":"bit.ly/168zqJ5"}],"mentions":{},"annotations":{}},"text":"We published the CHMP meeting highlights on Friday: http://t.co/K2VuSWS55e","created_at":"2013-10-28T11:36:34.000Z","author_id":"116716199","lang":"en","conversation_id":"394789787074179072","possibly_sensitive":false,"id":"394789787074179072","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":116,"end":138,"url":"http://t.co/3xgZsY8ibC","expanded_url":"http://bit.ly/Hl7GXV","display_url":"bit.ly/Hl7GXV"}],"mentions":{},"annotations":{}},"text":"On Friday CMDh endorsed PRAC recommendation to restrict use of short-acting beta-agonists in obstetric indications: http://t.co/3xgZsY8ibC","created_at":"2013-10-28T11:35:44.000Z","author_id":"116716199","lang":"en","conversation_id":"394789575681261568","possibly_sensitive":false,"id":"394789575681261568","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":47,"end":66,"tag":"hydroxyethylstarch"}],"urls":[{"start":118,"end":140,"url":"http://t.co/VPZjYBvoRW","expanded_url":"http://bit.ly/1ihWzuQ","display_url":"bit.ly/1ihWzuQ"}],"mentions":{},"annotations":{}},"text":"On Friday CMDh endorsed PRAC recommendation on #hydroxyethylstarch solutions - no longer to be used in some patients: http://t.co/VPZjYBvoRW","created_at":"2013-10-28T11:34:39.000Z","author_id":"116716199","lang":"en","conversation_id":"394789302665625600","possibly_sensitive":false,"id":"394789302665625600","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":28,"end":45,"tag":"compassionateuse"},{"start":49,"end":60,"tag":"sofosbuvir"},{"start":73,"end":84,"tag":"hepatitisC"}],"urls":[{"start":86,"end":108,"url":"http://t.co/1sgl6nsG8D","expanded_url":"http://bit.ly/HfThNk","display_url":"bit.ly/HfThNk"}],"mentions":{},"annotations":{}},"text":"On Friday we gave advice on #compassionateuse of #sofosbuvir for chronic #hepatitisC: http://t.co/1sgl6nsG8D","created_at":"2013-10-28T11:33:31.000Z","author_id":"116716199","lang":"en","conversation_id":"394789018493149186","possibly_sensitive":false,"id":"394789018493149186","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":15,"end":23,"tag":"insulin"},{"start":33,"end":41,"tag":"NovoMix"},{"start":45,"end":53,"tag":"FlexPen"},{"start":58,"end":66,"tag":"Penfill"}],"urls":[{"start":83,"end":105,"url":"http://t.co/yorxjZ6UK6","expanded_url":"http://bit.ly/1a4G3cK","display_url":"bit.ly/1a4G3cK"}],"mentions":{},"annotations":{}},"text":"Batches of the #insulin medicine #NovoMix 30 #FlexPen and #Penfill to be recalled: http://t.co/yorxjZ6UK6","created_at":"2013-10-28T11:31:51.000Z","author_id":"116716199","lang":"en","conversation_id":"394788597666029568","possibly_sensitive":false,"id":"394788597666029568","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":73,"end":95,"url":"http://t.co/IXgQDNL5aQ","expanded_url":"http://nyti.ms/Hq8ZFd","display_url":"nyti.ms/Hq8ZFd"}],"mentions":[{"start":3,"end":19,"username":"IlariaPassarani","id":"1106659014"}],"annotations":{}},"text":"RT @IlariaPassarani: F.D.A. Shift on Painkillers Was Years in the Making http://t.co/IXgQDNL5aQ","created_at":"2013-10-28T11:09:25.000Z","author_id":"116716199","lang":"en","conversation_id":"394782951650512896","possibly_sensitive":false,"id":"394782951650512896","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"394779689908051969"}]},{"entities":{"hashtags":[{"start":13,"end":23,"tag":"Defitelio"},{"start":25,"end":37,"tag":"defibrotide"},{"start":70,"end":84,"tag":"venoocclusive"}],"urls":[{"start":112,"end":134,"url":"http://t.co/MFSR4K1sm1","expanded_url":"http://bit.ly/16xVAa7","display_url":"bit.ly/16xVAa7"}],"mentions":{},"annotations":{}},"text":"The EPAR for #Defitelio (#defibrotide), an orphan medicine for severe #venoocclusive disease, is now published: http://t.co/MFSR4K1sm1","created_at":"2013-10-28T10:49:07.000Z","author_id":"116716199","lang":"en","conversation_id":"394777845639024641","possibly_sensitive":false,"id":"394777845639024641","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":13,"username":"AlzDisInt","id":"198970635"},{"start":112,"end":126,"username":"alzheimerssoc","id":"34267043"}],"annotations":{}},"text":"RT @AlzDisInt: Study reveals 'clearer picture' of genetics and dementia. Who is at risk of developing dementia? @alzheimerssoc http://t.co/…","created_at":"2013-10-28T10:16:24.000Z","author_id":"116716199","lang":"en","conversation_id":"394769612065083392","possibly_sensitive":false,"id":"394769612065083392","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"394769502975451136"}]},{"entities":{"hashtags":{},"urls":[{"start":49,"end":71,"url":"http://t.co/yeo6ykgQ5Q","expanded_url":"http://www.youtube.com/watch?v=ytENvEZOeZ0&feature=youtube_gdata","display_url":"youtube.com/watch?v=ytENvE…"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"text":"RT @GCessak: H7N9 flu vaccine developed in China http://t.co/yeo6ykgQ5Q","created_at":"2013-10-28T09:25:52.000Z","author_id":"116716199","lang":"fr","conversation_id":"394756893337743361","possibly_sensitive":false,"id":"394756893337743361","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"394755960230522880"}]},{"entities":{"hashtags":[{"start":56,"end":71,"tag":"ResponsibleUse"},{"start":75,"end":91,"tag":"animalmedicines"},{"start":111,"end":118,"tag":"EUPets"}],"urls":{},"mentions":{},"annotations":{}},"text":"RT @IFAHEurope: Speaking later on the importance of the #ResponsibleUse of #animalmedicines for animal welfare #EUPets http://t.co/KJpGJUFd…","created_at":"2013-10-28T09:23:34.000Z","author_id":"116716199","lang":"en","conversation_id":"394756316868378624","possibly_sensitive":false,"id":"394756316868378624","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"394755324470513665"}]},{"entities":{"hashtags":[{"start":19,"end":23,"tag":"FDA"},{"start":118,"end":126,"tag":"Vizamyl"}],"urls":{},"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"annotations":[{"start":89,"end":97,"probability":0.6838,"type":"Other","normalized_text":"Alzheimer"}]},"text":"RT @FDA_Drug_Info: #FDA approves second brain imaging drug to help evaluate patients for Alzheimer’s disease,dementia #Vizamyl http://t.co/…","created_at":"2013-10-25T15:31:11.000Z","author_id":"116716199","lang":"en","conversation_id":"393761664920596481","possibly_sensitive":false,"id":"393761664920596481","source":"TweetDeck","public_metrics":{"retweet_count":32,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"393757305226797056"}]},{"entities":{"hashtags":[{"start":32,"end":37,"tag":"H7N9"}],"urls":[{"start":102,"end":124,"url":"http://t.co/7MSmoDd5Uq","expanded_url":"http://bit.ly/1hd2gfZ","display_url":"bit.ly/1hd2gfZ"}],"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"},{"start":85,"end":101,"username":"Eurosurveillanc","id":"455839750"}],"annotations":{}},"text":"RT @ECDC_Flu: Avian influenza A(#H7N9) virus re-emerges in China in winter 2013? via @Eurosurveillanc http://t.co/7MSmoDd5Uq","created_at":"2013-10-25T15:30:46.000Z","author_id":"116716199","lang":"es","conversation_id":"393761558901178368","possibly_sensitive":false,"id":"393761558901178368","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"393757741560233984"}]},{"entities":{"hashtags":[{"start":29,"end":39,"tag":"Defitelio"},{"start":41,"end":53,"tag":"defibrotide"},{"start":86,"end":91,"tag":"veno"}],"urls":[{"start":111,"end":133,"url":"http://t.co/A0EYt5zskA","expanded_url":"http://bit.ly/16xVAa7","display_url":"bit.ly/16xVAa7"}],"mentions":{},"annotations":{}},"text":"We've published the EPAR for #Defitelio (#defibrotide), an orphan medicine for severe #veno-occlusive disease: http://t.co/A0EYt5zskA","created_at":"2013-10-25T14:34:02.000Z","author_id":"116716199","lang":"en","conversation_id":"393747285001383936","possibly_sensitive":false,"id":"393747285001383936","source":"bitly bitlink","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":54,"end":66,"tag":"nicardipine"}],"urls":[{"start":68,"end":90,"url":"http://t.co/nRJQLRbWpL","expanded_url":"http://bit.ly/19DEndl","display_url":"bit.ly/19DEndl"}],"mentions":{},"annotations":{}},"text":"We've given recommendations on the use of intravenous #nicardipine: http://t.co/nRJQLRbWpL","created_at":"2013-10-25T12:29:12.000Z","author_id":"116716199","lang":"en","conversation_id":"393715869962227712","possibly_sensitive":false,"id":"393715869962227712","source":"bitly bitlink","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":63,"end":85,"url":"http://t.co/PJfiwMbFCe","expanded_url":"http://bit.ly/168zqJ5","display_url":"bit.ly/168zqJ5"}],"mentions":{},"annotations":{}},"text":"We've just published the CHMP meeting highlights: October 2013 http://t.co/PJfiwMbFCe","created_at":"2013-10-25T12:24:44.000Z","author_id":"116716199","lang":"en","conversation_id":"393714745758732289","possibly_sensitive":false,"id":"393714745758732289","source":"bitly bitlink","public_metrics":{"retweet_count":5,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":111,"end":133,"url":"http://t.co/whdO2VX7Km","expanded_url":"http://bit.ly/Hl7GXV","display_url":"bit.ly/Hl7GXV"}],"mentions":{},"annotations":[{"start":0,"end":3,"probability":0.4139,"type":"Person","normalized_text":"CMDh"}]},"text":"CMDh has endorsed PRAC recommendation to restrict use of short-acting beta-agonists in obstetric indications:  http://t.co/whdO2VX7Km","created_at":"2013-10-25T11:41:02.000Z","author_id":"116716199","lang":"en","conversation_id":"393703745428930560","possibly_sensitive":false,"id":"393703745428930560","source":"bitly bitlink","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":41,"end":60,"tag":"hydroxyethylstarch"}],"urls":[{"start":112,"end":134,"url":"http://t.co/0uQstLh7NV","expanded_url":"http://bit.ly/1ihWzuQ","display_url":"bit.ly/1ihWzuQ"}],"mentions":{},"annotations":[{"start":0,"end":3,"probability":0.3964,"type":"Person","normalized_text":"CMDh"}]},"text":"CMDh has endorsed PRAC recommendation on #hydroxyethylstarch solutions - no longer to be used in some patients: http://t.co/0uQstLh7NV","created_at":"2013-10-25T11:38:43.000Z","author_id":"116716199","lang":"en","conversation_id":"393703165054709760","possibly_sensitive":false,"id":"393703165054709760","source":"bitly bitlink","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":22,"end":39,"tag":"compassionateuse"},{"start":43,"end":54,"tag":"sofosbuvir"},{"start":67,"end":78,"tag":"hepatitisC"}],"urls":[{"start":80,"end":102,"url":"http://t.co/rFLlKdbGCk","expanded_url":"http://bit.ly/HfThNk","display_url":"bit.ly/HfThNk"}],"mentions":{},"annotations":{}},"text":"We've given advice on #compassionateuse of #sofosbuvir for chronic #hepatitisC: http://t.co/rFLlKdbGCk","created_at":"2013-10-25T11:34:37.000Z","author_id":"116716199","lang":"en","conversation_id":"393702131485908992","possibly_sensitive":false,"id":"393702131485908992","source":"bitly bitlink","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":15,"end":23,"tag":"insulin"},{"start":33,"end":41,"tag":"NovoMix"},{"start":45,"end":53,"tag":"FlexPen"},{"start":58,"end":66,"tag":"Penfill"}],"urls":[{"start":83,"end":105,"url":"http://t.co/bs9xeVastf","expanded_url":"http://bit.ly/1a4G3cK","display_url":"bit.ly/1a4G3cK"}],"mentions":{},"annotations":{}},"text":"Batches of the #insulin medicine #NovoMix 30 #FlexPen and #Penfill to be recalled: http://t.co/bs9xeVastf","created_at":"2013-10-25T11:32:33.000Z","author_id":"116716199","lang":"en","conversation_id":"393701613736833024","possibly_sensitive":false,"id":"393701613736833024","source":"bitly bitlink","public_metrics":{"retweet_count":5,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"text":"RT @WHO: Since WHO established the Int'l Nonproprietary Name (INN) programme in 1950, it has allocated some 8500 names http://t.co/B2IjiZPc…","created_at":"2013-10-25T08:32:20.000Z","author_id":"116716199","lang":"en","conversation_id":"393656259368321024","possibly_sensitive":false,"id":"393656259368321024","source":"TweetDeck","public_metrics":{"retweet_count":18,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"393654129718870016"}]},{"entities":{"hashtags":[{"start":13,"end":20,"tag":"Tybost"},{"start":22,"end":33,"tag":"cobicistat"},{"start":54,"end":58,"tag":"HIV"},{"start":69,"end":80,"tag":"atazanavir"},{"start":87,"end":97,"tag":"darunavir"}],"urls":[{"start":122,"end":144,"url":"http://t.co/LRYFPOPGCu","expanded_url":"http://bit.ly/1aHxd5A","display_url":"bit.ly/1aHxd5A"}],"mentions":{},"annotations":{}},"text":"The EPAR for #Tybost (#cobicistat), a booster for the #HIV medicines #atazanavir &amp; #darunavir, is now on our website: http://t.co/LRYFPOPGCu","created_at":"2013-10-25T08:11:13.000Z","author_id":"116716199","lang":"en","conversation_id":"393650942957998080","possibly_sensitive":false,"id":"393650942957998080","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":12,"end":21,"tag":"FDAVoice"}],"urls":[{"start":110,"end":132,"url":"http://t.co/7J69hzMNIX","expanded_url":"http://go.usa.gov/WxU3","display_url":"go.usa.gov/WxU3"}],"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"annotations":[{"start":66,"end":68,"probability":0.9332,"type":"Organization","normalized_text":"FDA"}]},"text":"RT @US_FDA: #FDAVoice: As nanotechnology helps develop new drugs, FDA is working to ensure quality and safety http://t.co/7J69hzMNIX","created_at":"2013-10-24T16:28:14.000Z","author_id":"116716199","lang":"en","conversation_id":"393413636820975617","possibly_sensitive":false,"id":"393413636820975617","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"393411886718263296"}]},{"entities":{"hashtags":{},"urls":[{"start":109,"end":131,"url":"http://t.co/yvR1jT4pLY","expanded_url":"http://ow.ly/q8Il6","display_url":"ow.ly/q8Il6"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"annotations":{}},"text":"RT @myESMO: International Agency for Research on Cancer Releases Latest Global Cancer Trends in 5 Continents http://t.co/yvR1jT4pLY","created_at":"2013-10-24T16:27:30.000Z","author_id":"116716199","lang":"en","conversation_id":"393413448425418752","possibly_sensitive":false,"id":"393413448425418752","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"393409662902861824"}]},{"entities":{"hashtags":{},"urls":[{"start":112,"end":134,"url":"http://t.co/X2Cgmml2Kg","expanded_url":"http://bit.ly/HdOjAR","display_url":"bit.ly/HdOjAR"}],"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"annotations":{}},"text":"RT @AEMPSGOB: Updated information - Ketoconazole for systemic administration (tablets): suspension of marketing http://t.co/X2Cgmml2Kg","created_at":"2013-10-24T16:10:21.000Z","author_id":"116716199","lang":"en","conversation_id":"393409134453739520","possibly_sensitive":false,"id":"393409134453739520","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":{},"mentions":[{"start":0,"end":13,"username":"fezziwig2008","id":"376154503"}],"annotations":{}},"text":"@fezziwig2008 Yes, we respond to all queries. Please bear with us.","created_at":"2013-10-24T15:52:37.000Z","author_id":"116716199","lang":"en","conversation_id":"393319004741189633","possibly_sensitive":false,"id":"393404670586023936","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":3,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"393394444352757760"}],"in_reply_to_user_id":"376154503"},{"entities":{"hashtags":{},"urls":[{"start":42,"end":64,"url":"http://t.co/2GgYaf4QpV","expanded_url":"http://bit.ly/19A6g60","display_url":"bit.ly/19A6g60"}],"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"annotations":{}},"text":"RT @LV_MPA: New Drug Facts launched today http://t.co/2GgYaf4QpV","created_at":"2013-10-24T13:38:59.000Z","author_id":"116716199","lang":"en","conversation_id":"393371043164721152","possibly_sensitive":false,"id":"393371043164721152","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":76,"end":98,"url":"http://t.co/xeDSU3gFSA","expanded_url":"http://bit.ly/1dmQM9x","display_url":"bit.ly/1dmQM9x"}],"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"annotations":{}},"text":"RT @LV_MPA: Drug treatment of schizophrenia - New treatment recommendations http://t.co/xeDSU3gFSA","created_at":"2013-10-24T13:38:18.000Z","author_id":"116716199","lang":"en","conversation_id":"393370870762074112","possibly_sensitive":false,"id":"393370870762074112","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":26,"end":33,"tag":"pharma"},{"start":61,"end":74,"tag":"transparency"},{"start":98,"end":105,"tag":"ctdata"}],"urls":[{"start":75,"end":97,"url":"http://t.co/gHmnyI8Q9L","expanded_url":"http://bit.ly/1dmOrLM","display_url":"bit.ly/1dmOrLM"}],"mentions":{},"annotations":{}},"text":"RT @sailinsomnia: Another #pharma company commits to greater #transparency http://t.co/gHmnyI8Q9L #ctdata","created_at":"2013-10-24T13:29:54.000Z","author_id":"116716199","lang":"en","conversation_id":"393368755884937217","possibly_sensitive":false,"id":"393368755884937217","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":18,"end":37,"tag":"EuropeanParliament"},{"start":58,"end":76,"tag":"Pharmacovigilance"}],"urls":[{"start":104,"end":126,"url":"http://t.co/DbYPYgVLIu","expanded_url":"http://www.raps.org/focus-online/news/news-article-view/article/4222/european-parliament-proposes-changes-to-pharmacovigilance-user-fee-collection-s.aspx#.UmkegH4ix_o.twitter","display_url":"raps.org/focus-online/n…"}],"mentions":{},"annotations":{}},"text":"RT @sailinsomnia: #EuropeanParliament Proposes Changes to #Pharmacovigilance User Fee Collection System http://t.co/DbYPYgVLIu","created_at":"2013-10-24T13:28:39.000Z","author_id":"116716199","lang":"en","conversation_id":"393368439969955841","possibly_sensitive":false,"id":"393368439969955841","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"393366352607449088"}]},{"entities":{"hashtags":[{"start":90,"end":101,"tag":"poliovirus"}],"urls":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":[{"start":32,"end":34,"probability":0.8152,"type":"Organization","normalized_text":"AFP"},{"start":45,"end":49,"probability":0.9832,"type":"Place","normalized_text":"Syria"},{"start":105,"end":106,"probability":0.5555,"type":"Place","normalized_text":"EU"}]},"text":"RT @ECDC_EU: ECDC assessment on AFP cases in Syria: increases risk of importation of wild #poliovirus to EU, EEA countries http://t.co/s4Ys…","created_at":"2013-10-24T12:26:12.000Z","author_id":"116716199","lang":"en","conversation_id":"393352725691260928","possibly_sensitive":false,"id":"393352725691260928","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"393350532246831105"}]},{"entities":{"hashtags":[{"start":42,"end":49,"tag":"Tybost"},{"start":51,"end":62,"tag":"cobicistat"},{"start":77,"end":81,"tag":"HIV"},{"start":92,"end":103,"tag":"atazanavir"},{"start":110,"end":120,"tag":"darunavir"}],"urls":[{"start":122,"end":144,"url":"http://t.co/CRxzVzD2GS","expanded_url":"http://bit.ly/1aHxd5A","display_url":"bit.ly/1aHxd5A"}],"mentions":{},"annotations":{}},"text":"We've published the assessment report for #Tybost (#cobicistat) to boost the #HIV medicines #atazanavir &amp; #darunavir: http://t.co/CRxzVzD2GS","created_at":"2013-10-24T11:41:37.000Z","author_id":"116716199","lang":"en","conversation_id":"393341507568418816","possibly_sensitive":false,"id":"393341507568418816","source":"bitly bitlink","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":19,"username":"AlzheimerEurope","id":"1536274003"},{"start":38,"end":47,"username":"EMA_News","id":"116716199"}],"annotations":{}},"text":"RT @AlzheimerEurope: Been informed by @EMA_News that we continue to fulfull criteria for our involvement as a patient organisation in EMA a…","created_at":"2013-10-24T11:37:03.000Z","author_id":"116716199","lang":"en","conversation_id":"393340356948807680","possibly_sensitive":false,"id":"393340356948807680","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"393340230083702785"}]},{"entities":{"hashtags":[{"start":26,"end":34,"tag":"vacancy"},{"start":56,"end":67,"tag":"compliance"},{"start":122,"end":134,"tag":"recruitment"}],"urls":[{"start":99,"end":121,"url":"http://t.co/EE0sywjNYa","expanded_url":"http://bit.ly/1gZOrP7","display_url":"bit.ly/1gZOrP7"}],"mentions":{},"annotations":{}},"text":"Last day to apply for our #vacancy for a (non-)clinical #compliance officer. Deadline is tomorrow: http://t.co/EE0sywjNYa #recruitment","created_at":"2013-10-24T11:28:53.000Z","author_id":"116716199","lang":"en","conversation_id":"393338299638484992","possibly_sensitive":false,"id":"393338299638484992","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":26,"end":34,"tag":"vacancy"},{"start":41,"end":47,"tag":"legal"},{"start":119,"end":131,"tag":"recruitment"}],"urls":[{"start":96,"end":118,"url":"http://t.co/JwtLUu05F8","expanded_url":"http://bit.ly/19DXfGq","display_url":"bit.ly/19DXfGq"}],"mentions":{},"annotations":{}},"text":"Last day to apply for our #vacancy for a #legal officer. Deadline for applications is tomorrow: http://t.co/JwtLUu05F8 #recruitment","created_at":"2013-10-24T11:28:30.000Z","author_id":"116716199","lang":"en","conversation_id":"393338204012560384","possibly_sensitive":false,"id":"393338204012560384","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":82,"end":86,"tag":"flu"},{"start":87,"end":96,"tag":"vaccines"}],"urls":[{"start":98,"end":120,"url":"http://t.co/KE1DvoRtdJ","expanded_url":"http://bit.ly/16htHxA","display_url":"bit.ly/16htHxA"}],"mentions":{},"annotations":{}},"text":"One week left to comment on our explanatory note on the withdrawal of guidance on #flu #vaccines: http://t.co/KE1DvoRtdJ","created_at":"2013-10-24T11:27:43.000Z","author_id":"116716199","lang":"en","conversation_id":"393338008822218752","possibly_sensitive":false,"id":"393338008822218752","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":97,"end":104,"tag":"cancer"}],"urls":[{"start":116,"end":138,"url":"http://t.co/5dbmJU4yMi","expanded_url":"http://bit.ly/1etgd7d","display_url":"bit.ly/1etgd7d"}],"mentions":{},"annotations":{}},"text":"One week left to comment on need to revise condition–specific guidance on the evaluation of anti-#cancer medicines: http://t.co/5dbmJU4yMi","created_at":"2013-10-24T11:27:02.000Z","author_id":"116716199","lang":"en","conversation_id":"393337834410491905","possibly_sensitive":false,"id":"393337834410491905","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":84,"end":96,"tag":"biosimilars"}],"urls":[{"start":99,"end":121,"url":"http://t.co/eP6eLuld9g","expanded_url":"http://bit.ly/1etg4k0","display_url":"bit.ly/1etg4k0"}],"mentions":{},"annotations":{}},"text":"One week left to comment on our guideline on similar biological medicinal products (#biosimilars): http://t.co/eP6eLuld9g","created_at":"2013-10-24T11:26:19.000Z","author_id":"116716199","lang":"en","conversation_id":"393337653833134080","possibly_sensitive":false,"id":"393337653833134080","source":"Twitter Web Client","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":63,"end":72,"tag":"parabens"}],"urls":[{"start":112,"end":134,"url":"http://t.co/X7nXdWRWMD","expanded_url":"http://bit.ly/15KxJkS","display_url":"bit.ly/15KxJkS"}],"mentions":{},"annotations":{}},"text":"One week left to comment on our reflection paper on the use of #parabens as excipients in oral human medicines: http://t.co/X7nXdWRWMD","created_at":"2013-10-24T11:25:44.000Z","author_id":"116716199","lang":"en","conversation_id":"393337506659176449","possibly_sensitive":false,"id":"393337506659176449","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":56,"end":67,"tag":"phthalates"}],"urls":[{"start":102,"end":124,"url":"http://t.co/slqCKReqR4","expanded_url":"http://bit.ly/174dVvR","display_url":"bit.ly/174dVvR"}],"mentions":{},"annotations":{}},"text":"One week left to comment on our guideline on the use of #phthalates as excipients in human medicines: http://t.co/slqCKReqR4","created_at":"2013-10-24T11:25:17.000Z","author_id":"116716199","lang":"en","conversation_id":"393337393517821953","possibly_sensitive":false,"id":"393337393517821953","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":13,"end":21,"tag":"Ovaleap"},{"start":23,"end":35,"tag":"follitropin"}],"urls":[{"start":71,"end":93,"url":"http://t.co/WlWm326vKE","expanded_url":"http://bit.ly/1dj8n25","display_url":"bit.ly/1dj8n25"}],"mentions":{},"annotations":{}},"text":"The EPAR for #Ovaleap (#follitropin alfa) is available on our website: http://t.co/WlWm326vKE","created_at":"2013-10-24T11:24:22.000Z","author_id":"116716199","lang":"en","conversation_id":"393337164974391296","possibly_sensitive":false,"id":"393337164974391296","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":13,"end":22,"tag":"Imatinib"},{"start":32,"end":40,"tag":"generic"},{"start":44,"end":51,"tag":"Glivec"},{"start":73,"end":80,"tag":"cancer"}],"urls":[{"start":111,"end":133,"url":"http://t.co/3k40DKEOYJ","expanded_url":"http://bit.ly/1bWAsZi","display_url":"bit.ly/1bWAsZi"}],"mentions":{},"annotations":{}},"text":"The EPAR for #Imatinib medac, a #generic of #Glivec for the treatment of #cancer, is available on our website: http://t.co/3k40DKEOYJ","created_at":"2013-10-24T11:21:41.000Z","author_id":"116716199","lang":"en","conversation_id":"393336490790367232","possibly_sensitive":false,"id":"393336490790367232","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":71,"end":93,"url":"http://t.co/rMxJXKOpHn","expanded_url":"http://bit.ly/X4lXwT","display_url":"bit.ly/X4lXwT"}],"mentions":[{"start":0,"end":13,"username":"fezziwig2008","id":"376154503"}],"annotations":{}},"text":"@fezziwig2008 Thanks for your message. Please send your query to us at http://t.co/rMxJXKOpHn so that we can reply to you directly.","created_at":"2013-10-24T11:18:07.000Z","author_id":"116716199","lang":"en","conversation_id":"393319004741189633","possibly_sensitive":false,"id":"393335590516580352","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":2,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"393319004741189633"}],"in_reply_to_user_id":"376154503"},{"entities":{"hashtags":{},"urls":[{"start":98,"end":120,"url":"http://t.co/LDEzivrRB5","expanded_url":"http://www.raps.org/focus-online/news/news-article-view/article/4222/european-parliament-proposes-changes-to-pharmacovigilance-user-fee-collection-s.aspx#.Umj9nc3gYRY.twitter","display_url":"raps.org/focus-online/n…"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"text":"RT @GCessak: European Parliament Proposes Changes to Pharmacovigilance User Fee Collection System http://t.co/LDEzivrRB5","created_at":"2013-10-24T11:11:49.000Z","author_id":"116716199","lang":"fr","conversation_id":"393334007527510016","possibly_sensitive":false,"id":"393334007527510016","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"393330998349279232"}]},{"entities":{"hashtags":[{"start":56,"end":74,"tag":"pharmacovigilance"}],"urls":{},"mentions":[{"start":3,"end":13,"username":"HAIEurope","id":"3314634701"}],"annotations":[{"start":15,"end":33,"probability":0.285,"type":"Organization","normalized_text":"EU's ENVI Committee"}]},"text":"RT @HAIEurope: EU's ENVI Committee calls for changes to #pharmacovigilance user fee system, aiming for a more cost-based approach http://t.…","created_at":"2013-10-24T09:25:09.000Z","author_id":"116716199","lang":"en","conversation_id":"393307163281461248","possibly_sensitive":false,"id":"393307163281461248","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"393305771166793728"}]},{"entities":{"hashtags":[{"start":30,"end":38,"tag":"vacancy"},{"start":60,"end":71,"tag":"compliance"},{"start":124,"end":136,"tag":"recruitment"}],"urls":[{"start":100,"end":122,"url":"http://t.co/EE0sywjNYa","expanded_url":"http://bit.ly/1gZOrP7","display_url":"bit.ly/1gZOrP7"}],"mentions":{},"annotations":{}},"text":"One day left to apply for our #vacancy for a (non-)clinical #compliance officer. Deadline tomorrow: http://t.co/EE0sywjNYa  #recruitment","created_at":"2013-10-24T08:31:32.000Z","author_id":"116716199","lang":"en","conversation_id":"393293669312114688","possibly_sensitive":false,"id":"393293669312114688","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":30,"end":38,"tag":"vacancy"},{"start":45,"end":51,"tag":"legal"},{"start":124,"end":136,"tag":"recruitment"}],"urls":[{"start":100,"end":122,"url":"http://t.co/JwtLUu05F8","expanded_url":"http://bit.ly/19DXfGq","display_url":"bit.ly/19DXfGq"}],"mentions":{},"annotations":{}},"text":"One day left to apply for our #vacancy for a #legal officer. Deadline for applications is tomorrow: http://t.co/JwtLUu05F8  #recruitment","created_at":"2013-10-24T08:31:10.000Z","author_id":"116716199","lang":"en","conversation_id":"393293575259054080","possibly_sensitive":false,"id":"393293575259054080","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":82,"end":86,"tag":"flu"},{"start":87,"end":96,"tag":"vaccines"}],"urls":[{"start":98,"end":120,"url":"http://t.co/KE1DvoRtdJ","expanded_url":"http://bit.ly/16htHxA","display_url":"bit.ly/16htHxA"}],"mentions":{},"annotations":{}},"text":"One more week to comment on our explanatory note on the withdrawal of guidance on #flu #vaccines: http://t.co/KE1DvoRtdJ","created_at":"2013-10-24T08:30:04.000Z","author_id":"116716199","lang":"en","conversation_id":"393293299802320897","possibly_sensitive":false,"id":"393293299802320897","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":97,"end":104,"tag":"cancer"}],"urls":[{"start":116,"end":138,"url":"http://t.co/5dbmJU4yMi","expanded_url":"http://bit.ly/1etgd7d","display_url":"bit.ly/1etgd7d"}],"mentions":{},"annotations":{}},"text":"One more week to comment on need to revise condition–specific guidance on the evaluation of anti-#cancer medicines: http://t.co/5dbmJU4yMi","created_at":"2013-10-24T08:25:50.000Z","author_id":"116716199","lang":"en","conversation_id":"393292234243592192","possibly_sensitive":false,"id":"393292234243592192","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":84,"end":96,"tag":"biosimilars"}],"urls":[{"start":99,"end":121,"url":"http://t.co/eP6eLuld9g","expanded_url":"http://bit.ly/1etg4k0","display_url":"bit.ly/1etg4k0"}],"mentions":{},"annotations":{}},"text":"One more week to comment on our guideline on similar biological medicinal products (#biosimilars): http://t.co/eP6eLuld9g","created_at":"2013-10-24T08:20:19.000Z","author_id":"116716199","lang":"en","conversation_id":"393290847225004032","possibly_sensitive":false,"id":"393290847225004032","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":63,"end":72,"tag":"parabens"}],"urls":[{"start":112,"end":134,"url":"http://t.co/X7nXdWRWMD","expanded_url":"http://bit.ly/15KxJkS","display_url":"bit.ly/15KxJkS"}],"mentions":{},"annotations":{}},"text":"One more week to comment on our reflection paper on the use of #parabens as excipients in oral human medicines: http://t.co/X7nXdWRWMD","created_at":"2013-10-24T08:16:41.000Z","author_id":"116716199","lang":"en","conversation_id":"393289930979299328","possibly_sensitive":false,"id":"393289930979299328","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":56,"end":67,"tag":"phthalates"}],"urls":[{"start":102,"end":124,"url":"http://t.co/slqCKReqR4","expanded_url":"http://bit.ly/174dVvR","display_url":"bit.ly/174dVvR"}],"mentions":{},"annotations":{}},"text":"One more week to comment on our guideline on the use of #phthalates as excipients in human medicines: http://t.co/slqCKReqR4","created_at":"2013-10-24T08:11:12.000Z","author_id":"116716199","lang":"en","conversation_id":"393288550633832448","possibly_sensitive":false,"id":"393288550633832448","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":72,"end":94,"url":"http://t.co/rMxJXKOpHn","expanded_url":"http://bit.ly/X4lXwT","display_url":"bit.ly/X4lXwT"}],"mentions":[{"start":0,"end":14,"username":"PRMNewsletter","id":"372715566"}],"annotations":{}},"text":"@PRMNewsletter Thanks for your message. Please send your query to us at http://t.co/rMxJXKOpHn so that we can reply to you directly.","created_at":"2013-10-24T08:03:46.000Z","author_id":"116716199","lang":"en","conversation_id":"393046401422487552","possibly_sensitive":false,"id":"393286682012696576","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"393046401422487552"}],"in_reply_to_user_id":"372715566"},{"entities":{"hashtags":{},"urls":[{"start":68,"end":90,"url":"http://t.co/mTwKBsqnYM","expanded_url":"http://bit.ly/1dj8n25","display_url":"bit.ly/1dj8n25"}],"mentions":{},"annotations":{}},"text":"We have published the EPAR for the newly approved medicine Ovaleap: http://t.co/mTwKBsqnYM","created_at":"2013-10-23T16:27:10.000Z","author_id":"116716199","lang":"en","conversation_id":"393050976753827840","possibly_sensitive":false,"id":"393050976753827840","source":"bitly bitlink","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":75,"end":97,"url":"http://t.co/nY86P8LhCx","expanded_url":"http://bit.ly/1bWAsZi","display_url":"bit.ly/1bWAsZi"}],"mentions":{},"annotations":{}},"text":"We have published the EPAR for the newly approved medicine Imatinib medac: http://t.co/nY86P8LhCx","created_at":"2013-10-23T16:02:32.000Z","author_id":"116716199","lang":"en","conversation_id":"393044778734354432","possibly_sensitive":false,"id":"393044778734354432","source":"bitly bitlink","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":11,"username":"FDACBER","id":"303777686"}],"annotations":{}},"text":"RT @FDACBER: Public Workshop–Complex Issues in Developing Drug &amp; Biological Products for Rare Diseases   January 6-7,2014 http://t.co/wBxAx…","created_at":"2013-10-23T15:21:27.000Z","author_id":"116716199","lang":"en","conversation_id":"393034440072380417","possibly_sensitive":false,"id":"393034440072380417","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"393009281814917120"}]},{"entities":{"hashtags":[{"start":101,"end":105,"tag":"flu"},{"start":106,"end":115,"tag":"vaccines"}],"urls":{},"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{}},"text":"RT @IMI_JU: Tomorrow at 15:00 (CEST): IMI webinar on 10th Call topic on correlates of protection for #flu #vaccines. Sign up at http://t.co…","created_at":"2013-10-23T08:28:05.000Z","author_id":"116716199","lang":"en","conversation_id":"392930412311220225","possibly_sensitive":false,"id":"392930412311220225","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"392927089319739392"}]},{"entities":{"hashtags":[{"start":18,"end":25,"tag":"Gilead"},{"start":53,"end":57,"tag":"JnJ"},{"start":68,"end":72,"tag":"FDA"}],"urls":[{"start":74,"end":96,"url":"http://t.co/lOaM2V0xB6","expanded_url":"http://www.fool.com/investing/general/2013/10/21/gilead-and-johnson-johnson-face-the-fda.aspx#.UmaQ_swMFd8.twitter","display_url":"fool.com/investing/gene…"}],"mentions":[{"start":101,"end":115,"username":"themotleyfool","id":"15568127"}],"annotations":[{"start":30,"end":36,"probability":0.9752,"type":"Person","normalized_text":"Johnson"},{"start":40,"end":46,"probability":0.8653,"type":"Person","normalized_text":"Johnson"}]},"text":"RT @sailinsomnia: #Gilead and Johnson &amp; Johnson (#JnJ) Face the #FDA: http://t.co/lOaM2V0xB6 via @themotleyfool","created_at":"2013-10-22T16:58:34.000Z","author_id":"116716199","lang":"en","conversation_id":"392696492869566464","possibly_sensitive":false,"id":"392696492869566464","source":"Twitter for iPhone","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"392674774117134336"}]},{"entities":{"hashtags":[{"start":18,"end":22,"tag":"FDA"},{"start":29,"end":36,"tag":"Osiris"},{"start":52,"end":60,"tag":"Medical"}],"urls":[{"start":92,"end":114,"url":"http://t.co/TFsryMKRdR","expanded_url":"http://www.thestreet.com/story/12076152/1/fda-slaps-osiris-for-misleading-medical-claims-about-stem-cell-bandage.html","display_url":"thestreet.com/story/12076152…"}],"mentions":[{"start":120,"end":130,"username":"TheStreet","id":"15281391"}],"annotations":{}},"text":"RT @sailinsomnia: #FDA Slaps #Osiris For Misleading #Medical Claims About Stem-Cell Bandage http://t.co/TFsryMKRdR  via @TheStreet","created_at":"2013-10-22T16:58:13.000Z","author_id":"116716199","lang":"en","conversation_id":"392696406525640704","possibly_sensitive":false,"id":"392696406525640704","source":"Twitter for iPhone","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"392674403613290496"}]},{"entities":{"hashtags":[{"start":18,"end":32,"tag":"ClinicalTrial"}],"urls":[{"start":102,"end":124,"url":"http://t.co/8y2mgcPoZ0","expanded_url":"http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/pharmaceuticals/clinical-trial-must-be-done-for-our-benefit-not-for-mncs-sc/articleshow/24493574.cms?intenttarget=no","display_url":"economictimes.indiatimes.com/news/news-by-i…"}],"mentions":[{"start":129,"end":143,"username":"ArchiveDigger","id":"21736388"}],"annotations":{}},"text":"RT @sailinsomnia: #ClinicalTrial must be done for our benefit &amp; not for MNCs: SC - Economic Times http://t.co/8y2mgcPoZ0 via @ArchiveDigger","created_at":"2013-10-22T16:57:58.000Z","author_id":"116716199","lang":"en","conversation_id":"392696342784802816","possibly_sensitive":false,"id":"392696342784802816","source":"Twitter for iPhone","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"392674321937604608"}]},{"entities":{"hashtags":[{"start":34,"end":40,"tag":"India"}],"urls":[{"start":95,"end":117,"url":"http://t.co/Fr0JW7T1J9","expanded_url":"http://ecoti.ms/-o-aoY","display_url":"ecoti.ms/-o-aoY"}],"mentions":{},"annotations":[{"start":76,"end":93,"probability":0.6193,"type":"Organization","normalized_text":"The Economic Times"}]},"text":"RT @sailinsomnia: Third Wockhardt #India plant hit by export restrictions - The Economic Times http://t.co/Fr0JW7T1J9","created_at":"2013-10-22T16:57:37.000Z","author_id":"116716199","lang":"en","conversation_id":"392696251999088640","possibly_sensitive":false,"id":"392696251999088640","source":"Twitter for iPhone","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"392673877102297090"}]},{"entities":{"hashtags":{},"urls":[{"start":84,"end":106,"url":"http://t.co/mdYabdfwNH","expanded_url":"http://nej.md/1fSvSjH","display_url":"nej.md/1fSvSjH"}],"mentions":[{"start":3,"end":12,"username":"cancereu","id":"140344419"}],"annotations":{}},"text":"RT @cancereu: Access to Patient-Level Trial Data — A Boon to Drug Developers — NEJM http://t.co/mdYabdfwNH","created_at":"2013-10-22T16:57:24.000Z","author_id":"116716199","lang":"en","conversation_id":"392696198148407296","possibly_sensitive":false,"id":"392696198148407296","source":"Twitter for iPhone","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"392673274368237568"}]},{"entities":{"hashtags":[{"start":27,"end":38,"tag":"Biosimilar"}],"urls":[{"start":95,"end":117,"url":"http://t.co/aptCxZr2za","expanded_url":"http://www.pharmalive.com/changing-biosimilar-naming-rules-is-a-delay-tactic-ramachandra-explains","display_url":"pharmalive.com/changing-biosi…"}],"mentions":{},"annotations":{}},"text":"RT @sailinsomnia: Changing #Biosimilar Naming Rules Is A 'Delay Tactic:' Ramachandra Explains  http://t.co/aptCxZr2za","created_at":"2013-10-22T16:56:07.000Z","author_id":"116716199","lang":"en","conversation_id":"392695875434450944","possibly_sensitive":false,"id":"392695875434450944","source":"Twitter for iPhone","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"392665494844473345"}]},{"entities":{"hashtags":[{"start":49,"end":59,"tag":"Parkinson"}],"urls":{},"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"annotations":{}},"text":"RT @euparkinsons: Unexplained lower limb pain in #Parkinson's disease: A phenotypic variant of “painful Parkinson's disease” - http://t.co/…","created_at":"2013-10-22T16:55:29.000Z","author_id":"116716199","lang":"en","conversation_id":"392695717892214785","possibly_sensitive":false,"id":"392695717892214785","source":"Twitter for iPhone","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"392659125282168832"}]},{"entities":{"hashtags":[{"start":75,"end":88,"tag":"patientsvote"},{"start":89,"end":97,"tag":"epf2014"}],"urls":{},"mentions":[{"start":3,"end":19,"username":"eupatientsforum","id":"545343465"},{"start":117,"end":130,"username":"GasteinForum","id":"370067163"}],"annotations":{}},"text":"RT @eupatientsforum: Our Newsletter's October Issue is out! Updates on our #patientsvote #epf2014 campaign, our work @GasteinForum, etc htt…","created_at":"2013-10-22T16:55:21.000Z","author_id":"116716199","lang":"en","conversation_id":"392695682458726401","possibly_sensitive":false,"id":"392695682458726401","source":"Twitter for iPhone","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"392658685542948864"}]},{"entities":{"hashtags":[{"start":34,"end":42,"tag":"ESCAIDE"}],"urls":[{"start":100,"end":122,"url":"http://t.co/4XBdRj7QWr","expanded_url":"http://bit.ly/MzrCEY","display_url":"bit.ly/MzrCEY"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"text":"RT @ECDC_EU: Did you register for #ESCAIDE 2013? Online registration closes in few days, 25 October http://t.co/4XBdRj7QWr","created_at":"2013-10-22T16:55:08.000Z","author_id":"116716199","lang":"en","conversation_id":"392695630566817792","possibly_sensitive":false,"id":"392695630566817792","source":"Twitter for iPhone","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"392658177331720192"}]},{"entities":{"hashtags":{},"urls":[{"start":102,"end":124,"url":"http://t.co/n0mRAn8g9s","expanded_url":"http://bit.ly/16pT6KG","display_url":"bit.ly/16pT6KG"}],"mentions":{},"annotations":[{"start":63,"end":64,"probability":0.5001,"type":"Organization","normalized_text":"EU"}]},"text":"RT @EUlondonrep: Is a universal flu vaccine in sight thanks to EU research collaboration and funding? http://t.co/n0mRAn8g9s","created_at":"2013-10-22T16:54:53.000Z","author_id":"116716199","lang":"en","conversation_id":"392695564217114625","possibly_sensitive":false,"id":"392695564217114625","source":"Twitter for iPhone","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"392654643668348928"}]},{"entities":{"hashtags":[{"start":20,"end":32,"tag":"RareDisease"}],"urls":{},"mentions":[{"start":3,"end":18,"username":"rarediseaseday","id":"19982434"}],"annotations":{}},"text":"RT @rarediseaseday: #RareDisease Day 2014 slogan: Join together for better care. Start planning your event for Friday, Feb. 28th now","created_at":"2013-10-22T16:39:03.000Z","author_id":"116716199","lang":"en","conversation_id":"392691580802719744","possibly_sensitive":false,"id":"392691580802719744","source":"Twitter for iPhone","public_metrics":{"retweet_count":29,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"392650432495243264"}]},{"entities":{"hashtags":{},"urls":[{"start":60,"end":82,"url":"http://t.co/1OnYi6FycA","expanded_url":"http://bit.ly/1bSIouI","display_url":"bit.ly/1bSIouI"}],"mentions":[{"start":0,"end":7,"username":"LV_MPA","id":"77047226"}],"annotations":{}},"text":"@LV_MPA: PSURs for generic drugs need not be sent routinely http://t.co/1OnYi6FycA","created_at":"2013-10-22T16:38:49.000Z","author_id":"116716199","lang":"en","conversation_id":"392649926326251520","possibly_sensitive":false,"id":"392691520585080832","source":"Twitter for iPhone","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"392649926326251520"}],"in_reply_to_user_id":"77047226"},{"entities":{"hashtags":[{"start":35,"end":50,"tag":"clinicaltrials"},{"start":127,"end":134,"tag":"ctdata"}],"urls":[{"start":104,"end":126,"url":"http://t.co/x4UMqHhDmK","expanded_url":"http://bit.ly/17GH0ry","display_url":"bit.ly/17GH0ry"}],"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"annotations":{}},"text":"RT @eurordis: \"Releasing data from #clinicaltrials would help drug companies hunting for new medicines\" http://t.co/x4UMqHhDmK #ctdata","created_at":"2013-10-22T15:58:45.000Z","author_id":"116716199","lang":"en","conversation_id":"392681440917192705","possibly_sensitive":false,"id":"392681440917192705","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":133,"end":140,"tag":"ctdata"}],"urls":[{"start":110,"end":132,"url":"http://t.co/OniuH0UMfM","expanded_url":"http://bit.ly/1cRLrEr","display_url":"bit.ly/1cRLrEr"}],"mentions":{},"annotations":{}},"text":"Our senior staff published an article on how access to clinical-trial data will benefit medicines developers: http://t.co/OniuH0UMfM #ctdata","created_at":"2013-10-22T15:03:42.000Z","author_id":"116716199","lang":"en","conversation_id":"392667586929766400","possibly_sensitive":false,"id":"392667586929766400","source":"Twitter Web Client","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":88,"end":100,"tag":"antibiotics"},{"start":107,"end":112,"tag":"EAAD"}],"urls":{},"mentions":[{"start":3,"end":11,"username":"EAAD_EU","id":"1725283578"}],"annotations":{}},"text":"RT @EAAD_EU: Satisfaction of patients depends more on effective comms than on receiving #antibiotics. Read #EAAD patient dialogue http://t.…","created_at":"2013-10-22T14:00:16.000Z","author_id":"116716199","lang":"en","conversation_id":"392651622427271168","possibly_sensitive":false,"id":"392651622427271168","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"392624675051667456"}]},{"entities":{"hashtags":{},"urls":[{"start":91,"end":113,"url":"http://t.co/3DbkW2phu5","expanded_url":"http://nej.md/1fSvSjH","display_url":"nej.md/1fSvSjH"}],"mentions":[{"start":3,"end":19,"username":"IlariaPassarani","id":"1106659014"}],"annotations":{}},"text":"RT @IlariaPassarani: Access to Patient-Level Trial Data — A Boon to Drug Developers — NEJM http://t.co/3DbkW2phu5","created_at":"2013-10-22T13:56:36.000Z","author_id":"116716199","lang":"en","conversation_id":"392650701119029248","possibly_sensitive":false,"id":"392650701119029248","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"392609239463510016"}]},{"entities":{"hashtags":[{"start":93,"end":105,"tag":"RareDisease"}],"urls":[{"start":116,"end":138,"url":"http://t.co/ksBuvFeKMa","expanded_url":"http://bit.ly/1aDX2n0","display_url":"bit.ly/1aDX2n0"}],"mentions":[{"start":3,"end":14,"username":"sanidadgob","id":"232124120"}],"annotations":{}},"text":"RT @sanidadgob: Ministry of Health, Social Services and Equality launches website on Spanish #RareDisease Year 2013 http://t.co/ksBuvFeKMa","created_at":"2013-10-22T13:56:01.000Z","author_id":"116716199","lang":"en","conversation_id":"392650553638916096","possibly_sensitive":false,"id":"392650553638916096","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":92,"end":113,"tag":"personalisedmedicine"},{"start":114,"end":123,"tag":"genetics"}],"urls":[{"start":69,"end":91,"url":"http://t.co/uqbYgkl1CN","expanded_url":"http://ow.ly/q3icN","display_url":"ow.ly/q3icN"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"annotations":{}},"text":"RT @myESMO: Mutational Landscape Identified in 12 Major Cancer Types http://t.co/uqbYgkl1CN #personalisedmedicine #genetics","created_at":"2013-10-22T10:54:19.000Z","author_id":"116716199","lang":"en","conversation_id":"392604825721913344","possibly_sensitive":false,"id":"392604825721913344","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"392604693975027712"}]},{"entities":{"hashtags":[{"start":48,"end":55,"tag":"ctdata"}],"urls":{},"mentions":[{"start":3,"end":19,"username":"Martinharvey100","id":"113148426"},{"start":21,"end":30,"username":"EMA_News","id":"116716199"},{"start":112,"end":117,"username":"NEJM","id":"25950355"}],"annotations":{}},"text":"RT @Martinharvey100: @ema_news argues access to #ctdata will benefit drug developers and patients. New paper in @NEJM today  http://t.co/oW…","created_at":"2013-10-22T10:15:50.000Z","author_id":"116716199","lang":"en","conversation_id":"392595140339986432","possibly_sensitive":false,"id":"392595140339986432","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"392593512661012480"}]},{"entities":{"hashtags":[{"start":14,"end":18,"tag":"Flu"},{"start":19,"end":31,"tag":"vaccination"}],"urls":[{"start":118,"end":140,"url":"http://t.co/wURYBQ4nUo","expanded_url":"http://bit.ly/15ZMkJ7","display_url":"bit.ly/15ZMkJ7"}],"mentions":[{"start":3,"end":12,"username":"agesnews","id":"223456379"}],"annotations":[{"start":109,"end":116,"probability":0.9504,"type":"Person","normalized_text":"Dr Indra"}]},"text":"RT @agesnews: #Flu #vaccination vs risk, mortality and the ideal time for vaccination: interview with expert Dr Indra http://t.co/wURYBQ4nUo","created_at":"2013-10-22T10:14:56.000Z","author_id":"116716199","lang":"en","conversation_id":"392594915089055745","possibly_sensitive":false,"id":"392594915089055745","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":30,"end":45,"tag":"clinicaltrials"},{"start":101,"end":114,"tag":"transparency"},{"start":139,"end":146,"tag":"ctdata"}],"urls":[{"start":116,"end":138,"url":"http://t.co/WwlcnrDgxQ","expanded_url":"http://bit.ly/18FtKak","display_url":"bit.ly/18FtKak"}],"mentions":[{"start":3,"end":13,"username":"HAIEurope","id":"3314634701"}],"annotations":{}},"text":"RT @HAIEurope: Paper supports #clinicaltrials data disclosure benefits for R&amp;D, efficiency &amp; #transparency  http://t.co/WwlcnrDgxQ #ctdata","created_at":"2013-10-22T09:12:11.000Z","author_id":"116716199","lang":"en","conversation_id":"392579123450638336","possibly_sensitive":false,"id":"392579123450638336","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":49,"end":58,"tag":"residues"}],"urls":[{"start":121,"end":143,"url":"http://t.co/FQe1L4Vy6A","expanded_url":"http://bit.ly/17bJHHg","display_url":"bit.ly/17bJHHg"}],"mentions":{},"annotations":{}},"text":"Comments open on our guideline on injection-site #residues for veterinary medicines: risk assessment &amp; surveillance: http://t.co/FQe1L4Vy6A","created_at":"2013-10-22T08:25:45.000Z","author_id":"116716199","lang":"en","conversation_id":"392567437486342144","possibly_sensitive":false,"id":"392567437486342144","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":68,"end":81,"tag":"intramammary"},{"start":95,"end":102,"tag":"cattle"}],"urls":[{"start":104,"end":126,"url":"http://t.co/MH7VrBw8Mh","expanded_url":"http://bit.ly/1a7q29P","display_url":"bit.ly/1a7q29P"}],"mentions":{},"annotations":{}},"text":"Send us your comments on our draft guideline on efficacy studies of #intramammary medicines in #cattle: http://t.co/MH7VrBw8Mh","created_at":"2013-10-22T08:24:45.000Z","author_id":"116716199","lang":"en","conversation_id":"392567188663459840","possibly_sensitive":false,"id":"392567188663459840","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":65,"end":76,"tag":"withdrawal"},{"start":89,"end":100,"tag":"veterinary"}],"urls":[{"start":112,"end":134,"url":"http://t.co/iNcscRKFfc","expanded_url":"http://bit.ly/16qgaDZ","display_url":"bit.ly/16qgaDZ"}],"mentions":{},"annotations":{}},"text":"We've started a consultation on our guidance on harmonisation of #withdrawal periods for #veterinary medicines: http://t.co/iNcscRKFfc","created_at":"2013-10-22T08:24:11.000Z","author_id":"116716199","lang":"en","conversation_id":"392567045008551936","possibly_sensitive":false,"id":"392567045008551936","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":14,"end":28,"tag":"blacktriangle"}],"urls":[{"start":108,"end":130,"url":"http://t.co/ZzDNIqm0Nk","expanded_url":"http://bit.ly/10EQUGI","display_url":"bit.ly/10EQUGI"}],"mentions":{},"annotations":{}},"text":"What does the #blacktriangle mean? Find out about additional monitoring of medicines by watching our video: http://t.co/ZzDNIqm0Nk","created_at":"2013-10-22T08:21:32.000Z","author_id":"116716199","lang":"en","conversation_id":"392566375182368768","possibly_sensitive":false,"id":"392566375182368768","source":"Twitter Web Client","public_metrics":{"retweet_count":8,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":102,"end":109,"tag":"ctdata"}],"urls":[{"start":79,"end":101,"url":"http://t.co/UEtOekEw1d","expanded_url":"http://bit.ly/1cRLrEr","display_url":"bit.ly/1cRLrEr"}],"mentions":{},"annotations":{}},"text":"How access to full clinical-trial data sets will benefit medicines developers: http://t.co/UEtOekEw1d #ctdata","created_at":"2013-10-22T08:19:35.000Z","author_id":"116716199","lang":"en","conversation_id":"392565887402012672","possibly_sensitive":false,"id":"392565887402012672","source":"bitly bitlink","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":68,"end":90,"url":"http://t.co/rMxJXKOpHn","expanded_url":"http://bit.ly/X4lXwT","display_url":"bit.ly/X4lXwT"}],"mentions":{},"annotations":{}},"text":"@PinkyG123 Thanks for your message. Please send your query to us at http://t.co/rMxJXKOpHn so that we can reply to you directly.","created_at":"2013-10-22T08:02:51.000Z","author_id":"116716199","lang":"en","conversation_id":"392353334910545920","possibly_sensitive":false,"id":"392561676081328128","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"392353334910545920"}],"in_reply_to_user_id":"1506550260"},{"entities":{"hashtags":[{"start":47,"end":56,"tag":"residues"}],"urls":[{"start":117,"end":139,"url":"http://t.co/KG6grANjRB","expanded_url":"http://bit.ly/17bJHHg","display_url":"bit.ly/17bJHHg"}],"mentions":{},"annotations":{}},"text":"We've started a consultation on injection-site #residues for veterinary medicines: risk assessment and surveillance: http://t.co/KG6grANjRB","created_at":"2013-10-21T14:10:31.000Z","author_id":"116716199","lang":"en","conversation_id":"392291815107604480","possibly_sensitive":false,"id":"392291815107604480","source":"bitly bitlink","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":74,"end":87,"tag":"intramammary"},{"start":101,"end":108,"tag":"cattle"}],"urls":[{"start":110,"end":132,"url":"http://t.co/GYJAPfl4Cx","expanded_url":"http://bit.ly/1a7q29P","display_url":"bit.ly/1a7q29P"}],"mentions":{},"annotations":{}},"text":"We've started a public consultation on a guideline on efficacy studies of #intramammary medicines in #cattle: http://t.co/GYJAPfl4Cx","created_at":"2013-10-21T13:33:26.000Z","author_id":"116716199","lang":"en","conversation_id":"392282482990919680","possibly_sensitive":false,"id":"392282482990919680","source":"bitly bitlink","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":95,"end":106,"tag":"withdrawal"}],"urls":[{"start":117,"end":139,"url":"http://t.co/bov9nhTYmn","expanded_url":"http://bit.ly/16qgaDZ","display_url":"bit.ly/16qgaDZ"}],"mentions":{},"annotations":{}},"text":"We've started a public consultation on revision of our guidance on harmonisation of veterinary #withdrawal periods:  http://t.co/bov9nhTYmn","created_at":"2013-10-21T13:24:50.000Z","author_id":"116716199","lang":"en","conversation_id":"392280315928276992","possibly_sensitive":false,"id":"392280315928276992","source":"bitly bitlink","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":49,"end":73,"tag":"antimicrobialresistance"}],"urls":[{"start":117,"end":139,"url":"http://t.co/ezAeYf8aHr","expanded_url":"http://bit.ly/18BItTM","display_url":"bit.ly/18BItTM"}],"mentions":{},"annotations":{}},"text":"We published a draft reflection paper on risk of #antimicrobialresistance transfer from companion animals to humans: http://t.co/ezAeYf8aHr","created_at":"2013-10-21T13:09:14.000Z","author_id":"116716199","lang":"en","conversation_id":"392276389530828801","possibly_sensitive":false,"id":"392276389530828801","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":49,"end":73,"tag":"antimicrobialresistance"}],"urls":[{"start":117,"end":139,"url":"http://t.co/EPUwMmAb7t","expanded_url":"http://bit.ly/18BItTM","display_url":"bit.ly/18BItTM"}],"mentions":{},"annotations":{}},"text":"Comment on our draft reflection paper on risk of #antimicrobialresistance transfer from companion animals to humans: http://t.co/EPUwMmAb7t","created_at":"2013-10-21T10:13:13.000Z","author_id":"116716199","lang":"en","conversation_id":"392232094560428032","possibly_sensitive":false,"id":"392232094560428032","source":"bitly bitlink","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":87,"end":109,"url":"http://t.co/b0IU38wB96","expanded_url":"http://1.usa.gov/H5IVQw","display_url":"1.usa.gov/H5IVQw"}],"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"annotations":{}},"text":"RT @FDAanimalhealth: Follow the journey of an animal drug through the approval process http://t.co/b0IU38wB96","created_at":"2013-10-18T17:42:59.000Z","author_id":"116716199","lang":"en","conversation_id":"391258118325567488","possibly_sensitive":false,"id":"391258118325567488","source":"Twitter for iPhone","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"391236937874296832"}]},{"entities":{"hashtags":[{"start":43,"end":51,"tag":"ESCAIDE"}],"urls":[{"start":120,"end":142,"url":"http://t.co/50LEK7LVPd","expanded_url":"http://bit.ly/QGplxI","display_url":"bit.ly/QGplxI"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"text":"RT @ECDC_EU: All abstracts of the upcoming #ESCAIDE presentations &amp; posters are now online. See 2013 abstract book: http://t.co/50LEK7LVPd","created_at":"2013-10-18T15:22:45.000Z","author_id":"116716199","lang":"en","conversation_id":"391222828445343744","possibly_sensitive":false,"id":"391222828445343744","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"391221965668630528"}]},{"entities":{"hashtags":{},"urls":[{"start":74,"end":96,"url":"http://t.co/tKnRLGi5ju","expanded_url":"http://bit.ly/H7Vgm7","display_url":"bit.ly/H7Vgm7"}],"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"annotations":{}},"text":"RT @LV_MPA: Nezeril 0.1 mg / ml nasal drops and nasal sprays deregistered http://t.co/tKnRLGi5ju","created_at":"2013-10-18T14:24:17.000Z","author_id":"116716199","lang":"ro","conversation_id":"391208113904156673","possibly_sensitive":false,"id":"391208113904156673","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":28,"end":35,"tag":"trials"},{"start":43,"end":50,"tag":"Indian"},{"start":51,"end":56,"tag":"drug"}],"urls":[{"start":73,"end":95,"url":"http://t.co/RnSJ8ljBBh","expanded_url":"http://www.newscientist.com/article/dn24421-badly-run-trials-behind-indian-drug-testing-freeze.html?cmpid=RSS|NSNS|2012-GLOBAL|online-news","display_url":"newscientist.com/article/dn2442…"}],"mentions":{},"annotations":{}},"text":"RT @sailinsomnia: Badly run #trials behind #Indian #drug testing freeze\n http://t.co/RnSJ8ljBBh","created_at":"2013-10-18T13:42:39.000Z","author_id":"116716199","lang":"en","conversation_id":"391197638185345024","possibly_sensitive":false,"id":"391197638185345024","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"391196963271491584"}]},{"entities":{"hashtags":[{"start":27,"end":36,"tag":"westnile"}],"urls":[{"start":77,"end":99,"url":"http://t.co/0TdNsiVALm","expanded_url":"http://bit.ly/1atIFSg","display_url":"bit.ly/1atIFSg"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":[{"start":52,"end":57,"probability":0.9947,"type":"Place","normalized_text":"Europe"}]},"text":"RT @ECDC_EU: The latest on #westnile fever cases in Europe in the last week: http://t.co/0TdNsiVALm. See also our infographic: http://t.co/…","created_at":"2013-10-18T13:34:30.000Z","author_id":"116716199","lang":"en","conversation_id":"391195588294746112","possibly_sensitive":false,"id":"391195588294746112","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"391194497679253505"}]},{"entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":15,"username":"EUombudsman","id":"873777758"},{"start":70,"end":79,"username":"EMA_News","id":"116716199"}],"annotations":[{"start":21,"end":29,"probability":0.4349,"type":"Organization","normalized_text":"Ombudsman"}]},"text":"RT @EUombudsman: The Ombudsman welcomes the constructive responses of @EMA_News to most of his suggestions.","created_at":"2013-10-18T12:27:55.000Z","author_id":"116716199","lang":"en","conversation_id":"391178829068115968","possibly_sensitive":false,"id":"391178829068115968","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"391174699729682432"}]},{"entities":{"hashtags":[{"start":125,"end":138,"tag":"transparency"}],"urls":[{"start":102,"end":124,"url":"http://t.co/XngA9SJ47q","expanded_url":"http://bit.ly/19X8pti","display_url":"bit.ly/19X8pti"}],"mentions":[{"start":3,"end":15,"username":"EUombudsman","id":"873777758"},{"start":92,"end":101,"username":"EMA_News","id":"116716199"}],"annotations":[{"start":66,"end":90,"probability":0.4385,"type":"Organization","normalized_text":"European Medicines Agency"}]},"text":"RT @EUombudsman: Decision on inquiry OI/9/2011/IJH concerning the European Medicines Agency @EMA_News http://t.co/XngA9SJ47q #transparency …","created_at":"2013-10-18T12:27:51.000Z","author_id":"116716199","lang":"en","conversation_id":"391178814148968448","possibly_sensitive":false,"id":"391178814148968448","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"391174476424949760"}]},{"entities":{"hashtags":[{"start":24,"end":31,"tag":"EPRUMA"},{"start":68,"end":83,"tag":"ResponsibleUse"}],"urls":[{"start":110,"end":132,"url":"http://t.co/xmwid9TQqX","expanded_url":"http://bit.ly/GTBomY","display_url":"bit.ly/GTBomY"}],"mentions":{},"annotations":{}},"text":"RT @IFAHEurope: Spanish #EPRUMA equivalent Vetresponsable publishes #ResponsibleUse guidelines for beekeeping http://t.co/xmwid9TQqX","created_at":"2013-10-18T12:25:38.000Z","author_id":"116716199","lang":"en","conversation_id":"391178255014690816","possibly_sensitive":false,"id":"391178255014690816","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"391165616544948227"}]},{"entities":{"hashtags":[{"start":31,"end":39,"tag":"vacancy"},{"start":61,"end":72,"tag":"compliance"},{"start":127,"end":139,"tag":"recruitment"}],"urls":[{"start":104,"end":126,"url":"http://t.co/EE0sywjNYa","expanded_url":"http://bit.ly/1gZOrP7","display_url":"bit.ly/1gZOrP7"}],"mentions":{},"annotations":{}},"text":"One more week to apply for our #vacancy for a (non-)clinical #compliance officer. Deadline: 25 October: http://t.co/EE0sywjNYa #recruitment","created_at":"2013-10-18T11:03:46.000Z","author_id":"116716199","lang":"en","conversation_id":"391157654128582658","possibly_sensitive":false,"id":"391157654128582658","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":31,"end":39,"tag":"vacancy"},{"start":46,"end":52,"tag":"legal"},{"start":127,"end":139,"tag":"recruitment"}],"urls":[{"start":103,"end":125,"url":"http://t.co/JwtLUu05F8","expanded_url":"http://bit.ly/19DXfGq","display_url":"bit.ly/19DXfGq"}],"mentions":{},"annotations":{}},"text":"One more week to apply for our #vacancy for a #legal officer. Deadline for applications is 25 October: http://t.co/JwtLUu05F8  #recruitment","created_at":"2013-10-18T11:03:13.000Z","author_id":"116716199","lang":"en","conversation_id":"391157514042998784","possibly_sensitive":false,"id":"391157514042998784","source":"Twitter Web Client","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":54,"end":59,"tag":"CHMP"}],"urls":[{"start":118,"end":140,"url":"http://t.co/2NHTa8if2J","expanded_url":"http://bit.ly/1c1i1Xq","display_url":"bit.ly/1c1i1Xq"}],"mentions":{},"annotations":{}},"text":"The October meeting of our human medicines committee (#CHMP) is next week. We're publishing the highlights on Friday: http://t.co/2NHTa8if2J","created_at":"2013-10-18T11:02:34.000Z","author_id":"116716199","lang":"en","conversation_id":"391157350167347202","possibly_sensitive":false,"id":"391157350167347202","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":79,"end":101,"url":"http://t.co/sZZXn84JjE","expanded_url":"http://bit.ly/1i1qnvC","display_url":"bit.ly/1i1qnvC"}],"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"annotations":{}},"text":"RT @INFARMED_IP: Voluntary recall of batches of the medicine Captopril Zentiva http://t.co/sZZXn84JjE","created_at":"2013-10-18T10:47:18.000Z","author_id":"116716199","lang":"en","conversation_id":"391153508210049024","possibly_sensitive":false,"id":"391153508210049024","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":13,"end":23,"tag":"influenza"},{"start":25,"end":38,"tag":"tuberculosis"},{"start":40,"end":48,"tag":"disease"},{"start":49,"end":59,"tag":"outbreaks"},{"start":85,"end":93,"tag":"ESCAIDE"}],"urls":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"text":"RT @ECDC_EU: #influenza, #tuberculosis, #disease #outbreaks &amp; other topics @ 2nd #ESCAIDE poster session. See programme: http://t.co/ctaNil…","created_at":"2013-10-18T10:43:49.000Z","author_id":"116716199","lang":"en","conversation_id":"391152633567653889","possibly_sensitive":false,"id":"391152633567653889","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"391130257924702209"}]},{"entities":{"hashtags":{},"urls":[{"start":50,"end":72,"url":"http://t.co/EGLF1QGHTC","expanded_url":"http://eepurl.com/G6vDr","display_url":"eepurl.com/G6vDr"}],"mentions":[{"start":3,"end":15,"username":"EUneurology","id":"619868597"}],"annotations":{}},"text":"RT @EUneurology: Check out EFNA e-News: Issue 5 - http://t.co/EGLF1QGHTC","created_at":"2013-10-18T10:43:20.000Z","author_id":"116716199","lang":"ht","conversation_id":"391152508887777282","possibly_sensitive":false,"id":"391152508887777282","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"391129280689610752"}]},{"entities":{"hashtags":[{"start":63,"end":73,"tag":"Parkinson"}],"urls":[{"start":107,"end":129,"url":"http://t.co/3hxQNjgUiC","expanded_url":"http://bit.ly/15FDSQV","display_url":"bit.ly/15FDSQV"}],"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"annotations":{}},"text":"RT @euparkinsons: Did u know we have an extensive directory of #Parkinson's resources &amp; organisations? http://t.co/3hxQNjgUiC","created_at":"2013-10-18T08:58:30.000Z","author_id":"116716199","lang":"en","conversation_id":"391126129664196608","possibly_sensitive":false,"id":"391126129664196608","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"391124218345037825"}]},{"entities":{"hashtags":[{"start":59,"end":63,"tag":"HTA"},{"start":64,"end":73,"tag":"oncology"},{"start":74,"end":88,"tag":"immunotherapy"},{"start":89,"end":96,"tag":"ageing"}],"urls":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"text":"RT @EFPIA: READ (!) the new EFPIA Newsletter! With news on #HTA #oncology #immunotherapy #ageing populations and more! http://t.co/zh6uY9ls…","created_at":"2013-10-18T08:45:11.000Z","author_id":"116716199","lang":"en","conversation_id":"391122776951513089","possibly_sensitive":false,"id":"391122776951513089","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"391117587414659073"}]},{"entities":{"hashtags":[{"start":74,"end":86,"tag":"antibiotics"},{"start":122,"end":127,"tag":"EAAD"}],"urls":[{"start":99,"end":121,"url":"http://t.co/6p6Ej1S4CH","expanded_url":"http://bit.ly/1d1vxdp","display_url":"bit.ly/1d1vxdp"}],"mentions":[{"start":3,"end":11,"username":"EAAD_EU","id":"1725283578"}],"annotations":{}},"text":"RT @EAAD_EU: Antibiotics are not effective against colds or the flu. Take #antibiotics responsibly http://t.co/6p6Ej1S4CH #EAAD","created_at":"2013-10-18T08:13:50.000Z","author_id":"116716199","lang":"en","conversation_id":"391114887205634048","possibly_sensitive":false,"id":"391114887205634048","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":31,"end":39,"tag":"vacancy"},{"start":61,"end":72,"tag":"compliance"},{"start":127,"end":139,"tag":"recruitment"}],"urls":[{"start":104,"end":126,"url":"http://t.co/EE0sywjNYa","expanded_url":"http://bit.ly/1gZOrP7","display_url":"bit.ly/1gZOrP7"}],"mentions":{},"annotations":{}},"text":"One week left to apply for our #vacancy for a (non-)clinical #compliance officer. Deadline: 25 October: http://t.co/EE0sywjNYa #recruitment","created_at":"2013-10-18T08:06:34.000Z","author_id":"116716199","lang":"en","conversation_id":"391113058434568192","possibly_sensitive":false,"id":"391113058434568192","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":31,"end":39,"tag":"vacancy"},{"start":46,"end":52,"tag":"legal"},{"start":126,"end":138,"tag":"recruitment"}],"urls":[{"start":103,"end":125,"url":"http://t.co/JwtLUu05F8","expanded_url":"http://bit.ly/19DXfGq","display_url":"bit.ly/19DXfGq"}],"mentions":{},"annotations":{}},"text":"One week left to apply for our #vacancy for a #legal officer. Deadline for applications is 25 October: http://t.co/JwtLUu05F8 #recruitment","created_at":"2013-10-18T08:05:46.000Z","author_id":"116716199","lang":"en","conversation_id":"391112858500489216","possibly_sensitive":false,"id":"391112858500489216","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":31,"end":36,"tag":"CHMP"}],"urls":[{"start":87,"end":109,"url":"http://t.co/vEvAo1Ydxo","expanded_url":"http://bit.ly/1c1i1Xq","display_url":"bit.ly/1c1i1Xq"}],"mentions":{},"annotations":{}},"text":"Our human medicines committee (#CHMP) meets next week. Highlights published on Friday: http://t.co/vEvAo1Ydxo","created_at":"2013-10-18T08:03:23.000Z","author_id":"116716199","lang":"en","conversation_id":"391112260112093184","possibly_sensitive":false,"id":"391112260112093184","source":"bitly bitlink","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":40,"end":46,"tag":"H3N2v"},{"start":73,"end":77,"tag":"flu"}],"urls":{},"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"annotations":[{"start":51,"end":52,"probability":0.8372,"type":"Place","normalized_text":"EU"}]},"text":"RT @ECDC_Flu: Likelihood of influenza A(#H3N2v) in EU is low; monitoring #flu in pigs to be reinforced, conclude 3 EU agencies: http://t.co…","created_at":"2013-10-17T15:04:13.000Z","author_id":"116716199","lang":"en","conversation_id":"390855774252961792","possibly_sensitive":false,"id":"390855774252961792","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"390849161051918336"}]},{"entities":{"hashtags":[{"start":49,"end":63,"tag":"antimicrobial"},{"start":76,"end":85,"tag":"vaccines"},{"start":87,"end":97,"tag":"influenza"},{"start":98,"end":111,"tag":"surveillance"},{"start":113,"end":117,"tag":"hiv"}],"urls":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"text":"RT @ECDC_EU: Interested in scientific posters on #antimicrobial resistance, #vaccines, #influenza #surveillance, #hiv?  http://t.co/CJ0jrV4…","created_at":"2013-10-17T13:54:54.000Z","author_id":"116716199","lang":"en","conversation_id":"390838331816157184","possibly_sensitive":false,"id":"390838331816157184","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"390824033349943296"}]},{"entities":{"hashtags":{},"urls":[{"start":115,"end":137,"url":"http://t.co/v6LWl0Qur3","expanded_url":"http://newsletter.echa.europa.eu/","display_url":"newsletter.echa.europa.eu"}],"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"annotations":[{"start":54,"end":68,"probability":0.3686,"type":"Organization","normalized_text":"ECHA Newsletter"}]},"text":"RT @EU_ECHA: We just published the new edition of the ECHA Newsletter. Read online the interesting articles in it. http://t.co/v6LWl0Qur3","created_at":"2013-10-17T13:51:57.000Z","author_id":"116716199","lang":"en","conversation_id":"390837588996550656","possibly_sensitive":false,"id":"390837588996550656","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"390835752549892096"}]},{"entities":{"hashtags":[{"start":75,"end":93,"tag":"multiplesclerosis"}],"urls":[{"start":114,"end":136,"url":"http://t.co/Ku0BgqkPYh","expanded_url":"http://bit.ly/19SAr9r","display_url":"bit.ly/19SAr9r"}],"mentions":{},"annotations":{}},"text":"Follow today's EMA workshop on clinical investigation of new medicines for #multiplesclerosis via live broadcast: http://t.co/Ku0BgqkPYh","created_at":"2013-10-17T12:56:06.000Z","author_id":"116716199","lang":"en","conversation_id":"390823534756253697","possibly_sensitive":false,"id":"390823534756253697","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":83,"end":87,"tag":"flu"},{"start":88,"end":97,"tag":"vaccines"}],"urls":[{"start":99,"end":121,"url":"http://t.co/KE1DvoRtdJ","expanded_url":"http://bit.ly/16htHxA","display_url":"bit.ly/16htHxA"}],"mentions":{},"annotations":{}},"text":"Two weeks left to comment on our explanatory note on the withdrawal of guidance on #flu #vaccines: http://t.co/KE1DvoRtdJ","created_at":"2013-10-17T11:03:42.000Z","author_id":"116716199","lang":"en","conversation_id":"390795249695481856","possibly_sensitive":false,"id":"390795249695481856","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":98,"end":105,"tag":"cancer"}],"urls":[{"start":117,"end":139,"url":"http://t.co/5dbmJU4yMi","expanded_url":"http://bit.ly/1etgd7d","display_url":"bit.ly/1etgd7d"}],"mentions":{},"annotations":{}},"text":"Two weeks left to comment on need to revise condition–specific guidance on the evaluation of anti-#cancer medicines: http://t.co/5dbmJU4yMi","created_at":"2013-10-17T11:02:58.000Z","author_id":"116716199","lang":"en","conversation_id":"390795061803233280","possibly_sensitive":false,"id":"390795061803233280","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":85,"end":97,"tag":"biosimilars"}],"urls":[{"start":100,"end":122,"url":"http://t.co/eP6eLuld9g","expanded_url":"http://bit.ly/1etg4k0","display_url":"bit.ly/1etg4k0"}],"mentions":{},"annotations":{}},"text":"Two weeks left to comment on our guideline on similar biological medicinal products (#biosimilars): http://t.co/eP6eLuld9g","created_at":"2013-10-17T11:02:09.000Z","author_id":"116716199","lang":"en","conversation_id":"390794859105103872","possibly_sensitive":false,"id":"390794859105103872","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":64,"end":73,"tag":"parabens"}],"urls":[{"start":113,"end":135,"url":"http://t.co/X7nXdWRWMD","expanded_url":"http://bit.ly/15KxJkS","display_url":"bit.ly/15KxJkS"}],"mentions":{},"annotations":{}},"text":"Two weeks left to comment on our reflection paper on the use of #parabens as excipients in oral human medicines: http://t.co/X7nXdWRWMD","created_at":"2013-10-17T11:01:26.000Z","author_id":"116716199","lang":"en","conversation_id":"390794679215611904","possibly_sensitive":false,"id":"390794679215611904","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":57,"end":68,"tag":"phthalates"}],"urls":[{"start":103,"end":125,"url":"http://t.co/slqCKReqR4","expanded_url":"http://bit.ly/174dVvR","display_url":"bit.ly/174dVvR"}],"mentions":{},"annotations":{}},"text":"Two weeks left to comment on our guideline on the use of #phthalates as excipients in human medicines: http://t.co/slqCKReqR4","created_at":"2013-10-17T11:01:09.000Z","author_id":"116716199","lang":"en","conversation_id":"390794608508030976","possibly_sensitive":false,"id":"390794608508030976","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":94,"end":116,"url":"http://t.co/1PWiatKdsS","expanded_url":"http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON326449","display_url":"mhra.gov.uk/NewsCentre/Pre…"}],"mentions":[{"start":3,"end":13,"username":"MHRApress","id":"330990243"}],"annotations":[{"start":80,"end":92,"probability":0.9657,"type":"Organization","normalized_text":"Wockhardt Ltd"}]},"text":"RT @MHRApress: Medicines watchdog initiates recall of medicines manufactured by Wockhardt Ltd http://t.co/1PWiatKdsS","created_at":"2013-10-17T10:42:03.000Z","author_id":"116716199","lang":"en","conversation_id":"390789800417976320","possibly_sensitive":false,"id":"390789800417976320","source":"TweetDeck","public_metrics":{"retweet_count":17,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"390789532745879552"}]},{"entities":{"hashtags":[{"start":13,"end":21,"tag":"Giotrif"},{"start":23,"end":32,"tag":"afatinib"},{"start":53,"end":58,"tag":"lung"},{"start":59,"end":66,"tag":"cancer"}],"urls":[{"start":96,"end":118,"url":"http://t.co/QX71C4I0RH","expanded_url":"http://bit.ly/1fCB0bA","display_url":"bit.ly/1fCB0bA"}],"mentions":{},"annotations":{}},"text":"The EPAR for #Giotrif (#afatinib) for non-small-cell #lung #cancer is available on our website: http://t.co/QX71C4I0RH","created_at":"2013-10-17T08:28:42.000Z","author_id":"116716199","lang":"en","conversation_id":"390756241196064768","possibly_sensitive":false,"id":"390756241196064768","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":83,"end":87,"tag":"flu"},{"start":88,"end":97,"tag":"vaccines"}],"urls":[{"start":99,"end":121,"url":"http://t.co/Jg6CgtTCcu","expanded_url":"http://bit.ly/16htHxA","display_url":"bit.ly/16htHxA"}],"mentions":{},"annotations":{}},"text":"Two more weeks to comment on our explanatory note on the withdrawal of guidance on #flu #vaccines: http://t.co/Jg6CgtTCcu","created_at":"2013-10-17T08:27:25.000Z","author_id":"116716199","lang":"en","conversation_id":"390755919157805056","possibly_sensitive":false,"id":"390755919157805056","source":"bitly bitlink","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":98,"end":105,"tag":"cancer"}],"urls":[{"start":117,"end":139,"url":"http://t.co/3D36KUfv2W","expanded_url":"http://bit.ly/1etgd7d","display_url":"bit.ly/1etgd7d"}],"mentions":{},"annotations":{}},"text":"Two more weeks to comment on need to revise condition–specific guidance on the evaluation of anti-#cancer medicines: http://t.co/3D36KUfv2W","created_at":"2013-10-17T08:24:46.000Z","author_id":"116716199","lang":"en","conversation_id":"390755252951330816","possibly_sensitive":false,"id":"390755252951330816","source":"bitly bitlink","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":85,"end":97,"tag":"biosimilars"}],"urls":[{"start":100,"end":122,"url":"http://t.co/XJxo6F0G1K","expanded_url":"http://bit.ly/1etg4k0","display_url":"bit.ly/1etg4k0"}],"mentions":{},"annotations":{}},"text":"Two more weeks to comment on our guideline on similar biological medicinal products (#biosimilars): http://t.co/XJxo6F0G1K","created_at":"2013-10-17T08:22:41.000Z","author_id":"116716199","lang":"en","conversation_id":"390754726893355008","possibly_sensitive":false,"id":"390754726893355008","source":"bitly bitlink","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":64,"end":73,"tag":"parabens"}],"urls":[{"start":113,"end":135,"url":"http://t.co/qRK3f3LmIM","expanded_url":"http://bit.ly/15KxJkS","display_url":"bit.ly/15KxJkS"}],"mentions":{},"annotations":{}},"text":"Two more weeks to comment on our reflection paper on the use of #parabens as excipients in oral human medicines: http://t.co/qRK3f3LmIM","created_at":"2013-10-17T08:20:17.000Z","author_id":"116716199","lang":"en","conversation_id":"390754122322153472","possibly_sensitive":false,"id":"390754122322153472","source":"bitly bitlink","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":96,"end":114,"tag":"multiplesclerosis"}],"urls":[{"start":116,"end":138,"url":"http://t.co/HTqUr0CfwF","expanded_url":"http://bit.ly/19SAr9r","display_url":"bit.ly/19SAr9r"}],"mentions":{},"annotations":{}},"text":"Watch the live broadcast of today's EMA workshop on clinical investigation of new medicines for #multiplesclerosis: http://t.co/HTqUr0CfwF","created_at":"2013-10-17T08:19:26.000Z","author_id":"116716199","lang":"en","conversation_id":"390753907766751232","possibly_sensitive":false,"id":"390753907766751232","source":"bitly bitlink","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":57,"end":68,"tag":"phthalates"}],"urls":[{"start":103,"end":125,"url":"http://t.co/8n0mXLH7BN","expanded_url":"http://bit.ly/174dVvR","display_url":"bit.ly/174dVvR"}],"mentions":{},"annotations":{}},"text":"Two more weeks to comment on our guideline on the use of #phthalates as excipients in human medicines: http://t.co/8n0mXLH7BN","created_at":"2013-10-17T08:18:15.000Z","author_id":"116716199","lang":"en","conversation_id":"390753609631412224","possibly_sensitive":false,"id":"390753609631412224","source":"bitly bitlink","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":38,"end":53,"tag":"clinicaltrials"}],"urls":{},"mentions":[{"start":3,"end":19,"username":"eupatientsforum","id":"545343465"}],"annotations":{}},"text":"RT @eupatientsforum: “Transparency of #clinicaltrials data empowers patients to make fully informed decisions” we said at EFGCP meeting htt…","created_at":"2013-10-16T16:08:06.000Z","author_id":"116716199","lang":"en","conversation_id":"390509465973186560","possibly_sensitive":false,"id":"390509465973186560","source":"TweetDeck","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"390509066998403072"}]},{"entities":{"hashtags":{},"urls":[{"start":64,"end":86,"url":"http://t.co/QBzIFavx4w","expanded_url":"http://bit.ly/17tO1Mu","display_url":"bit.ly/17tO1Mu"}],"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"annotations":{}},"text":"RT @AEMPSGOB: Intravenous hydroxyethyl starch: use restrictions http://t.co/QBzIFavx4w","created_at":"2013-10-16T15:37:01.000Z","author_id":"116716199","lang":"en","conversation_id":"390501644112101376","possibly_sensitive":false,"id":"390501644112101376","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":36,"end":46,"tag":"stemcells"},{"start":47,"end":56,"tag":"research"}],"urls":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"text":"RT @EFPIA: Want to learn more about #stemcells #research ? See EFPIA's dedicated page with videos, news, presentation &amp; more! http://t.co/h…","created_at":"2013-10-16T14:40:45.000Z","author_id":"116716199","lang":"en","conversation_id":"390487481876873216","possibly_sensitive":false,"id":"390487481876873216","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"390486637328617472"}]},{"entities":{"hashtags":[{"start":42,"end":50,"tag":"Giotrif"},{"start":52,"end":61,"tag":"afatinib"},{"start":82,"end":87,"tag":"lung"},{"start":88,"end":95,"tag":"cancer"}],"urls":[{"start":97,"end":119,"url":"http://t.co/fjqifNmn4W","expanded_url":"http://bit.ly/1fCB0bA","display_url":"bit.ly/1fCB0bA"}],"mentions":{},"annotations":{}},"text":"We've published the assessment report for #Giotrif (#afatinib) for non-small-cell #lung #cancer: http://t.co/fjqifNmn4W","created_at":"2013-10-16T14:16:04.000Z","author_id":"116716199","lang":"en","conversation_id":"390481272726102017","possibly_sensitive":false,"id":"390481272726102017","source":"bitly bitlink","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":64,"end":86,"url":"http://t.co/E6latJpOzW","expanded_url":"http://www.pharmatimes.com/Article/13-10-15/EMA_launches_new_version_of_EudraCT.aspx","display_url":"pharmatimes.com/Article/13-10-…"}],"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"},{"start":91,"end":103,"username":"PharmaTimes","id":"52354784"}],"annotations":[{"start":25,"end":27,"probability":0.4903,"type":"Organization","normalized_text":"EMA"},{"start":53,"end":59,"probability":0.3009,"type":"Organization","normalized_text":"EudraCT"}]},"text":"RT @EAHPtweet: Article &gt; EMA launches new version of EudraCT http://t.co/E6latJpOzW via @PharmaTimes","created_at":"2013-10-16T12:58:49.000Z","author_id":"116716199","lang":"en","conversation_id":"390461828729294849","possibly_sensitive":false,"id":"390461828729294849","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"390461487870791681"}]},{"entities":{"hashtags":{},"urls":[{"start":56,"end":78,"url":"http://t.co/aer00ekobM","expanded_url":"http://asq.org/qualitynews/qnt/execute/displaySetup?newsID=17124","display_url":"asq.org/qualitynews/qn…"}],"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"}],"annotations":[{"start":15,"end":17,"probability":0.8823,"type":"Organization","normalized_text":"FDA"}]},"text":"RT @EAHPtweet: FDA Seeks Metrics to Define Drug Quality http://t.co/aer00ekobM","created_at":"2013-10-16T12:58:31.000Z","author_id":"116716199","lang":"en","conversation_id":"390461755475755009","possibly_sensitive":false,"id":"390461755475755009","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"390460273196150786"}]},{"entities":{"hashtags":[{"start":26,"end":31,"tag":"H7N9"},{"start":82,"end":92,"tag":"influenza"}],"urls":[{"start":59,"end":81,"url":"http://t.co/FFhVfAKhFd","expanded_url":"http://goo.gl/krzLPq","display_url":"goo.gl/krzLPq"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":[{"start":35,"end":39,"probability":0.997,"type":"Place","normalized_text":"China"}]},"text":"RT @WHO: Latest update on #H7N9 in China (16 October 2013) http://t.co/FFhVfAKhFd #influenza","created_at":"2013-10-16T12:33:30.000Z","author_id":"116716199","lang":"en","conversation_id":"390455459921928192","possibly_sensitive":false,"id":"390455459921928192","source":"TweetDeck","public_metrics":{"retweet_count":55,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"390454590614679553"}]},{"entities":{"hashtags":[{"start":23,"end":27,"tag":"FDA"}],"urls":[{"start":118,"end":140,"url":"http://t.co/YawrBjZFRh","expanded_url":"http://bit.ly/17ttuaD","display_url":"bit.ly/17ttuaD"}],"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"annotations":{}},"text":"RT @FDA_Drug_Info: The #FDA is investigating the medicine Iclusig after an increase in reports of serious blood clots http://t.co/YawrBjZFRh","created_at":"2013-10-16T12:33:10.000Z","author_id":"116716199","lang":"en","conversation_id":"390455375402512384","possibly_sensitive":false,"id":"390455375402512384","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":30,"end":37,"tag":"tender"},{"start":62,"end":74,"tag":"consultancy"},{"start":100,"end":112,"tag":"procurement"}],"urls":[{"start":76,"end":98,"url":"http://t.co/suUSdhvjp7","expanded_url":"http://bit.ly/18SjN71","display_url":"bit.ly/18SjN71"}],"mentions":{},"annotations":{}},"text":"One day left to apply for our #tender for high-level business #consultancy: http://t.co/suUSdhvjp7  #procurement","created_at":"2013-10-16T11:04:44.000Z","author_id":"116716199","lang":"en","conversation_id":"390433119997657088","possibly_sensitive":false,"id":"390433119997657088","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":67,"end":72,"tag":"H7N9"},{"start":101,"end":111,"tag":"influenza"}],"urls":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"text":"RT @WHO: To date, WHO has been informed of 136 lab-confirmed human #H7N9 cases, including 45 deaths. #influenza","created_at":"2013-10-16T10:59:09.000Z","author_id":"116716199","lang":"en","conversation_id":"390431715291693056","possibly_sensitive":false,"id":"390431715291693056","source":"TweetDeck","public_metrics":{"retweet_count":77,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"390424477567180802"}]},{"entities":{"hashtags":[{"start":55,"end":60,"tag":"H7N9"},{"start":102,"end":112,"tag":"influenza"}],"urls":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":[{"start":9,"end":13,"probability":0.9682,"type":"Place","normalized_text":"China"}]},"text":"RT @WHO: China has notified WHO of a new lab-confirmed #H7N9 human case - first since 11 August 2013. #influenza","created_at":"2013-10-16T10:58:45.000Z","author_id":"116716199","lang":"en","conversation_id":"390431614313836544","possibly_sensitive":false,"id":"390431614313836544","source":"TweetDeck","public_metrics":{"retweet_count":83,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"390423625339113472"}]},{"entities":{"hashtags":[{"start":25,"end":38,"tag":"animalhealth"},{"start":103,"end":114,"tag":"foodsafety"}],"urls":{},"mentions":{},"annotations":[{"start":48,"end":53,"probability":0.959,"type":"Place","normalized_text":"Europe"}]},"text":"RT @IFAHEurope: Thanks 2 #animalhealth products Europe manages animal diseases that had posed threat 2 #foodsafety &amp; health: http://t.co/J8…","created_at":"2013-10-16T10:48:57.000Z","author_id":"116716199","lang":"en","conversation_id":"390429150231535616","possibly_sensitive":false,"id":"390429150231535616","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"390418250401476608"}]},{"entities":{"hashtags":[{"start":59,"end":71,"tag":"antibiotics"},{"start":107,"end":112,"tag":"EAAD"}],"urls":[{"start":84,"end":106,"url":"http://t.co/ylbBYmexgc","expanded_url":"http://bit.ly/1bxKwaR","display_url":"bit.ly/1bxKwaR"}],"mentions":[{"start":3,"end":11,"username":"EAAD_EU","id":"1725283578"}],"annotations":{}},"text":"RT @EAAD_EU: Antibiotics do not work for flu or colds. Use #antibiotics responsibly http://t.co/ylbBYmexgc #EAAD","created_at":"2013-10-16T09:57:24.000Z","author_id":"116716199","lang":"en","conversation_id":"390416176217481217","possibly_sensitive":false,"id":"390416176217481217","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":65,"end":74,"tag":"Diabetes"}],"urls":[{"start":97,"end":119,"url":"http://t.co/YMqqTVdfCm","expanded_url":"http://bit.ly/18l2SMC","display_url":"bit.ly/18l2SMC"}],"mentions":[{"start":3,"end":7,"username":"WDD","id":"15179874"}],"annotations":{}},"text":"RT @WDD: What can we expect from the upcoming 6th edition of the #Diabetes Atlas? Find out here: http://t.co/YMqqTVdfCm","created_at":"2013-10-16T09:52:01.000Z","author_id":"116716199","lang":"en","conversation_id":"390414819938955264","possibly_sensitive":false,"id":"390414819938955264","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"390414722215841792"}]},{"entities":{"hashtags":[{"start":13,"end":21,"tag":"Vipidia"},{"start":23,"end":34,"tag":"alogliptin"},{"start":56,"end":65,"tag":"diabetes"}],"urls":[{"start":95,"end":117,"url":"http://t.co/I33aIN2E85","expanded_url":"http://bit.ly/1buHG6D","display_url":"bit.ly/1buHG6D"}],"mentions":{},"annotations":{}},"text":"The EPAR for #Vipidia (#alogliptin benzoate) for type-2 #diabetes is available on our website: http://t.co/I33aIN2E85","created_at":"2013-10-16T08:55:29.000Z","author_id":"116716199","lang":"en","conversation_id":"390400595808358400","possibly_sensitive":false,"id":"390400595808358400","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":30,"end":37,"tag":"tender"},{"start":62,"end":74,"tag":"consultancy"},{"start":99,"end":111,"tag":"procurement"}],"urls":[{"start":76,"end":98,"url":"http://t.co/suUSdhvjp7","expanded_url":"http://bit.ly/18SjN71","display_url":"bit.ly/18SjN71"}],"mentions":{},"annotations":{}},"text":"One more day to apply for our #tender for high-level business #consultancy: http://t.co/suUSdhvjp7 #procurement","created_at":"2013-10-16T08:54:35.000Z","author_id":"116716199","lang":"en","conversation_id":"390400365402660864","possibly_sensitive":false,"id":"390400365402660864","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":52,"end":67,"tag":"ClinicalTrials"},{"start":78,"end":86,"tag":"EudraCT"}],"urls":{},"mentions":[{"start":3,"end":13,"username":"HAIEurope","id":"3314634701"}],"annotations":[{"start":15,"end":17,"probability":0.4819,"type":"Organization","normalized_text":"EMA"}]},"text":"RT @HAIEurope: EMA launches new version of European #ClinicalTrials Database (#EudraCT), but publishing data is not yet mandatory http://t.…","created_at":"2013-10-16T08:52:36.000Z","author_id":"116716199","lang":"en","conversation_id":"390399867492655104","possibly_sensitive":false,"id":"390399867492655104","source":"TweetDeck","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"390399543709159424"}]},{"entities":{"hashtags":{},"urls":[{"start":114,"end":136,"url":"http://t.co/T2wBLSu3Wd","expanded_url":"http://bit.ly/1bxzDWI","display_url":"bit.ly/1bxzDWI"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"text":"RT @GCessak: Information on the recommendations of the PRAC for infusion solutions containing hydroxyethyl starch http://t.co/T2wBLSu3Wd","created_at":"2013-10-16T08:51:20.000Z","author_id":"116716199","lang":"en","conversation_id":"390399547328831488","possibly_sensitive":false,"id":"390399547328831488","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":116,"end":138,"url":"http://t.co/Jlo4IWcFP8","expanded_url":"http://bit.ly/18kTCZ2","display_url":"bit.ly/18kTCZ2"}],"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"annotations":{}},"text":"RT @URPLWMiPB: Information on the recommendations of the PRAC for infusion solutions containing hydroxyethyl starch http://t.co/Jlo4IWcFP8","created_at":"2013-10-16T08:49:24.000Z","author_id":"116716199","lang":"en","conversation_id":"390399062421544960","possibly_sensitive":false,"id":"390399062421544960","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":105,"end":127,"url":"http://t.co/PFd2dOI5GA","expanded_url":"http://bit.ly/18kTuJ0","display_url":"bit.ly/18kTuJ0"}],"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"annotations":{}},"text":"RT @URPLWMiPB: Communication of 16 October 2013 on the infusion solutions containing hydroxyethyl starch http://t.co/PFd2dOI5GA","created_at":"2013-10-16T08:48:21.000Z","author_id":"116716199","lang":"en","conversation_id":"390398799492820993","possibly_sensitive":false,"id":"390398799492820993","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":113,"end":135,"url":"http://t.co/Op5i3MoOYH","expanded_url":"http://bit.ly/16dFRHy","display_url":"bit.ly/16dFRHy"}],"mentions":{},"annotations":{}},"text":"We have published a draft qualification opinion on a statistical methodology for dose finding, for consultation: http://t.co/Op5i3MoOYH","created_at":"2013-10-16T08:44:15.000Z","author_id":"116716199","lang":"en","conversation_id":"390397766167298048","possibly_sensitive":false,"id":"390397766167298048","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":108,"end":130,"url":"http://t.co/YBl7ASwvuz","expanded_url":"http://bit.ly/1bxyrCO","display_url":"bit.ly/1bxyrCO"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"text":"RT @GCessak: Message from the Polish medicines agency on hydroxyethyl-starch-containing infusion solutions: http://t.co/YBl7ASwvuz","created_at":"2013-10-16T08:43:03.000Z","author_id":"116716199","lang":"en","conversation_id":"390397465431519232","possibly_sensitive":false,"id":"390397465431519232","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":112,"end":134,"url":"http://t.co/BKkWEkwCOM","expanded_url":"http://bit.ly/GPunDM","display_url":"bit.ly/GPunDM"}],"mentions":{},"annotations":{}},"text":"Our latest report on sales of veterinary antimicrobials is now available, covering 25 EU/EEA countries in 2011: http://t.co/BKkWEkwCOM","created_at":"2013-10-16T08:42:03.000Z","author_id":"116716199","lang":"en","conversation_id":"390397214305972226","possibly_sensitive":false,"id":"390397214305972226","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":117,"end":139,"url":"http://t.co/lwaS91Mnbz","expanded_url":"http://bit.ly/16dFRHy","display_url":"bit.ly/16dFRHy"}],"mentions":{},"annotations":{}},"text":"We have opened a public consultation on a draft qualification opinion on a statistical methodology for dose finding: http://t.co/lwaS91Mnbz","created_at":"2013-10-15T16:04:15.000Z","author_id":"116716199","lang":"en","conversation_id":"390146106677809152","possibly_sensitive":false,"id":"390146106677809152","source":"bitly bitlink","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":87,"end":91,"tag":"flu"},{"start":92,"end":101,"tag":"vaccines"}],"urls":{},"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{}},"text":"RT @IMI_JU: Sign up for our webinar on 10th Call topic on correlates of protection for #flu #vaccines – 24/10, 15:00 CEST http://t.co/2OozA…","created_at":"2013-10-15T14:11:02.000Z","author_id":"116716199","lang":"en","conversation_id":"390117615219142656","possibly_sensitive":false,"id":"390117615219142656","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"390117489423572993"}]},{"entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":9,"username":"EATGx","id":"273916420"}],"annotations":{}},"text":"RT @EATGx: CAARM Symposium at EACS: On October 16 a symposium on the CHAARM project (Combined Highly Active Anti-Retrovir... http://t.co/8r…","created_at":"2013-10-15T14:10:41.000Z","author_id":"116716199","lang":"en","conversation_id":"390117529227493376","possibly_sensitive":false,"id":"390117529227493376","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"390104423113822208"}]},{"entities":{"hashtags":{},"urls":[{"start":113,"end":135,"url":"http://t.co/nwk2My7Wlt","expanded_url":"http://bit.ly/GPunDM","display_url":"bit.ly/GPunDM"}],"mentions":{},"annotations":{}},"text":"We have published our latest report on sales of veterinary antimicrobials, covering 25 EU/EEA countries in 2011: http://t.co/nwk2My7Wlt","created_at":"2013-10-15T14:02:58.000Z","author_id":"116716199","lang":"en","conversation_id":"390115585532899328","possibly_sensitive":false,"id":"390115585532899328","source":"bitly bitlink","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":42,"end":50,"tag":"Vipidia"},{"start":52,"end":63,"tag":"alogliptin"},{"start":85,"end":94,"tag":"diabetes"}],"urls":[{"start":96,"end":118,"url":"http://t.co/yN5qGqdlqT","expanded_url":"http://bit.ly/1buHG6D","display_url":"bit.ly/1buHG6D"}],"mentions":{},"annotations":{}},"text":"We've published the assessment report for #Vipidia (#alogliptin benzoate) for type-2 #diabetes: http://t.co/yN5qGqdlqT","created_at":"2013-10-15T13:57:47.000Z","author_id":"116716199","lang":"en","conversation_id":"390114282194870272","possibly_sensitive":false,"id":"390114282194870272","source":"bitly bitlink","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":94,"end":116,"url":"http://t.co/GcHCgXQlta","expanded_url":"http://bit.ly/15B9HZr","display_url":"bit.ly/15B9HZr"}],"mentions":{},"annotations":{}},"text":"Companies are encouraged to submit any quality type I variations for 2013 by end of November: http://t.co/GcHCgXQlta","created_at":"2013-10-15T11:37:36.000Z","author_id":"116716199","lang":"en","conversation_id":"390079002636865536","possibly_sensitive":false,"id":"390079002636865536","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":13,"end":22,"tag":"Vipdomet"},{"start":24,"end":35,"tag":"alogliptin"},{"start":38,"end":48,"tag":"metformin"},{"start":61,"end":70,"tag":"diabetes"}],"urls":[{"start":100,"end":122,"url":"http://t.co/IUhVW4OzCE","expanded_url":"http://bit.ly/16JvKhl","display_url":"bit.ly/16JvKhl"}],"mentions":{},"annotations":{}},"text":"The EPAR for #Vipdomet (#alogliptin / #metformin) for type-2 #diabetes is available on our website: http://t.co/IUhVW4OzCE","created_at":"2013-10-15T11:01:46.000Z","author_id":"116716199","lang":"en","conversation_id":"390069987429199872","possibly_sensitive":false,"id":"390069987429199872","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":12,"end":15,"tag":"EU"},{"start":16,"end":24,"tag":"vacancy"}],"urls":[{"start":118,"end":140,"url":"http://t.co/BQCwGjOTCk","expanded_url":"http://goo.gl/tvjuvp","display_url":"goo.gl/tvjuvp"}],"mentions":[{"start":3,"end":10,"username":"EURLex","id":"294028805"},{"start":98,"end":105,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":111,"end":116,"probability":0.9796,"type":"Place","normalized_text":"Lisbon"}]},"text":"RT @EURLex: #EU #vacancy Director of the European Monitoring Centre for Drugs and Drug Addiction (@EMCDDA ) in Lisbon http://t.co/BQCwGjOTCk","created_at":"2013-10-15T10:12:02.000Z","author_id":"116716199","lang":"en","conversation_id":"390057472112619521","possibly_sensitive":false,"id":"390057472112619521","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"390033961713299456"}]},{"entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":11,"username":"EAAD_EU","id":"1725283578"}],"annotations":{}},"text":"RT @EAAD_EU: Many respiratory tract infections are self-limiting and do not require antibiotics. Information for doctors on http://t.co/HOG…","created_at":"2013-10-15T10:10:39.000Z","author_id":"116716199","lang":"en","conversation_id":"390057123515596801","possibly_sensitive":false,"id":"390057123515596801","source":"TweetDeck","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"390040828053180418"}]},{"entities":{"hashtags":[{"start":42,"end":51,"tag":"Vipdomet"},{"start":53,"end":64,"tag":"alogliptin"},{"start":67,"end":77,"tag":"metformin"},{"start":90,"end":99,"tag":"diabetes"}],"urls":[{"start":101,"end":123,"url":"http://t.co/lY42340CXj","expanded_url":"http://bit.ly/16JvKhl","display_url":"bit.ly/16JvKhl"}],"mentions":{},"annotations":{}},"text":"We've published the assessment report for #Vipdomet (#alogliptin / #metformin) for type-2 #diabetes: http://t.co/lY42340CXj","created_at":"2013-10-15T08:13:40.000Z","author_id":"116716199","lang":"en","conversation_id":"390027680999309312","possibly_sensitive":false,"id":"390027680999309312","source":"bitly bitlink","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":13,"end":23,"tag":"Incresync"},{"start":25,"end":36,"tag":"alogliptin"},{"start":39,"end":52,"tag":"pioglitazone"},{"start":65,"end":74,"tag":"diabetes"}],"urls":[{"start":104,"end":126,"url":"http://t.co/kP8yNAaZEm","expanded_url":"http://bit.ly/192i40G","display_url":"bit.ly/192i40G"}],"mentions":{},"annotations":{}},"text":"The EPAR for #Incresync (#alogliptin / #pioglitazone) for type-2 #diabetes is available on our website: http://t.co/kP8yNAaZEm","created_at":"2013-10-15T08:12:00.000Z","author_id":"116716199","lang":"en","conversation_id":"390027263036497920","possibly_sensitive":false,"id":"390027263036497920","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":14,"end":28,"tag":"blacktriangle"}],"urls":[{"start":101,"end":123,"url":"http://t.co/ZzDNIqm0Nk","expanded_url":"http://bit.ly/10EQUGI","display_url":"bit.ly/10EQUGI"}],"mentions":{},"annotations":{}},"text":"What does the #blacktriangle mean? Find out about additional monitoring of medicines with our video: http://t.co/ZzDNIqm0Nk","created_at":"2013-10-15T08:11:03.000Z","author_id":"116716199","lang":"en","conversation_id":"390027022627381248","possibly_sensitive":false,"id":"390027022627381248","source":"Twitter Web Client","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":130,"end":137,"tag":"pharma"}],"urls":[{"start":107,"end":129,"url":"http://t.co/NGpWzE4SwZ","expanded_url":"http://bit.ly/1gtlHhn","display_url":"bit.ly/1gtlHhn"}],"mentions":[{"start":3,"end":13,"username":"TOPRANEWS","id":"26739900"}],"annotations":[{"start":25,"end":45,"probability":0.3037,"type":"Person","normalized_text":"Regulatory Rapporteur"}]},"text":"RT @TOPRANEWS: October's Regulatory Rapporteur looks at the impact of recent pharmacovigilance legislation http://t.co/NGpWzE4SwZ #pharma #…","created_at":"2013-10-14T16:02:26.000Z","author_id":"116716199","lang":"en","conversation_id":"389783261817237504","possibly_sensitive":false,"id":"389783261817237504","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"389783186013556736"}]},{"entities":{"hashtags":{},"urls":[{"start":108,"end":130,"url":"http://t.co/DFHIkKvWtw","expanded_url":"http://bit.ly/1al6rQj","display_url":"bit.ly/1al6rQj"}],"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"annotations":{}},"text":"RT @INFARMED_IP: Annual conference from the Portuguese medicines agency - 'Medicines and health products...\nhttp://t.co/DFHIkKvWtw","created_at":"2013-10-14T15:32:02.000Z","author_id":"116716199","lang":"en","conversation_id":"389775611427684352","possibly_sensitive":false,"id":"389775611427684352","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":48,"end":55,"tag":"pharma"},{"start":79,"end":89,"tag":"medicines"}],"urls":{},"mentions":[{"start":3,"end":12,"username":"cancereu","id":"140344419"}],"annotations":{}},"text":"RT @cancereu: does society share the opinion of #pharma on supply shortages of #medicines as due to man. failures? (live at http://t.co/iXn…","created_at":"2013-10-14T15:18:29.000Z","author_id":"116716199","lang":"en","conversation_id":"389772203396325376","possibly_sensitive":false,"id":"389772203396325376","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"389772067765100544"}]},{"entities":{"hashtags":[{"start":36,"end":46,"tag":"medicines"}],"urls":[{"start":101,"end":123,"url":"http://t.co/iXn1ZT8BhE","expanded_url":"http://ustre.am/Ps5U","display_url":"ustre.am/Ps5U"}],"mentions":[{"start":3,"end":12,"username":"cancereu","id":"140344419"}],"annotations":{}},"text":"RT @cancereu: is supply shortage of #medicines only attributable to manufacturing failures? (live at http://t.co/iXn1ZT8BhE)","created_at":"2013-10-14T15:15:36.000Z","author_id":"116716199","lang":"en","conversation_id":"389771479170043904","possibly_sensitive":false,"id":"389771479170043904","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"389771398144479232"}]},{"entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":12,"username":"cancereu","id":"140344419"}],"annotations":{}},"text":"RT @cancereu: protecting the company's reputation? but if there is malpractice this shouldn't it  be made known? (live at http://t.co/iXn1Z…","created_at":"2013-10-14T15:11:05.000Z","author_id":"116716199","lang":"en","conversation_id":"389770341347639296","possibly_sensitive":false,"id":"389770341347639296","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"389769802182455296"}]},{"entities":{"hashtags":{},"urls":[{"start":75,"end":97,"url":"http://t.co/iXn1ZT8BhE","expanded_url":"http://ustre.am/Ps5U","display_url":"ustre.am/Ps5U"}],"mentions":[{"start":3,"end":12,"username":"cancereu","id":"140344419"}],"annotations":{}},"text":"RT @cancereu: ISPE we try to spot malpractices and remedy to them (live at http://t.co/iXn1ZT8BhE)","created_at":"2013-10-14T15:11:02.000Z","author_id":"116716199","lang":"en","conversation_id":"389770327795855360","possibly_sensitive":false,"id":"389770327795855360","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"389769418969853953"}]},{"entities":{"hashtags":{},"urls":{},"mentions":[{"start":0,"end":9,"username":"cancereu","id":"140344419"}],"annotations":{}},"text":"@cancereu Yes we will.","created_at":"2013-10-14T15:03:50.000Z","author_id":"116716199","lang":"en","conversation_id":"389763740888879105","possibly_sensitive":false,"id":"389768515198021633","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"389763740888879105"}],"in_reply_to_user_id":"140344419"},{"entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"text":"RT @GCessak: EMA workshop on prevention of product shortages due to manufacturing and quality problems takes place today http://t.co/CfpZHV…","created_at":"2013-10-14T14:59:00.000Z","author_id":"116716199","lang":"en","conversation_id":"389767298531065856","possibly_sensitive":false,"id":"389767298531065856","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"389767252947783680"}]},{"entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":13,"username":"AlzDisInt","id":"198970635"}],"annotations":{}},"text":"RT @AlzDisInt: At the moment, there is no known cure for dementia. Long term care must be a priority. Read our report here - http://t.co/UZ…","created_at":"2013-10-14T14:56:36.000Z","author_id":"116716199","lang":"en","conversation_id":"389766696686190592","possibly_sensitive":false,"id":"389766696686190592","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"389766658933280768"}]},{"entities":{"hashtags":{},"urls":[{"start":103,"end":125,"url":"http://t.co/iXn1ZT8BhE","expanded_url":"http://ustre.am/Ps5U","display_url":"ustre.am/Ps5U"}],"mentions":[{"start":3,"end":12,"username":"cancereu","id":"140344419"},{"start":14,"end":23,"username":"EMA_News","id":"116716199"}],"annotations":{}},"text":"RT @cancereu: @EMA_News well said! when the medicines shortage is there we have to see to it! (live at http://t.co/iXn1ZT8BhE)","created_at":"2013-10-14T14:47:40.000Z","author_id":"116716199","lang":"en","conversation_id":"389764448082096128","possibly_sensitive":false,"id":"389764448082096128","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"389762581285462016"}]},{"entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":12,"username":"cancereu","id":"140344419"},{"start":14,"end":23,"username":"EMA_News","id":"116716199"}],"annotations":[{"start":91,"end":96,"probability":0.9931,"type":"Place","normalized_text":"Europe"}]},"text":"RT @cancereu: @EMA_News live discussion on solutions to shortages of drugs, \"hot\" issue in Europe-position of patient groups?http://t.co/lq…","created_at":"2013-10-14T14:34:35.000Z","author_id":"116716199","lang":"en","conversation_id":"389761156237115392","possibly_sensitive":false,"id":"389761156237115392","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"389761032001839105"}]},{"entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"annotations":{}},"text":"RT @euparkinsons: Defining optimal cutoff scores 4 cognitive impairment using MDS task force criteria 4 mild cognitive impairment in PD htt…","created_at":"2013-10-14T14:32:24.000Z","author_id":"116716199","lang":"en","conversation_id":"389760604170227712","possibly_sensitive":false,"id":"389760604170227712","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"389760247427895296"}]},{"entities":{"hashtags":{},"urls":{},"mentions":[{"start":0,"end":9,"username":"cancereu","id":"140344419"}],"annotations":{}},"text":"@cancereu We'll pass the message on.","created_at":"2013-10-14T14:31:51.000Z","author_id":"116716199","lang":"en","conversation_id":"389759765196189696","possibly_sensitive":false,"id":"389760468337696770","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"389759765196189696"}],"in_reply_to_user_id":"140344419"},{"entities":{"hashtags":[{"start":42,"end":52,"tag":"Incresync"},{"start":54,"end":65,"tag":"alogliptin"},{"start":68,"end":81,"tag":"pioglitazone"},{"start":94,"end":103,"tag":"diabetes"}],"urls":[{"start":105,"end":127,"url":"http://t.co/9v38nXy1tL","expanded_url":"http://bit.ly/192i40G","display_url":"bit.ly/192i40G"}],"mentions":{},"annotations":{}},"text":"We've published the assessment report for #Incresync (#alogliptin / #pioglitazone) for type-2 #diabetes: http://t.co/9v38nXy1tL","created_at":"2013-10-14T14:30:04.000Z","author_id":"116716199","lang":"en","conversation_id":"389760019807608832","possibly_sensitive":false,"id":"389760019807608832","source":"bitly bitlink","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":{},"mentions":[{"start":0,"end":9,"username":"cancereu","id":"140344419"}],"annotations":{}},"text":"@cancereu We haven't suggested one for this workshop. Please feel free to use a hashtag of your choice.","created_at":"2013-10-14T14:28:32.000Z","author_id":"116716199","lang":"en","conversation_id":"389742290832334848","possibly_sensitive":false,"id":"389759633230798848","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"389758309231640576"}],"in_reply_to_user_id":"140344419"}]
